Novel routes towards antibiotics using organocatalytic and biocatalytic approaches by Steadman, D
1 
 
 
 
 
NOVEL ROUTES TOWARDS ANTIBIOTICS 
USING ORGANOCATALYTIC AND 
BIOCATALYTIC APPROACHES 
 
A Thesis Submitted to 
University College London 
By 
 
David Steadman 
 
For the Degree of 
Doctor of Philosophy 
 
Christopher Ingold Laboratories 
Department of Chemistry 
University College London 
20 Gordon Street 
London WC1H OAJ 
2 
 
I, David Steadman, confirm that the work presented in this thesis is my own. Where 
information has been derived from other sources, I confirm that this has been 
indicated in the thesis. 
 
 
Signature  
3 
 
Abstract 
Aromatic ketodiols and 2-amino-1,3-diols are present in many interesting 
biologically-active molecules. The aminodiol motif itself is present in the broad-
spectrum antibiotics chloramphenicol and thiamphenicol. This thesis describes 
organocatalytic and biocatalytic approaches to this family of compounds, using 
organocatalysts and transketolase and transaminase enzymes. 
Transketolase (TK) is a ThDP-dependent enzyme which has been used to prepare 
aliphatic ketodiols with good yields and high degrees of stereoselectivity. A 
biomimetic approach to racemic ketodiols has also been reported. Transaminases 
(TAms) are a broad family of enzymes which stereoselectively form amines from 
ketone or aldehyde functionalities. A two-step TK/TAm pathway has already been 
reported which gives access to aliphatic aminodiols, but the preparation of aromatic 
aminodiols using this combined TK/TAm strategy has yet to be investigated. 
A literature review of transketolase, transaminase and biocatalysis in general is 
presented in chapter 1. The substrate scope of the biomimetic TK reaction to prepare 
racemic aromatic ketodiols has been investigated, and an asymmetric variant 
developed which was used to transform aromatic aldehydes in water in up to 50% ee 
(chapter 2). A range of single TK mutants have been used to transform a small range 
of basic aromatic aldehydes (chapter 3) with low yields but good stereoselectivities 
(up to 80% ee). In order to create more active combination mutant TKs, a range of 
mutants were made and tested with aliphatic aldehdyes (chapter 4) to determine what 
combinations of single mutants could be created without sacrificing enzyme 
structure and function. With knowledge gained from this and by further study of the 
TK active-site, a range of combination mutants were then created which accepted a 
range of functionalised benzaldehydes with excellent yields and stereoselectivities 
(<98 % ee, <100% yield, chapter 5). With mutant TKs in hand which could 
transform aromatic aldehydes, the use of two step TK/TAm strategy toward aromatic 
aldehydes was then investigated (chapter 5). Finally, to assess the substrate range of 
TK with regards to donor substrate, a range of novel donor substrates was 
investigated (chapter 6). Mutant TKs were shown to accept several novel donor 
substrates, giving access to chiral ketols with excellent stereoselectivity (>95% ee). 
Possible future work is outlined in chapter 7. 
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1 Introduction 
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1.1 Enzymatic Catalysis in Synthesis 
 
Enzymes possess many attractive qualities for use in organic synthesis. With a 
current industrial focus on “Green Chemistry”,[1] alternative chemical processes are 
being sought which utilise more sustainable reaction conditions and reagents and 
produce less waste than current industrial processes. Enzymatic catalysis can fulfil 
many of these criteria, since many biocatalytic reactions can be performed at 
ambient temperature and pressure, using only water as a solvent. Enzymes are also 
attractive due to the exquisite levels of regio- and stereocontrol that they offer over 
standard chemical techniques, transforming specific chemical functionalities in the 
presence of other functional groups, negating the need for costly protecting group 
strategies. Indeed, since the first report of a biocatalytic reaction to produce (R)-
mandelonitrile from benzaldehyde and hydrogen cyanide using a plant extract,
[2]
 
biocatalysts have been used for over 100 years to produce a wide range of useful 
intermediates and final compounds for the food and flavour,
[3, 4]
 agrochemical,
[5]
 
cosmetic
[6]
 and pharmaceutical
[7, 8, 9, 10]
 industries.  
One of the most powerful examples of biocatalysis to make pharmaceutical 
intermediates is in the production of a precursor of the anti-malarial compound 
artemisinin (1) by engineered baker’s yeast (Scheme 1.1).[11] In this approach toward 
artemisinic acid (2), a direct precursor for the synthesis of artemisinin, the 
mevalonate pathway in baker’s yeast was engineered to allow the production of large 
amounts of farnesyl pyrophosphate (FPP) (3), the required starting material for the 
biosynthesis of the sesquiterpene artemisinic acid (2). This pathway was engineered 
by upregulating genes responsible for FPP (3) production, while downregulating 
genes responsible for the production of sterols which use FPP to make squalene in 
the first step of the steroid synthetic pathway. An extra biosynthetic pathway was 
then introduced into S. cerevisiae from A. annua to enable the conversion of FPP 
into artemisinic acid (2) in four enzymatic steps. The first step in this ‘inserted’ 
pathway was the conversion of FPP into amorpha-4,11-diene (4) by amorphadiene 
synthase, followed by a three step oxidation by a novel cytochrome P450. This gave 
artemisinic acid (2) which was transported out of the yeast cells but remained on the 
cell surface allowing easy extraction of the product from the cell pellet after 
centrifugation. This process was able to produce up to 100 mg/L of product, and 
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coupled with existing synthetic methods to produce artemisinin from artimisinic acid 
offers a sustainable, commercially viable alternative to this high value anti-malarial 
compound, with maximum yields of 25g/L predicted.
[11]
 This compares favourably 
with the shortest reported total synthesis of this compound to date, which was 
performed on a gram scale over 6 steps to give artemisinin (1) in 16% overall total 
yield.
[12]
 
 
 
Scheme 1.1. Biocatalytic formation of artemisinic acid (2) 
 
1.2 Thiamine diphosphate (ThDP) dependent enzymes 
 
Thiamine diphosphate (ThDP) (Figure 1.1) is an important cofactor that assists in 
carbon-carbon bond breaking and formation in many different enzymatic reactions. 
ThDP-dependent enzymes have been widely studied for their abilities to form not 
only carbon-carbon bonds but also carbon-nitrogen, carbon-sulphur and carbon-
oxygen bonds.
[13]
 Most interestingly from a synthetic organic chemistry perspective 
is the broad substrate scope demonstrated by this family of enzymes, allowing many 
non-natural substrates to be accepted and useful synthetic compounds to be accessed 
in a sustainable, atom-efficient fashion.
[13]
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Figure 1.1. Structure of thiamine diphosphate (ThDP) 
 
Many ThDP dependent enzymes demonstrate similar reaction mechanisms. Indeed, 
the reactivity of this family of enzymes derives from the initial reaction of a donor 
substrate (either a ketoacid or aldehyde) with the C-2 atom of thiazolium ring of 
ThDP (Figure 1.1), forming an enamine intermediate. This reactive species can 
couple to an acceptor substrate, forming an asymmetric carbon-carbon bond. The 
diversity of products which can be made by these enzymes is defined by the broad, 
yet distinct, substrate spectrum exhibited by each enzyme within the family, 
examples are given below.
[14]
 
 
1.2.1 Pyruvate decarboxylase (PDC) (EC 4.1.1.1) 
 
The first industrial scale, modern biotechnological process was developed in 1921, 
and utilized a whole cell Baker’s yeast biotransformation to produce (R)-
phenylacetylcarbinol ((R)-PAC, 5),
[13]
 a precursor to the alkaloid (-) ephedrine (6). It 
is now known that the enzyme responsible for this transformation is pyruvate 
decarboxylase (PDC). In this reaction, PDC transfers an activated ethanal unit from 
pyruvate (7) to benzaldehyde (8), to form (R)-PAC (5) (Scheme 1.2). 
 
 
Scheme 1.2. PDC catalysed formation of (R)-PAC (5) 
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(R)-PAC (5) formation occurs as part of a competing side reaction to the non-
oxidative decarboxylation of pyruvate (7), which is the main reaction catalysed by 
PDC, where ethanal (9) is released rather than acting as a reactive species in carbon-
carbon bond formation (Scheme 1.3).
[15, 16]
  
 
 
Scheme 1.3.Overall reaction scheme and mechanism for the in vivo decarboxylation of pyruvate 
(7) by PDC 
 
The first step (step A) is deprotonation of the thiazolium ring to form carbanion 10, 
which then adds to the α-keto acid, pyruvate (7). This is followed by subsequent 
protonation, decarboxylation (step C) and formation of the active enamine 
intermediate (11) which can then be protonated (step D) by a conserved glutamic 
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acid residue (E473). Subsequent deprotonation and reformation of the thiazolium 
ring releases ethanal (9) as a product.  
PDC has been shown to accept a range of linear and branched α-keto acids, and can 
be used to form ketols, such as in the formation of (R)-PAC (5) (Scheme 1.2).
[14]
 
PDC is available from variety of sources, however PDCs from Saccharomyces 
cerevisiae and Zymomonas mobilis have been the most widely studied and so are 
frequently used in organic synthesis. The crystal structure of PDC from Z. mobilis 
was solved in 1998 and shown to be comprised of 4 subunits.
[17]
 The mechanism of 
PDC catalysed ketol formation is similar to that of other ThDP dependent enzymes 
(Scheme 1.4) but differs from the main decarboxylation reaction (Scheme 1.3) at 
step D, where the enamine intermediate goes on to attack an acceptor aldehyde 
substrate, such as benzaldehyde (8), instead of being protonated (Scheme 1.4).
[15]
 
Studies aimed at increasing the activity of PDC from Z. mobilis toward 
benzaldehyde, to improve production of (R)-PAC (5), focussed on the mutation of a 
conserved E473 residue.
[15]
 This residue was chosen as it had been shown to be 
important for orienting the donor substrate carboxylate to aid decarboxylation and 
also to act as an acid to protonate active ThDP-enamine intermediate 11. In the 
reaction mechanism of the PDC catalysed decarboxylation of pyruvate (Scheme 1.3) 
E473 aids decarboxylation in step C and protonates the enamine intermediate (11) in 
step D. Hence, mutation of this residue to glutamine would prevent protonation of 
the enamine intermediate (11), stalling the reaction at this stage, preventing the 
enzyme from releasing the decarboxylated product (9) and favouring attack of the 
enamine (11) on the acceptor aldehyde substrate (8) (Scheme 1.4). Indeed, E473Q 
exhibited a 20-fold higher reaction rate for (R)-PAC (5) production and 2-4 fold 
increased yields compared to the wild-type enzyme (up to 98% yield) with no 
negative effect on the stereoselectivity of the new enzyme (>98% ee).
[15]
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Scheme 1.4. Overall reaction scheme and mechanism of pyruvate decarboxylase catalysed ketol 
formation 
 
1.2.2 Benzoylformate decarboxylase (BFD) (EC 4.1.1.7) 
 
Benzoylformate decarboxylase (BFD) is another ThDP dependent enzyme that has 
been investigated for use in biocatalysis. It is available from several sources, but 
only BFD from Pseudomonas putida has been studied for its potential use in 
biocatalysis.
[18]
 The crystal structure was solved in 1998, and BFD was shown to be 
tetrameric,
[19]
 having a similar structure to PDC from Z. mobilis.
[17]
 Indeed, BFD 
decarboxylates benzoylformate using an analogous mechanism to that by which PDC 
decarboxylates pyruvate. BFD is synthetically useful for its ability to form 
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asymmetric carbon-carbon bonds (Scheme 1.5), and it accepts a range of donor 
substrates including benzaldehyde (8). When ethanal (9) is used as the acceptor 
substrate, chiral ketols such as 12 can be accessed.
[20]
 
 
 
Scheme 1.5. Overall reaction scheme and mechanism of BFD catalysed ketol formation 
 
Step A proceeds in a similar fashion as for the PDC mechanism (Scheme 1.3), but 
the active enamine intermediate (13) is formed by addition of carbanion 10 to an 
aldehyde substrate (8) as opposed to a ketoacid. Attack of the resulting enamine 
intermediate (13) on an acceptor aldehyde (8), followed by deprotonation and 
subsequent reformation of the thiazolium ring releases the ketol product 12. A wide 
range of acceptor substrates have been reported to be accepted by BFD including; 
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benzaldehydes (1, 2, and 3-substituted, and 3, 5-disubstituted), heteroaromatic 
aldehydes, aliphatic and cyclic aldehydes.
[20]
 Using ethanal (9) as an acyl acceptor, 
BFD has been shown to form the (S)-2-hydroxyketone product in each case, in 
variable conversion yields (up to 100%) and stereoselectivities (up to 99% ee).
[20]
 
BFD can also accept benzaldehyde (8) as the acyl acceptor, and in a condensation 
reaction with another benzaldehyde molecule, was shown to form the benzoin 
product with excellent stereoselectivity (>99% (R)), albeit with very low conversion 
(0.4%).
[20]
  By creating a mutant of BFD, H281A, it was possible to access crossed 
benzoin products (14). Using 2-chlorobenzaldehyde (15) as the acceptor molecule 
(Scheme 1.6),
[21]
 3-formylbenzonitrile (16) (>99% conversion, 90% ee), 4-
bromobenzaldehyde (17) (90% conversion, 95% ee) and 4-
(trifluoromethyl)benzaldehyde (18) (75% conversion, 93% ee) were all transformed 
with high degrees of selectivity for the (R)-enantiomer.  
 
 
Scheme 1.6. Crossed benzoin formation catalysed by BFD mutant, H281A 
 
1.2.3 Transketolase (EC 2.2.1.1) 
 
The enzyme transketolase (TK) was first identified in 1953
[22]
 in the yeast 
Saccharomyces cerevisiae. Since then, TK been characterised, from a variety of 
sources, as a dimer composed of two identical subunits, each with a mass of 74 kDa, 
with the active site located at the interface of these two subunits.
[23] 
TK has been 
shown to have a crucial role in metabolic regulation in animals, catalysing ketol 
transfer in the non-oxidative branch of the pentose phosphate pathway (Scheme 1.7), 
while in plants and photosynthetic bacteria the reverse reactions are catalysed as part 
of carbon dioxide fixation in the Calvin cycle.
[24]
 In organic chemistry, the synthetic 
application of transketolase has been widely studied due to its value in 
stereoselective carbon-carbon bond formation.
[25] 
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1.2.4 TK Function in vivo 
 
In vivo, TK catalyses the reversible transfer of a two carbon ketol unit (also known 
as “activated glycolaldehyde”) from D-xylulose-5-phosphate (19) to D-ribose-5-
phosphate (20), in the presence of the co-factors Mg
2+
 and thiamine diphosphate 
(ThDP), to form D-sedoheptulose-7-phosphate (21) and glyceraldehyde-3-phosphate 
(22) (Scheme 1.7), in a key step of the pentose phosphate pathway.
[23]
  
 
 
Scheme 1.7. TK-catalysed reaction in vivo 
 
These reactions are fully reversible; the products of the reaction can also act as donor 
and acceptor substrates for the reverse reaction. Transketolase can be made more 
synthetically useful if hydroxypyruvate (HPA) (23) is employed as the ketol donor 
(Scheme 1.8), as the concomitant generation of carbon dioxide renders the reaction 
irreversible. A range of aldehydes, such as propanal (24), have been shown to be 
accepted by E.coli TK with HPA (23) as the donor substrate, giving access to 
ketodiol products, such as 25.
[25, 26] 
 
 
Scheme 1.8. TK-catalysed reaction in vitro with HPA as ketol donor 
 
1.2.5 Mechanism of TK catalysis 
 
TK catalyses the transfer of ketol groups from donor ketoses, such as HPA (23), to 
acceptor aldose substrates, usually an aldehyde, such as propanal (24) (Scheme 
1.9).
[24]
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The first step of catalysis (step A) is deprotonation of the C-2 atom of the thiazolium 
ring of ThDP leading to the formation of ylid 10. This is followed by nucleophilic 
attack of the carbanion on the ketose donor substrate (23). After nucleophilic attack, 
protonation of the carbonyl oxygen occurs followed by proton abstraction at the C-3 
hydroxyl group of the substrate leading to elimination of carbon dioxide and the 
formation of an enamine (step C), which then attacks the aldose acceptor substrate 
(24) (step D). This is followed by deprotonation from the enol unit of the “active 
glycoaldehyde” reforming the thiazolium ring and releasing the ketodiol product (25) 
(step E).
[24] 
The use of HPA (23) as a ketose donor in the in vitro reaction (Scheme 
1.8) renders the reaction irreversible, as the generation of carbon dioxide in the step 
before enamine formation (step C) is irreversible, driving the equilibrium towards 
the formation of products. The main drawback with using HPA (23), however, is that 
since the reaction is irreversible a proton will be consumed for each reaction cycle, 
raising the pH beyond the optimum of 7.5. This must be taken into account either by 
using buffering medium or by the addition of acid throughout the reaction.
[25]
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Scheme 1.9. Overall reaction scheme and mechanism for the in vitro TK reaction with HPA (23) 
as the ketol donor 
 
1.2.6 Sources of transketolase 
 
Transketolase has been isolated from a wide range of sources including: pig liver,
[27]
 
rat liver,
[28]
 rabbit liver,
[29]
 Candida utilis,
[30]
 mouse brain
[31]
 and human 
leukocytes
[32]
 and erythrocytes,
[33]
 though commonly for synthetic purposes it has 
been isolated from Baker’s yeast and spinach.[34] It can also be isolated from E. coli, 
where it has been over-expressed, giving access to substantial quantities of the 
enzyme which has proven to be useful for integration into industrial processes.
[35]
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1.2.7 Mutation and study of yeast transketolase 
 
TK from Saccharomyces cerevisiae was the first ThDP dependent enzyme for which 
a crystal structure was solved
[36]
 and the crystal structure of the enzyme with the 
acceptor substrate erthyrose-4-phosphate bound allowed the molecular basis for 
catalytic activity to be studied in detail (Figure 1.2).
[37]
 
Figure 1.2 Representation of ThDP adduct in the active-site of yeast TK with the function of 
conserved residues indicated (adapted from
[37]
) 
 
Site directed mutagenesis of the E162 amino acid residue allowed subunit-subunit 
interactions to be probed, and showed that this residue was crucial for formation and 
stabilization of the transketolase dimer.
[38]
 Replacement, by mutagenesis, of the 
E418 residue with glutamine and alanine gave an insight into ThDP activation. Both 
E418Q and E418A mutants showed a marked decrease in catalytic activity even 
though ThDP affinities were comparable to wild-type TK, showing that hydrogen 
bonding between ThDP and E418 was not required for ThDP binding but was 
essential for catalytic activity.
[39]
 The molecular basis for substrate binding and 
recognition was investigated by the substitution of H69
[40]
 (not shown) and H103 
with alanine residues, resulting in a substantial decrease in catalytic activity.
[41]
 This 
showed that these residues were crucial for substrate recognition and binding by the 
formation of hydrogen bonds with the C-1 hydroxyl group of the sugar 
phosphate.
[41],[40]
 The stereospecificity of the enzyme was attributed to the D477 
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residue which forms a hydrogen bond with the C-2-hydroxyl group of the acceptor 
substrate.
[41]
 Substitution of this residue for alanine gave a greatly reduced activity 
towards natural substrates as the hydrogen bonding which was present between the 
substrate and alanine was now disrupted, with no hydrogen bonding between the 
substrate and the new residue (Figure 1.2).
[42]
  
Since writing this thesis, the Hanefeld group has created a library of double mutant 
yeast TKs, using an in silico modelling approach, focused on the natural phosphate 
binding region.
[43]
 Five double mutants were found which increased the activity of 
yeast TK towards a non-phosphorylated substrate, glycolaldehyde, by up to 4-
fold.
[43]
 These libraries were screened using a novel GC-based assay which involved 
making trimethylsilyl derivatives of biotransformation products. This assay was 
shown to be very sensitive, and was able to detect bioconversions down to levels of 
1%.
[44]
 
 
1.2.8 Mutation and study of E. coli TK 
 
E. coli TK is of great interest synthetically as it has been shown to have a 30-fold 
higher specific activity towards the non-natural ketol donor, lithium-HPA (Li-23), 
and a broad tolerance for hydroxylated aliphatic aldehyde substrates, compared with 
yeast or spinach TK.
[45]
 However, its acceptance of non α-hydroxylated substrates, 
such as propanal, is poor with activities typically 5-35% less than for hydroxylated 
substrates.
[35]
 Mutants of E. coli TK have been created by various methods to 
increase substrate tolerance towards non-natural substrates, improving yields and 
stereoselectivities.
[46, 47]
 
Using directed evolution, two complementary methods were adopted to select E. coli 
TK active-site residues for modification to increase activity towards the non-natural 
substrate, glycolaldehyde (26, Scheme 1.10).
[46] 
The first approach was based simply 
on nearby residues in the active site, selecting all residues within 4 Å of the bound 
substrates (first shell mutants). The other set of residues was chosen on a 
phylogenetic basis, using residues within 10 Å of the bound substrates which have 
varied across bacterial and yeast TK evolution (second shell) (Figure 1.3).
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Figure 1.3. Structure of ThDP in the active site of E. coli TK, with 1st shell (green) and 2nd shell 
(cyan) amino acid residues. (Used with permission from Elsevier).
[46]  
 
By screening these mutants for the conversion of HPA (23) and glycolaldehyde (26) 
to erythrulose (27) (Scheme 1.10), several mutant TKs (both first and second shell) 
were identified with higher activities than wild-type. These were: H461S, R520V, 
A29E and A29D. The high activities for H461S and R520V with this non-natural 
substrate were attributed to their position in the phosphate-binding region at the 
entrance to the active-site, allowing non-phosphorylated substrates to enter.
[46]
 A29 
is a second shell mutant with a methyl side-chain which is in direct contact with the 
ThDP terminal phosphate; mutation of this residue appeared to directly affect the 
catalytic mechanism of TK. Indeed, A29E gave a 3-fold increase in activity relative 
to WT with the acceptor glycolaldehyde (26).
[46]  
 
 
Scheme 1.10 TK biotransformation of glycolaldehyde (26) to erythrulose (27) using HPA (23) as 
the donor substrate 
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Further work has been carried out to tune the specificity of TK towards non-
hydroxylated aldehyde substrates in order to improve the industrial viability of TK 
bioconversions with lipophilic substrates. By following the reaction of propanal (24) 
and Li-HPA (Li-23) to form ketodiol 25 (Scheme 1.11), five mutants were found 
with increased activity relative to wild-type; D469E, D469A, D469Y, D469T and 
R520V.
[47]
  
 
 
Scheme 1.11 TK biotransformation of propanal (24) to ketodiol (25) using HPA (23) as the 
donor substrate 
 
The D469 mutants were not previously identified as increasing the activity of the 
enzyme towards α-hydroxylated substrates,[46] but the analogous residue in yeast TK, 
D477, had been shown to be crucial for the binding of hydroxylated substrates.
[42]
 In 
E.coli TK, D469 interacts with the C-2 hydroxyl group of the natural substrates, but 
when propanal is used as the substrate, this hydroxyl group is now a methyl group. 
Therefore, high activity mutants were expected to have hydrogen bonding side-chain 
moieties replaced with non-polar groups to improve interactions with the new 
substrate. This is most likely to be why the D469 mutants, D469Y and D469T, 
showed increased specificity towards propanal compared to glycolaldehyde.
[47]
 
These studies clearly showed that active-site mutants could increase the activity and 
substrate specificity of the enzyme. However, stereoselectivities had not been 
considered. Since wild-type TK was shown to convert propanal with only 58% ee 
(3S-major isomer),
[48] 
mutations of active site residues were considered which could 
also improve the stereoselectivity of carbon-carbon bond formation (Scheme 1.11). 
D477 in yeast TK had previously been shown to be important in determining the 
stereoselectivity of the TK reaction.
[42]
 The importance of the analogous residue in E. 
coli TK, D469, in accepting hydroxylated substrates had been demonstrated, since 
mutation of this residue improved selectivity towards non-hydroxylated substrates 
such as propanal.
[46] 
Also, from studies of analogous residues in yeast TK, D469, 
H26 and H100 were shown to form a pocket and interact with the C-2 hydroxy group 
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of natural α-hydroxylated aldehyde substrates, affecting the stereoselectivity at this 
position and making them obvious choices for mutations to affect changes in 
stereoselectivities. The D469 mutants showed some good activities, as already 
discussed. When the stereoselectivities were assessed, D469E was shown to convert 
propanal with 90% ee for the 3S- product (25). Interestingly, several mutations of 
H26 were shown to reverse the stereoselectivity compared to wild-type, the best 
result being with H26Y which gave 88% ee for the 3R-product.
[48]
 A similar trend 
was shown in biotransformations of other longer-chain aliphatic aldehydes,
[26]
 with 
D469E favouring the formation of 3S-products and H26Y favouring 3R-product 
formation (Scheme 1.12).  
 
 
Scheme 1.12 Biotransformation of aliphatic aldehydes by D469E and H26Y TK 
 
For C3 to C9 aliphatic aldehydes (Scheme 1.12, R = C2H5 – C8H17), D469E showed 
improved stereoselectivities and activities compared to wild-type TK, while H26Y 
showed reversed stereoselectivities for C3 and C8. Interestingly, D469E gave greater 
than 99% ee when using the C3 and C5 cyclic aldehydes (Scheme 1.12, R = C3H5 and 
R = C5H9) and 97% ee for the C6 cyclic aldehyde (Scheme 1.12, R = C6H11). All 
isolated yields were comparable to, or better than, those obtained from wild-type 
TK.
[26]
  
Since writing this thesis, Yi et al, have published a pH-based high-throughput assay 
for TK.
[49]
 This assay was based on using phenol red as an indicator to measure the 
increase of pH which occurs when HPA is used in the TK reaction. The observed 
colour change was followed spectrophotometrically to allow specific activities to be 
calculated. WT, D469E and H26Y E. coli TKs, and WT yeast TK, were tested with 
this assay against a range of hydroxylated and non-hydroxylated non-natural 
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aldehdye substrates. This study confirmed that D469E was indeed more active 
towards non-hydroxylated aliphatic aldehydes, such as propanal, than either E.coli or 
yeast WT TKs, and was also more stereoselective.
[49]
 
The low yields but high stereoselectivities obtained for D469E with cyclic aldehydes 
suggested the possibility of transforming aromatic aldehydes (although the reactivity 
of aromatic aldehydes would be expected to be different). The only previous work 
with aromatic aldehydes and TK was performed with yeast and spinach TKs, where 
the enzymatic reactions were followed by HPLC and the consumption of HPA was 
monitored as evidence of reaction progress. No products were isolated from the 
reactions; yields and optical purities were not established, and since HPA has been 
shown to degrade during the TK reaction, it was unclear whether any ketodiol 
products were actually generated.
[34]
 Thus, if D469 mutants which accepted cyclic 
aldehydes could be used to transform aromatic aldehydes, this would represent the 
first example of aromatic ketodiol formation by mutant TKs. 
 
1.2.9 Biomimetic transketolase reaction 
 
A biomimetic TK reaction (Scheme 1.13) has been reported in which the tertiary 
amine N-methylmorpholine (NMM) (28) mediated carbon-carbon bond formation, 
using Li-HPA (Li-23) as a ketol donor group.
[50]
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Scheme 1.13. Overall reaction scheme and initial postulated mechanism for the NMM-catalysed 
biomimetic TK reaction
[50]
 
 
Aliphatic, α-hydroxylated and aromatic aldehydes were all tolerated in this reaction, 
showing its value for the preparation of racemic substrates (25).
[50]
 A postulated 
reaction mechanism (Scheme 1.13) included the conjugate addition of the tertiary 
amine to the enol (29) form of 23 or by direct addition to the tartronic semialdehyde 
(30) to generate enolate 31. Addition of the aldehyde (24) followed by proton 
transfer, decarboxylation and amine elimination would give the dihydroxyketone 
product (25). This reaction has proved to be useful in the preparation of racemic 
dihydroxyketone products which can be used as standards in the development of 
chiral assays to establish the optical purity of subsequent biotransformations.
[48]
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1.3 Use of TK in organic synthesis 
1.3.1 Spinach transketolase in synthesis 
 
Spinach TK has been used to prepare “naturally-labelled” molecules for use in the 
food and flavour industry.
[3]
 As opposed to synthetic products, nature identical 
alternatives are produced entirely by enzymatic “natural” processes and are therefore 
more desirable to consumers and of higher commercial value.
[51] “Naturally-labelled” 
molecules are typically made either by extraction from appropriate sources, or by 
biocatalytic processes.
[3] 
Spinach TK has been employed in the preparation of 
“natural-labelled” 6-deoxy-L-sorbose (32), a precursor of furaneol (33) which is an 
aromatic compound used industrially for its caramel-like flavour.
[51] 
Several different 
techniques were used in this synthesis (Scheme 1.14), including the enzymatic 
generation of HPA (23) from L-serine (34) using glyoxylate aminotransferase 
(SGAT) from spinach, and the microbial isomerisation of 4-deoxy-L-erythrulose (35) 
to 4-deoxy-L-threose (36) using intact cells of Corynebacterium equi or Sratia 
liquefaciens. Spinach TK was used in the final step to couple 4-deoxy-L-threose to 
HPA to yield 6-deoxy-L-sorbose (32) in 35% total yield. Transketolase was also used 
to prepare the “natural” 4-deoxy-L-erythrulose (35) from the coupling of HPA (23) 
with naturally available ethanal (9). 
 
 
Scheme 1.14. Synthesis of "natural-labelled" 6-deoxy-L-sorbose (32) using spinach transketolase 
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1.3.2 E. coli transketolase in synthesis 
 
The use of E. coli TK in multigram synthesis has been previously demonstrated in 
the coupling of 3-O-benzylglyceraldehyde (37) with Li-HPA (Li-23) in unbuffered 
medium (Scheme 1.15).
[52]
 The reaction was performed in an auto-titrator which 
maintained the pH of the reaction at 7 through the controlled addition of HCl. This 
product was then used in the subsequent synthesis of a potential glycosidase 
inhibitor (38),
[53]
 where the starting material was the triol (39) obtained from the 
initial TK reaction step (Scheme 1.15). After the TK mediated synthesis of 5-O-
benzyl-D-xylulose (39) in 80% yield, the next step was conversion to the silylated 
oxime (40), firstly by silylation (TBSOTf, triethylamine, 83% yield), then oxime 
formation (hydroxylamine hydrochloride, KHCO3, 71% yield, 2:1 mixture of (E)-
and (Z)-geometric isomers) and finally further treatment with TBSOTf and 
triethylamine with 95% yield. Debenzylation was achieved using a 10% Pd-C 
catalyst under hydrogen, to yield the alcohol quantitatively. This was then oxidised 
to aldehyde 41 using NaOCl and catalytic TEMPO in 60% yield. Treatment of 41 
with triethyl orthoformate and catalytic p-toluenesulfonic acid formed the oxazine 
(42) (no reported yield), which was reduced with sodium cyanoborohydride in acetic 
acid to give 43 as a single diastereoisomer (R) in 37% yield. Finally, desilylation was 
achieved using HF in 1:1 acetonitrile:THF which gave 38 in quantitative yield.
[53]
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Scheme 1.15. Synthetic route towards a novel N-hydroxypyrrolidine (38) using TK mediated 
carbon-carbon bond formation in the first step 
 
1.3.3 Large scale process development 
 
While the use of transketolase on a preparative scale has been shown to be useful in 
an organic laboratory environment,
[3], [52],[53]
 the use of transketolase for organic 
synthesis on an industrial scale will depend on its suitability for integration into 
novel and existing industrial processes. As a model large scale reaction, the E. coli 
TK-mediated coupling of Li-HPA (Li-23) and glycolaldehyde (26) to produce L-
erythrulose (27) (Scheme 1.16) has been studied and the important characteristics of 
the reaction evaluated from an industrial perspective.
[54]
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Scheme 1.16. Model TK catalysed carbon-carbon bond formation reaction of Li-HPA (Li-23) 
and glycolaldehyde (26) to generate L-erythrulose (27) 
 
The parameters investigated were; substrate solubility, pH, and the concentration of 
substrates. This investigation showed that both the substrates and products were 
sensitive to alkaline environments, with degradation observed for pH >8. This is 
most important with respect to the expense of using HPA as a ketol donor. The lower 
pH limit was due to enzyme stability, as below pH 6.5 TK was shown to be 
irreversibly denatured. The optimum pH range for TK activity was therefore shown 
to be 7.0-7.5 in the absence of buffer solution. Glycolaldehyde (26) was shown to 
deactivate the enzyme at a rate proportional to its concentration, decreasing the half-
life of the enzyme from ~65 hours at 50 mmol to ~3.5 hours at 500 mmol.
[54]
 This 
will clearly be an important factor in large scale reactions, depending on the 
concentration and type of aldehyde used, necessitating either the removal of excess 
aldehyde or use of a repetitive batch process to avoid toxic levels of substrate.
[55] 
The 
product, L-erythrulose (27), is itself a ketol donor and has been shown to have a 
deactivating effect on the enzyme, albeit to a lesser extent than glycolaldehyde.
[55]
 
The use of in-situ product removal (ISPR) techniques exploiting phenylboronate-diol 
interactions has been investigated. However, removal of L-erythrulose by this 
method was not effective, and free phenylboronic acid was shown to be toxic to the 
enzyme.
[56]
 Immobilized boronates showed the greatest potential but exhibited high 
levels of non-specific binding to substrates. To overcome the low selectivity of 
binding, substrate feeding of glycolaldehyde and immobilisation of TK was 
employed and ISPR using immobilised phenylboronate resin allowed the reaction to 
reach completion.
[56]
  
Enzyme immobilisation is a potential technique to increase the activity and stability 
of transketolase.
[57]
 Enzymes can lose catalytic activity in many different ways 
during a reaction. This can be due to substrate/product inhibition or denaturation due 
to reaction conditions such as temperature, pH or high concentrations of reactants.
[57]
 
By immobilisation onto two commercial supports, Eupergit-C and Amberlite XAD-
7, TK stability and activity was reported to increase.
[57]
 Immobilised enzyme was 
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shown to lose only 50% of its activity after two months of storage under nitrogen. It 
was thought the nitrogen environment prevented the oxidation of C159 in the ThDP-
binding site, which had been shown to promote enzyme deactivation.
[56]
 The stability 
of the enzyme with regards to glycolaldehyde concentration was also improved. The 
immobilised enzyme lost no activity after six hours of operation at 500 mM 
concentration of glycolaldehyde, while the free enzyme exhibited a half-life of less 
than an hour under the same conditions. 
In the end, the suitability of TK for use in large scale industrial processes will 
depend on the specific reaction environment (substrates, reagents, temperature, pH, 
etc.). Different techniques will need to be combined and altered, to ensure the 
enzymatic reaction is viable, as well as employing enzyme mutagenesis to improve 
enzyme stabilities. 
 
1.4 Transaminase 
 
1.4.1 Function in vivo  
 
Transaminases (TAms), or aminotransferases, are a class of metabolic enzymes 
which catalyse the reversible transfer of an amino group from an amine donor to an 
acceptor aldehyde or ketone. TAms are ubiquitous in nature as they play an 
important role in nitrogen metabolism in cells, indeed, most organisms will have 
several different TAms with differing substrate specificities. The sheer number of 
TAms makes them attractive candidates for use in biocatalysis, along with the 
potential for good enantio- and regio-selectivities, broad substrate tolerance, high 
reaction rates and good enzyme stabilities.
[58]
 
 
1.4.2 Mechanism of catalysis 
 
The co-factor for all transaminases is pyridoxal 5’-phosphate (PLP, 44, Figure 1.4), a 
form of vitamin B6 which acts as a co-factor for various amino acid metabolising 
enzymes.
[59]
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Figure 1.4. Structure of PLP (44) 
 
The mechanism by which TAms catalyse amine transfer consists of two half 
reactions (Scheme 1.17). The first half reaction involves the transfer of an amino 
group from the amino donor to PLP (44) to form pyridoxamine phosphate (PMP) 
(45). The second half reaction involves the transfer of the amino group from PMP 
(45) to an acceptor aldehyde or ketone moiety.
[60]
 PLP (44) is secured in the enzyme 
active site via an imine bond formed between the aldehyde group of PLP and a 
conserved lysine residue. In the first catalytic step this lysine residue is displaced by 
the introduction of an amine donor, forming an external aldimine (46) (step A). A 
quinoid (47) is then formed by abstraction of a proton form the α-carbon (step B), 
which is then protonated to from a ketimine intermediate (48) (step C). Subsequent 
hydrolysis releases the α-ketoacid derived from the amine donor, forming PMP (45) 
and completing the first half reaction (step D). The second half reaction begins with 
the formation of a Schiff base (49) between PMP and the acceptor α-ketoacid (step 
E), which upon proton abstraction (step F) and protonation of the resulting imine 
(50) (step G), gives another external aldimine (51). The newly formed amino acid is 
then displaced (step H) either by the conserved lysine residue, directly by another 
amine donor or by water to reform PLP (44). 
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Scheme 1.17 Overall reaction scheme and the combined half-reactions of the in vivo 
transaminase reaction 
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1.4.3 Classes of transaminase enzymes 
 
There is a diverse range of transaminases, as all organisms have numerous 
transaminase enzymes covering a range of functions in nitrogen metabolism. The 
first attempt to classify these enzymes was based on sequence homology of the 
available amino acid sequences. This approach allowed TAms to be divided into four 
groups based on their primary structure similarity.
[61]
 A more recent classification 
attempt using a larger database of newly identified TAm sequences allowed further 
diversification in classes of TAms to be made, with class I subdivided into two 
classes (class I and II) and class VI containing sugar aminotransferases.
[58]
 However, 
only classes I, II, IV and V actually catalyse amino group transfer to keto acids.
[62]
 
Class III TAms appear to be more useful as biocatalysts, as they have a broader 
substrate tolerance and can transfer amino groups to many different aldehyde and 
ketone containing substrates.
[62]
 As well as being divided into six classes, TAms can 
be identified as being α, β, γ, δ, ε or ω. This nomenclature refers to the position of 
the amino group in the donor substrate. It is possible for enzymes from the same 
class of TAm to exhibit different positional specificity, since they are classified by 
their total sequence similarity, not substrate acceptance. 
[62]
 
 
1.4.4 Omega transaminases (ω-transaminases) 
 
Omega transaminases are class III transaminase enzymes and are interesting from a 
biocatalysis perspective due to their broad substrate tolerance. The omega 
nomenclature refers to their acceptance of the amine group in any position of the 
amino donor molecule. The first ω-transaminase to be studied was ω-amino acid-
pyruvate-aminotransferase from Pseudomonas sp. F-126.
[63]
 This enzyme was shown 
to have good activity for a host of amino donors, including a range of amino acids, 
amines and diamines. Interestingly, despite this broad donor tolerance, the enzyme 
was specific for pyruvate as an acceptor molecule, and was inactive with a range of 
other acceptors.
[64]
 However, for biocatalytic applications it is important to have a 
biocatalyst which accepts a range of acceptors as well as donors. To that end, the ω-
transaminase from Vibrio fluvialis (V. fluvialis) was studied and shown to have 
activity not only towards the expected α-keto acids, but also aldehydes such as 
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propanal and interestingly, benzaldehyde.
[65]
 Improved substrate tolerance was 
demonstrated by a TAm cloned from Chromobacterium violaceum DSM30191 
which showed 38% sequence similarity to the V. fluvialis enzyme. This TAm, 
referred to as CV2025, showed increased activity towards a range of aliphatic and 
aromatic aldehydes, suggesting that the enzyme might be useful for use in amination 
in biotechnological applications.
[66]
 
 
1.5 TAms in organic synthesis 
 
Chiral amines and amino acids are valuable pharmaceutical synthons, and are also 
useful in industry, nutrition and health care. Transaminases are increasingly being 
used to address the problems inherent in preparing compounds of this nature.
[67]
 For 
example, a range of commercially available ω-transaminases have been used in the 
preparation of an analogue of 3-aryl-γ-aminobutyric acid (52) (Scheme 1.18).[68] 
 
 
Scheme 1.18. Synthesis of (R)-4-phenylpyrrolidin-2-one (52) via dynamic kinetic resolution 
catalysed by TAm 
 
Preparation of the racemic intermediate (53) proceeded by reacting cinnamyl alcohol 
(54) with triethyl orthoacetate and hexanoic acid catalyst to give 55 in 95% yield. 
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This was followed by ozonolysis of the double bond to give racemic aldehyde 53 in 
62% yield. Various TAms were tested in the final dynamic kinetic resolution step, 
using L or D- alanine as an amine donor and removal of the resulting pyruvate by 
reduction using lactate dehydrogenase combined with a glucose 
dehydrogenase/glucose recycling system. This shifted the equilibrium of the reaction 
towards the amine product. All of the TAms tested gave good conversions (>90%) to 
the final 4-phenylpyrrolidin-2-one (52), three gave access to the (S)-enantiomer (< 
46% ee), while the remaining nine gave the (R)-enantiomer (< 69% ee).
[68]
 
(S)-Rivastigmine (56) is a drug which has been used to treat the early stages of 
Parkinson’s disease. Previously, it has been synthesised via various resolution 
methods which require complex multi-step procedures. A concise chemoenzymatic 
strategy (Scheme 1.19) has been described which utilizes an ω-transaminase to 
install the necessary stereochemistry.
[69]
  
 
 
Scheme 1.19. Chemoenzymatic synthesis of (S)-Rivastigmine (56) 
 
The initial biotransformation step was investigated using a variety of different 
protecting groups, solvent systems and ω-transaminase enzymes. L- or D- alanine 
was used as the amine donor and the co-product, pyruvate, was once again removed 
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using lactate dehydrogenase combined with a glucose dehydrogenase/glucose 
recycling system. Initial testing without a hydroxyl protecting group gave good 
stereoselectivities (>99% ee) but low conversions (15-64%) and attempts at 
improving reaction rates using co-solvents were unsuccessful. However, protection 
of the hydroxyl group resulted in increased conversions without affecting the 
stereochemical outcome, the best of which was the methoxymethyl (MOM) ether 
which gave an isolated yield of 57 of 80% and >99% ee. The MOM protecting group 
was also useful from a synthetic perspective as it could easily be cleaved using 
mildly acidic conditions. The rest of the synthesis proceeded by N-methylation of the 
biotransformation product (57) in the presence of formaldehyde and 
triacetoxyborohydride to give 58 in 95% yield. Removal of the methoxymethyl ether 
was achieved quantitatively at room temperature using 5 M HCl. Carbamoylation by 
reaction with N-ethyl-N-methylcarbamoyl chloride (59), which had been prepared 
from triphosgene (60), gave (S)-Rivastigmine (56) in its enantiopure form in 97% 
yield.
[69]
  
One of the most powerful examples of the use of transaminase in organic synthesis is 
in the production of the anti-diabetic compound, sitagliptin (61). The final step in the 
synthesis of this compound relied upon a rhodium catalysed stereoselective 
hydrogenation of an enamine of prositagliptin ketone at 50 
o
C and pressure of 17 
atmospheres (Scheme 1.20). While good yields and stereoselectivities were obtained, 
the process was far from ideal from an environmental perspective, as high pressure 
hydrogen and non-sustainable rhodium catalyst were required. In this work, a 
transaminase which had previously been shown to generate (R)-amines, ATA-117, a 
homologue of an enzyme from Arthrobacter., was used as a starting point to develop 
an (R)-specific TAm which could accept prositagliptin ketone (62) as a substrate, 
giving access to sitagliptin (61) in a sustainable fashion and at a low cost.
[7]
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Scheme 1.20. Two catalytic routes to the synthesis of sitagliptin (61) 
 
In order to develop an active biocatalyst, a substrate walking approach was used 
wherein a truncated model of the substrate was docked into the active-site of the 
enzyme in order to design the enzyme active-site in such a way that a larger substrate 
would be accepted. A larger analogue was then docked into the active-site of the 
enzyme designed in the first step, in order to identify active-site residues which 
would need to be mutated in order for the active-site to accommodate the desired 
substrate. Finally, the residues identified from the docking studies were altered by 
saturation mutagenesis and mutants were tested for activity against the prositagliptin 
ketone (62). In the first round of mutation, residues were targeted to relieve steric 
hindrance within the active site. These mutations were combined to give a mutant 
which, for the first time, showed activity towards the prositagliptin ketone (62). This 
mutant, Y26H/V65A/V69G/F122I/A284G was then used as the basis for a second 
round of mutation, again aimed at reducing steric hindrance within the active site. 
This second library was screened, and the most active mutant showed a 75-fold 
increase in activity over the parent enzyme. In order for the biocatalyst to be 
industrially useful however, it needed to be active in >25% DMSO which was 
required to solubilise the prositagliptin ketone (62), and also active in 1 M 
concentration of amine donor, required to drive the equilibrium of the reaction 
toward product formation. Hence, more rounds of iterative mutagenesis were carried 
out, screening the mutants at these conditions, until a mutant containing 27 
mutations was identified which produced 200 g/L of sitagliptin with 99.95% ee. This 
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final catalyst contained 4 structure aided mutations and 1 site saturation mutation in 
the small binding pocket, 5 site saturated mutations in the large binding pocket, 2 
site saturation mutations of positions outside both binding pockets, 10 mutations 
based on homology libraries and 5 mutations from random mutagenesis. The final 
biocatalytic process was performed in 50% DMSO and gave a 13% increase in 
overall yield, a 53% increase in overall productivity and a 19% reduction in waste 
including total elimination of heavy metal waste compared to the previous rhodium 
catalysed process.
[7]
 
 
1.6 Aminodiol synthesis by TK and TAm 
 
Many chiral aminodiols have been reported which exhibit useful biological activities 
(Figure 1.5). N-butyl-deoxynojirimycin (63) is an iminosugar which has been 
reported as an inhibitor of glucosylceramide synthase and can be used as a treatment 
for lysosomal storage disease. It has also been shown to prevent HIV replication in 
vitro.
[70]
 Swainsonine (64) is an α-mannosidase inhibitor, and has been shown to 
possess anti-cancer properties.
[71]
 Sphingosine (65) is an important sphingolipid 
which accounts for a large proportion of the cell membranes of eukaryotic cells,
[72]
 
while chloramphenicol (66) is a broad spectrum antibiotic which is active against 
many bacterial infections.
[73]
 
 
 
Figure 1.5. Structures of some biologically active aminodiols 
 
Each of these compounds exhibit specific stereochemistries required for their 
biological activities which can be difficult to introduce using standard synthetic 
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manipulations. The production of chiral aminodiols using enzymatic catalysis, 
however can offer a synthetically useful alternative to incorporate specific 
stereocentres. 
A one-pot synthesis of 2-amino-1,3,4-butanetriol (ABT, 67) (Scheme 1.21) has been 
reported using a single E. coli host containing two plasmids for the overexpression 
of TK (from plasmid pQR411) and a β-alanine:pyruvate aminotransaminase 
(overexpressed from plasmid pQR428).
[74] 
This created a novel biocatalyst capable 
of the synthesis of chiral amino-alcohols via a one-pot, two-step synthetic pathway.  
 
Scheme 1.21. ABT (67) synthesis via a TK/TAm mediated synthetic pathway
[74]
 
 
The TAm step required (S)-α-methylbenzylamine as an amine donor and the co-
factor pyridoxal phosphate to transform the ketone moiety (27) to an amine (67). As 
a proof of concept the synthesis worked well, yielding a single diastereoisomer in 
21% mol/mol yield. The TK catalysed condensation of Li-HPA (Li-23) and 
glycolaldehyde (26) was shown to proceed much faster than the TAm step, 
indicating that further work would be needed to identify a more active TAm enzyme, 
possibly by mutagenesis, to develop a more efficient process.
[74]
 
The chemoenzymatic synthesis of aromatic aminodiols has been studied to establish 
the substrate tolerance and stereoselectivity of an ω-transaminase from 
Chromobacterium violaceum.
[75]
 The amino donor for the reaction was (S)-α-
methylbenzylamine, and the acceptor was racemic 1,3-dihydroxy-1-phenylpropan-2-
one (68) synthesised using the biomimetic transketolase reaction with benzaldehyde 
as the acceptor substrate. Chemical reductive amination of this racemic compound 
resulted  in a mixture of four stereoisomers (69) (Scheme 1.22).
[75]
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Scheme 1.22. Four possible stereoisomers of 69 resulting from chemical reductive amination of 
ketodiol 68 
 
However, using CV2025 TAm, it was shown that only two stereoisomers were 
produced (Scheme 1.23). Asymmetric synthesis of three of the four stereoisomers, 
followed by chiral HPLC analysis of the acetylated products showed that the TAm 
accepted both (R) and (S)-isomers of ketodiol 68 but formed the new stereocentre 
(69) with (2S)-orientation exclusively.  
 
 
Scheme 1.23.TAm reaction using ketodiol 68 as a substrate exclusively forming a new (S) 
stereocentre 
 
In the future, and of particular importance to this PhD project, if new TK enzymes 
can be found which exclusively produce (R) or (S) aromatic ketodiols, optically pure 
aromatic aminodiols of syn and anti configuration should be accessible using a 
suitable TAm in the second step. This strategy could then be used to synthesise 
antibiotic molecules such as chloramphenicol (66). 
 
1.7 Syntheses of chloroamphenicol and thiamphenicol 
 
Chloramphenicol (Figure 1.6, 66) and thiamphenicol (Figure 1.6, 70) are both broad 
spectrum antibiotics with a wide range of antimicrobial applications and both contain 
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an aminodiol moiety. Their potent biological activities have made them attractive 
targets for organic synthesis. Indeed, chloramphenicol was one of the first antibiotics 
to be produced in its optically active D-threo (2R,3R) form by chemical synthesis 
rather than by fermentation techniques.
[76]
 
 
 
Figure 1.6. Structures of chloramphenicol (66) and thiamphenicol (70) 
 
Several different syntheses to these molecules exist, with most relying on a Sharpless 
asymmetric epoxidation step to introduce the chiral alcohol.
[76] 
A method used by 
Bhaskar et al (Scheme 1.24) started with the reaction of commercially available 4-
nitrobenzaldehyde (71) with divinyl zinc to give the allylic alcohol (72) which was 
then subjected to Sharpless asymmetric epoxidation conditions to give the chiral 
epoxyalcohol (73) in 95% ee. Treatment with dichloroacetonitrile in the presence of 
sodium hydride was followed by an in situ epoxide opening of the dichloroamidate 
(74) using BF3.OEt2. Excess BF3.OEt2 complexed with the oxazoline (75) and 
hydrolysed the resulting ring, which gave 66 in 23% overall yield.  
 
Scheme 1.24. Three- step synthesis of chloramphenicol (66)
[76]
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Thiamphenicol (70) has been produced using a similar epoxidation strategy (Scheme 
1.25). 4-(Methylthio)benzaldehyde (76) was converted to the allylic alcohol (77) 
using vinyl magnesium bromide and then selectively oxidised to the sulfone (78) 
using oxone. Sharpless asymmetric epoxidation was then carried out to give the 
chiral epoxyalcohol (79) in 95% ee. The rest of the synthesis proceeded as before, 
involving treatment with dichloroacetonitrile and sodium hydride to give 80, which 
upon epoxide opening gave 81. Hydrolysis using excess BF3.OEt2 gave 70 in 21% 
overall yield.  
Scheme 1.25. Four step synthesis of thiamphenicol (70)
[76]
 
 
An alternate reaction has been proposed which uses the naturally available and 
cheaper reagent [(+)-DIPT], under kinetic resolution conditions, to install the chiral 
alcohol (S-72).
[77]
 The second chiral centre was induced by a tethered 
aminohydroxylation (Scheme 1.26).
[77]
 Here, the synthesis of chloramphenicol 
begins as shown previously (Scheme 1.24) using divinyl zinc to prepare the same 
allylic alcohol (72) from 4-nitrobenzaldehyde (71), followed by asymmetric 
epoxidation, this time using [(+)-DIPT], to give the chiral allylic alcohol (S-72) in 
98% ee. Reduction with trichloroacetyl isocyanate, then treatment with potassium 
carbonate and methanol in water gave the carbamate (82). This was then subjected to 
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a tethered aminohydroxylation protocol using a tert-butyl hypochlorite oxidant, 
potassium osmate, NaOH, DIPEA, and propan-1-ol as the solvent. This gave the 
protected aminoalcohol 83 as a single isomer which upon treatment with NaOH in 
methanol and heating in methyl dichloroacetate gave 66 in an overall 29% yield and 
98% ee. 
 
Scheme 1.26. 5 step Synthesis of chloramphenicol (66) using a tethered aminohydroxylation 
approach
[77]
 
 
This strategy was also used for thiamphenicol synthesis with the allylic alcohol and 
sulfone preparation achieved as previously described.
[76]
 
 
1.8 Project aims and objectives 
 
The aims of this project are 4-fold; firstly, to investigate the substrate scope of the 
biomimetic TK reaction and its potential for the asymmetric synthesis of aromatic 
ketodiols; secondly, to investigate the synthesis of ketodiols by TK and to develop 
and study mutants with increased activities and stereoselectivities for the production 
of aromatic ketodiols; thirdly, to investigate a two-step TK/TAm strategy towards 
aromatic aminodiol synthesis using the best TK mutants and CV2025 TAm; and 
finally to increase the synthetic utility of TK by investigating the tolerance of mutant 
TKs towards novel donor substrates other than HPA, to allow the stereoselective 
preparation of ketol compounds.  
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2 The Biomimetic Transketolase Reaction 
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2.1 Previous work carried out by the group before starting 
the PhD 
 
The first biomimetic transketolase reaction was reported in 2006.
[50]
 While screening 
suitable buffers for the transketolase reaction it was found that 3-
morpholinopropane-1-sulfonic acid (MOPS) (Scheme 2.1, 84) catalysed ketodiol 
(25) formation between Li-HPA (Li-23) and propanal (24) without the addition of 
TK. However, no reaction was observed under comparable conditions when using 
glycylglycine (85) or tris(hydroxymethyl)aminomethane, (TRIS) (86), buffers. 
 
 
Scheme 2.1 Reaction scheme of buffer catalysed ketodiol formation 
 
The co-factor ThDP was not required for this reaction, indicating that some 
structural feature in MOPS (84) was required for the reaction to occur. A range of 
sulfonic acids and secondary and tertiary amines were therefore screened for the 
conversion of propanal (24) to ketodiol 25, in order to determine which functional 
motif was responsible for mediating the reaction (Figure 2.1, Table 2.1).
[50]
 
 
 
Figure 2.1 Tertiary amines and sulfonate screened with propanal for ketodiol formation 
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Table 2.1 Tertiary amine catalysts screened for ketodiol formation with propanal
[50]
 
Putative catalyst Product (25) yield % 
N-N’-dimethylpiperazine (87) 26 
N-methylmorpholine (28) 27 
N-methylpiperidine (88) 8 
morpholine (89) 0 
piperidine (90) 0 
triethylamine (91) 0 
sodium 1-decanesulfonate (92) 0 
 
Reactions were carried out in water at room temperature with 3 equivalents of 
aldehyde (24), 1 equivalent of LiHPA (Li-23) and 1 equivalent of catalyst (28, 87-
92). Only the use of N-N’-dimethylpiperazine (87), N-methylmorpholine (NMM, 28) 
and N-methylpiperidine (88) as catalysts led to formation of the desired product (25) 
(Table 2.1). None of the other putative catalysts (89-92) gave any product, indicating 
that the cyclic tertiary amine motif was critical for catalytic activity. Upon 
optimisation of the reaction conditions using NMM (28), isolated yields of up to 
35% of ketodiol 25 were obtained in only five hours at room temperature.
[50]
 
 
2.2 Substrate scope of the racemic biomimetic reaction 
 
In the initial report of the biomimetic transketolase reaction only propanal (24), 
glycolaldehyde (26) and benzaldehyde (8) were screened with MOPS buffer (84) 
(Figure 2.2).
[50]
 
 
 
Figure 2.2 Aldehydes screened in initial investigation into the biomimetic TK reaction 
 
Clearly this reaction was useful for creating racemic substrates which could be used 
to develop chiral assays for analysing optically-active ketodiols formed from 
transketolase biotransformations. Therefore at the start of this PhD the substrate 
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scope of the biomimetic transketolase reaction was explored with aromatic aldehydes 
(8, 17, 18, 93-102) to prepare racemic ketodiols (68, 103-114) (Table 2.2). Some 
slight variations were made to the initial reaction conditions of the biomimetic 
reaction;
[50]
 a 1:1 mixture of acetonitrile (AcN):water (total volume of 10 mL) was 
used to increase the solubility of the various aromatic aldehydes, and equimolar 
amounts of catalyst, Li-HPA (Li-23) and aldehyde were used, to ease purification. 
Since NMM (28) had been shown to be the best catalyst in the initial studies of the 
biomimetic TK reaction,
[50]
 the conversion of these aromatic aldehydes were also 
studied with this catalyst. 
 
Table 2.2 Yields obtained for benzaldehydes screened in biomimetic TK reaction* 
 
Entry Aldehyde (R=) Product yield (%) 
1 H (8) 15 (68) 
2 3-OH (93) 6 (103) 
3 3-Br (17) 20 (104) 
4 3-F (94) 23 (105) 
5 3-CO2Me (95) 29 (106) 
6 3-vinyl (96) 6 (107) 
7 3-CO2H (97) 20 (108) (Conversion yield) 
8 3-NO2 (98) 22 (109) 
9 3-CN (18) 10 (110) 
10 4-Cl (99) 2 (111) 
11 4-F (100) 2 (112) 
12 4-Br (101) 1 (113) 
13 4-I (102) 3 (114) 
*Reaction conditions; 1.0 mmol aldehyde, 1.0 mmol LiHPA, 1.0 mmol NMM, 1:1 AcN:H2O (10 mL 
total volume), pH 7, 24 hour reaction time. 
 
The reaction showed a fairly wide substrate tolerance, accepting both meta- and  
para-substituted benzaldehydes. Benzaldehyde (8) (entry 1) gave ketodiol 68 (Table 
2.2, R=H) in 15% isolated yield, which was slightly lower than the previously 
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reported 25% yield achieved using MOPS (84) as a catalyst,
[50]
 presumably due to 
the 3-fold lower aldehyde concentration used to simplify product purification. Meta-
substituted benzaldehydes were generally well tolerated in this reaction, 3-
hydroxybenzaldehyde (93) gave a 6% yield of ketodiol 103 and halogenated 
derivatives 17 and 94 (entries 3 and 4), and aldehydes 95, 97, 98 and 18 (entries 5, 7, 
8 and 9) gave isolated yields of ketodiol products of >20%. Interestingly, the para-
substituted benzaldehydes 99-102 were less well tolerated in the reaction (entries 10-
13), with no yields above 3% observed for ketodiols 111-114. Some benzaldehydes 
(115-119) were not accepted in the reaction at all, with no product formation 
observed by TLC analysis (Figure 2.3).  
 
 
Figure 2.3 Benzaldehydes 115-119 not accepted in biomimetic TK reaction 
 
No product formation was observed for 4-nitrobenzaldehyde (115), 2-
nitrobenzaldehyde (116), 2-hydroxy-5-nitrobenzaldehyde (117), 4-
hydroxybenzaldehyde (118) or methyl-4-formylbenzoate (119). Substitution at the 
ortho position did not seem favourable, as none of the ortho-substituted 
benzaldehydes were tolerated in the biomimetic reaction, possibly due to steric 
crowding of the aldehyde functionality. Also, substitution at the para position 
seemed to be poorly tolerated with only the para halogen benzaldehydes, 99-102, 
transformed with low yields. 
Some non-aromatic aldehydes (120-122) were also studied for conversion to the 
corresponding ketodiols (123-125) with Li-HPA (Li-23) and NMM (28), under the 
same reaction conditions (Table 2.3)  
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Table 2.3 Yields obtained for aliphatic aldehydes screened in biomimetic TK reaction* 
 
Aldehyde (R=) Product yield % 
C4H9 (120) 56 (123) 
C5H11 (121) 48 (124) 
(122) 
4 (125) 
*Reaction conditions; 1.0 mmol aldehyde, 1.0 mmol LiHPA, 1.0 mmol NMM, 1:1 AcN:H2O (10 mL 
total volume), pH 7, 24 hour reaction time. 
 
The longer chain aliphatic aldehydes were well tolerated in the biomimetic reaction 
with similar isolated yields of ketodiols 123 and 124 obtained as reported for the 
biomimetic reaction with propanal (23).
[26, 50]
 Butanal (120) and pentanal (121) had 
been previously investigated with the biomimetic reaction, though on a larger-scale, 
and lower isolated yields of ketodiols 123 and 124 of 12 % and 35%, respectively, 
had been obtained.
[26]
  
The cyclic aldehyde, 3,4-dimethylcyclohex-3-enecarbaldehyde (122), was prepared 
by the Diels-Alder reaction of acrolein (126) and 2,3-dimethylbutadiene (127) 
(Scheme 2.2). This aldehyde (122) was of particular interest, as its synthesis is being 
investigated in a biocatalytic flowcell, which could then be combined with a second 
TK step, giving a two-step microfluidic reaction toward a complex, chiral substrate 
(125) (Scheme 2.2).
[78]
 3,4-Dimethylcyclohex-3-enecarbaldehyde (122) was 
prepared by reacting 2,3-dimethylbutadiene (127) with acrolein (126) in a sealed 
tube, with a catalytic amount of zinc chloride at 60 
o
C. After 18 hours the product 
was purified by flash silica chromatography to give 3,4-dimethylcyclohex-3-
enecarbaldehyde (122) in 56% yield.  
 
 
Scheme 2.2 Synthesis of 3,4-dimethylcyclohex-3-enecarbaldehyde (122) and its potential use as a 
substrate in TK biotransformations 
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Using this cyclic aldehyde (122) as a substrate in the biomimetic reaction gave a 4% 
isolated yield of ketodiol (125), much lower than the isolated yields of ketodiols 123 
and 124 from butanal and pentanal (Table 2.3). Indeed this aldehyde (122) was less 
well tolerated than most of the aromatic aldehydes tested (Table 2.2). 
Comparing the isolated yields obtained for all of the different aldehydes used it is 
interesting to note that the highest yields observed were for aliphatic aldehydes. It 
would therefore appear that steric factors are important in determining reactivity in 
the biomimetic TK reaction, which would also explain why no ortho-substituted 
benzaldehydes were tolerated as substrates. 
While studying the biomimetic reaction with aromatic substrates it became clear that 
it was very important to keep the reaction as close to neutral pH as possible. When 
the reaction was performed at acidic or basic pH, or if the reaction was left for 
extended periods, one major side-product was isolated. This was identified as the 
1,2-ketodiol (128) formed from the isomerisation of the desired 1,3-ketodiol product 
(68) (Scheme 2.3). 
 
 
Scheme 2.3 Possible mechanisms of formation of rearranged ketodiol (128) 
 
Formation of this product was also observed during TK biotransformations and will 
be discussed later (Chapter 3). 
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2.3 Mechanistic study of the biomimetic transketolase 
reaction[79]* 
 
After establishing that the biomimetic reaction could be used to transform a more 
extensive range of aliphatic and aromatic aldehydes (Table 2.2, Table 2.3), it was 
decided to elucidate the mechanism further to fully understand the differences in 
reactivity observed for different aldehydes and to see if an asymmetric variant of the 
reaction could be developed. 
Four different reaction mechanisms were postulated for the biomimetic TK reaction. 
To distinguish between these mechanisms a 
13
C labelling approach was used, 
utilising 
13
C labelled HPA as the ketol donor and benzaldehyde (8) as the acceptor. 
The first mechanism, mechanism A (Scheme 2.4), proceeded by the addition of the 
tertiary amine either directly to the ene-diol (29) or tartronic acid semialdehyde (30) 
to give the quarternary amine enolate (31). This would then undergo an aldol 
addition to the acceptor aldehyde (8), which, followed by proton transfer would give 
(129). Elimination of CO2 and the tertiary amine catalyst would furnish the ene-diol 
which could subsequently tautomerise to the 1,3-ketodiol (68).
[79]
  
  
 
 
* All isotopic labelling and MS studies were carried out by James Galman 
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Scheme 2.4 Possible mechanism of the biomimetic TK reaction - Mechanisms A and B 
 
An aldol-based mechanism was also envisaged, as in mechanism B (Scheme 2.4), 
where the direct aldol addition of 29 to 8 would give 130, which upon elimination of 
carbon dioxide, proton transfer and subsequent tautomerisation would give the 1,3-
ketodiol (68).
[79]
 Here the role of tertiary amine would be to act as a base, promoting 
the aldol reaction. An alternative mechanism could occur from an aldol addition to 
the less hindered carbon of ene-diol 29, as in mechanism C (Scheme 2.5). This 
would be followed by tautomerisation, decarboxylation, and further tautomerisation 
to give the 1,3-ketodiol (68).
[79]
 Here the role of tertiary amine would once again be 
to act as a base, promoting the aldol reaction, however in this case the label would be 
incorporated at C-2. A fourth possible mechanism, mechanism D (Scheme 2.5), 
would involve the decarboxylation of (30) to give a symmetrical enediolate 
intermediate which could then undergo aldol addition to the acceptor aldehyde. 
Subsequent tautomerisation would then give the 1,3-ketodiol product (68).
[79]
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Scheme 2.5 Possible mechanisms of the biomimetic TK reaction – Mechanisms C and D 
 
The position of the 
13
C label could be established by 
13
C-NMR and hence allow the 
correct mechanism to be established, since mechanisms A and B would result in 
incorporation of the 
13
C label at C-1 (Scheme 2.4), mechanism C would lead to 
labelling at C-2 (Scheme 2.5) and mechanism D would lead to scrambling of the 
13
C 
label at positions C-1 and C-2 (Scheme 2.5).
[79]
  
 3-
13
C labelled HPA was prepared by James Galman via the bromination of 
13
C 
sodium pyruvate, and subsequent reaction with lithium hydroxide following a 
standard procedure.
[50]
 The standard biomimetic reaction was then performed with 
benzaldehyde (8) as the acceptor substrate and 3-
13
C-LiHPA (3-
13
C Li-23) as the 
ketol donor to give the 
13
C labelled ketodiol (68) in 10% isolated yield (Scheme 2.6). 
The position of the 
13
C label was then established.
[79]
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Scheme 2.6. Biomimetic TK reaction with 
13
C-labelled HPA and benzaldehyde 
 
13
C-NMR analysis confirmed the incorporation of 
13
C at C-1, shown by the intensity 
of the C-1 signal compared to the unlabelled natural abundance spectra previously 
observed. The 
1
H-NMR spectra also confirmed the incorporation of 
13
C at C-1 by the 
observed coupling, 
1
JCH of 145 Hz. Since incorporation of 
13
C at C-1 was observed 
exclusively, and no scrambling of the label was seen, this approach showed that only 
mechanisms A and B (Scheme 2.4) could be operating and mechanisms C and D 
(Scheme 2.5) were not involved.
[79]
  
This labelling study could not distinguish between mechanisms A and B, so another 
approach was needed to further elucidate the mechanism. Electrospray ionisation 
mass spectrometry (ESI-MS) and tandem ESI-MS/MS have previously been 
successfully used to detect reaction intermediates and minor reaction products.
[80, 81]
 
With mechanisms A and B both implicated in the biomimetic TK reaction, ESI-MS 
and ESI-MS/MS were used to intercept and identify ions formed from reaction 
intermediates.
[79]
 The reaction was continuously monitored by direct infusion of the 
reaction mixture into the ESI probe and highly charged covalent species were 
detected which corresponded to intermediates from both mechanisms A and B.
[79]
 
Tandem MS was then used to produce fragments of these intermediates to confirm 
their structures. While fragments were isolated and identified using this method, it 
was still not possible to determine whether mechanism A or B was operating as the 
identified fragements could have been formed from either mechanism,
[79]
 though 
work by Rohr et al has shown that direct aldol additions can occur between suitable 
ketoacids and aldehydes in the presence of a tertiary amine catalyst,
[82]
 supporting 
the existence of mechanism B.  
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2.4 The asymmetric biomimetic TK reaction* 
 
If mechanism A (Scheme 2.4) was indeed operating it was proposed that by using a 
chiral tertiary amine catalyst the addition of the aldehyde could be directed to its re- 
or si-face and hence some asymmetry induced in the final product. To investigate 
whether the biomimetic TK reaction could be made asymmetric, a range of chiral 
tertiary amine catalysts were tested using LiHPA (Li-23) as the ketol donor and 
benzaldehyde (8) as the acceptor.
[79]
 The best catalyst was found to be quinine ether 
131 (Figure 2.4), so this was screened against a larger range of benzaldehydes (8, 94, 
99-101, 132-136) (Table 2.4) and isolated yields of ketodiol products (68, 105, 106, 
111-113, 137-140) obtained to establish whether more functionalised compounds 
would be tolerated in the reaction.
[79]
  
 
 
Figure 2.4 Structure of hydroquinine 4-methyl-2-quinolyl ether (131) 
 
Low yields were consistently observed for all substrates tested; lower even than 
when using NMM (28) as the catalyst (Section 2.2), suggesting that the increased 
steric bulk of 131 may have been responsible for the reduced yields. However, the 
stereoselectivities observed were promising. 
   
 
 
* Some of the transformations carried out in Table 2.4 were carried out by James Galman 
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Table 2.4 Yield and stereoselectivity data for substituted benzaldehydes screened in asymmetric 
biomimetic TK reaction
*
 
 
 
Entry Aldehyde (R=) Time (h) Product yield % ee (%) 
1 H (8) 12 4 (68) 22 
2 4-Me (132) 12 2 (137) 21 
3 4-F (100) 48 3 (112) 36 
4 4-Cl (99) 24 2 (111) 50 
5 4-OMe (133) 72 3 (138) 0 
6 4-Br (101) 12 2 (113) 0 
7 3-F (94) 48 2 (105) 38 
8 3-OMe (134) 24 3 (139) 36 
9 3-CO2Me (95) 24 4 (106) 25 
10 2-F (135) 48 3 (140) 0 
11 2,4-Cl (136) 48 0 ND 
* Reaction conditions: Entries 1,2 and 6,7, 1.0 mmol aldehyde, 1.0 mmol LiHPA, 5 mol% 131, 1:1 
THF:H2O (2 mL total volume). Entries 3-5 1.0 mmol aldehyde, 1.0 mmol LiHPA, 20 mol% 131, 1:2 
THF:H2O (2 mL total volume). Entries 8-9 1.0 mmol aldehyde, 1.0 mmol LiHPA, 10 mol% 131, 1:1 
THF:H2O (2 mL total volume). 
 
Para-substituted fluorobenzaldehyde (100) and 4-Cl benzaldehyde (99) (entries 3 
and 4) gave moderate ees (36% and 50% respectively), whereas substrates with 
larger para-substituents such as 4-methoxy (133) (entry 5) and 4-Br (101) (entry 6) 
showed no stereoselectivity whatsoever, suggesting that increasing the size of the 
para-substituent had a detrimental effect on the stereoselectivity of the reaction. 
Meta-substituents were fairly well tolerated, with both electron withdrawing (94, 95) 
(entries 7 and 9) and donating groups (134) (entry 8) giving moderate ees, suggesting 
that meta-substituents were not as critical for stereochemical induction. Substitution 
at the ortho-position was not well tolerated, however. 2-Fluorobenzaldehyde (135) 
(entry 10) was accepted in the reaction but no stereoselectivity was observed, 
whereas 2,4-dichlorobenzaldehyde (136) was not transformed to the corresponding 
ketodiol, and so ortho-substituted benzaldehydes were not investigated further. 
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Higher yields (15-20%) were observed for some aliphatic aldehydes but no 
stereoselectivity was observed for any aliphatic substrates.
[79]
 
 
2.4.1 Chiral analysis of ketodiol products from asymmetric 
biomimetic TK reaction 
 
The stereoselectivities for these products were assigned by a combination of chiral 
HPLC analysis (of mono- or di-benzoylated derivatives) and the analysis of 
Mosher’s ester derivatives.[83] Racemic standards were prepared using the NMM-
catalysed biomimetic reaction and used to develop chiral HPLC assays which could 
then be used to analyse products from the asymmetric reaction. A hindered 2,4,6-
collidine base was used to avoid racemisation of the products, as discussed further in 
Chapter 3. Good separation was achieved for all derivatives using a 90:10 n-
hexane:isopropanol solvent system, a Chiralcel OD column at 1.0 mL/min and 
detection at 214 nm (Figure 2.5). Mosher’s ester derivatives of ketodiol products 
were prepared and isolated to allow the absolute stereochemistry to be tentatively 
assigned as R by comparing the integrations of the diastereotopic protons as 
previously described,
[26, 83]
 and as further discussed in Chapters 3 and 6. 
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Figure 2.5 Chiral HPLC traces of mono-benzoylated derivatives of (105) and (106). Elution 
times shown in minutes. 
 
The tentatively assigned R-selectivity was rationalised by considering reaction 
intermediate (129). In this intermediate the lower face of the enolate would not be 
accessible to the aldehyde, and so addition of the enolate would occur to the si-face 
of the aldehyde (Figure 2.6, underside as drawn) to give the R-product. 
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Figure 2.6 Possible rationale for the formation of the assigned R-stereocentre (reproduced 
from
[79]
) 
 
As previously mentioned, the two reactions mechanisms, A and B (Scheme 2.4), had 
been proposed for the biomimetic TK reaction. That any stereoselectivity was 
observed at all suggests that mechanism A operates to some extent, since the 
intermediate formed from the addition of the chiral amine catalyst to HPA would 
allow facial stereodifferentiation of the approaching aldehyde, with only one face of 
the enolate exposed for attack. Mechanism B could also be expected to have an 
influence on facial stereodifferentiation, with the tertiary amine catalyst non-
covalently interacting with the enolate, directing addition of the aldehyde. However, 
the required electrostatics would have to be very strong, and in water this seems 
unlikely. For substitutents where lower or negligible ees were observed, this suggests 
the predominance of mechanism B, though the actual mechanism in operation still 
remains uncertain and is likely to depend on the catalyst, the aldehyde or a 
combination of both. The suitability of using the Mosher’s ester analysis method to 
assign the absolute stereochemistry for these aromatic compounds has subsequently 
been studied, and will be discussed further in chapter 6. 
 
2.5 Summary of chapter 2 
 
In conclusion, the biomimetic TK reaction has been studied in detail. The substrate 
scope of the NMM-catalysed biomimetic reaction has been investigated with a range 
of functionalised benzaldehydes and several aliphatic aldehydes. The mechanism of 
the reaction has been probed by isotopic labelling studies and mass spectrometry and 
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an asymmetric variant of the reaction has been established using a chiral tertiary 
amine catalyst. Chiral analysis methods for aromatic ketodiols have been developed 
and the asymmetric biomimetic reaction has been used to access aromatic ketodiols 
in water in up to 50% ee.
[79]
 These are useful preliminary asymmetric results that can 
be used as a foundation for further studies with other chiral catalysts and a wider 
range of substrates. 
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3 Aromatic aldehydes with single point mutant TKs 
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Single point mutant TKs had previously been shown to accept a range of aliphatic 
aldehydes, with good yields (up to 70%) and excellent stereoselectivities (>99% ee). 
Interestingly, the cyclic aldehydes cyclopropanecarboxaldehyde (141), 
cyclopentanecarboxaldehyde (142) and cyclohexanecarboxaldehyde (143), which 
were barely tolerated by WT-TK (<3% yield), were accepted by several D469 
mutants, especially D469E (Scheme 3.1).
[26]
 
 
 
 
Scheme 3.1 Transketolase catalysed ketodiol formation with cyclic aldehydes and D469E TK 
 
D469E was generally the most active mutant towards these cyclic aliphatics, though 
D469T and D469K also showed activity, but lower yields and stereoselectivities 
were observed.
[26]
  
 
3.1 Previous work done by the group to identify active 
mutant TKs using a colorimetric assay 
 
The TK mutants studied with aliphatic aldehydes
[26]
 were identified using a 
previously established high-throughput colorimetric assay.
[84]
 In this assay, the 
ketodiol product was oxidised, reducing 2,3,5-triphenyltetrazolium chloride to 1,3,5-
triphenylformazan in the process. 2,3,5-Triphenyltetrazolium chloride is colourless, 
but 1,3,5-triphenylformazan is red coloured and the optical density at 485nm was 
measured  to quantify the amount of ketodiol produced in work previously carried 
out by the group. (Scheme 3.2).
[84]
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Scheme 3.2 Colorimetric assay used to identify active TK mutants 
 
To establish whether TK mutants could accept aromatic aldehydes, the colorimetric 
assay had been performed using benzaldehyde (8) (Scheme 3.1, R = Ph) and LiHPA 
(Li-23) to identify active mutants.
[85]
 The assay gave several positive hits and 
subsequent sequencing revealed they were; D469E, D469K, D469S and D469T. 
Interestingly, 3 of these mutants; D469E, D469K, and D469T had previously shown 
activity toward cyclic aldehydes (Scheme 3.1).
[26]
 Another mutant, F434A that had 
been previously prepared by site-directed mutagenesis was investigated as it was 
thought that this mutant would remove some unfavourable steric and electronic 
interactions in the active site to allow larger aromatic substrates to enter. From the 
colorimetric assay, D469S had appeared to give significant amounts of product and 
was investigated further. Upon scale-up and isolation of product however, only trace 
amounts of the desired ketodiol product (68) were observed. The main product from 
this reaction was 144, the formation of which was postulated to be from the aldol 
addition of the ketodiol product (68) to glycolaldehyde (26) (Scheme 3.3) 
(presumably formed in situ from the decarboxylation of HPA) (23) to give a “double 
addition” product (144). 
 
 
Scheme 3.3 Proposed mechanism for the formation of the observed double addition product 144 
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No double addition product was observed when the biomimetic TK reaction was 
performed with the same substrate concentrations, suggesting that the aldol addition 
of the ketodiol product to glycolaldehyde may occur in the TK active-site, either 
when the product is still attached to the ThDP-enamine, or after it has been displaced 
by another HPA molecule. The observation of this double addition product (144) 
made clear a serious limitation with the colorimetric assay, as it could not distinguish 
between the desired product and the double addition product, as both could be 
oxidised, thus reducing 2,3,5-triphenyltetrazolium chloride, forming the red colour 
associated with a “positive” hit. However, formation of the desired product (68), 
even as an intermediate, was a promising start, and the assay allowed identification 
of several mutants (D469E, D469T, D469K) which could be investigated further, 
along with F434A.
[85]
 
 
3.2 Biotransformations of aromatic aldehydes with active 
single mutant TKs 
 
Benzaldehyde (8) was the first aromatic substrate screened in scaled-up reactions 
with F434A and the D469 mutants which had given positive hits in the colorimetric 
screen (Table 3.1). Li-HPA (Li-23) was used as the ketol donor, and isolated yields 
and stereoselectivities of ketodiol 68 were established, where possible. 
 
Table 3.1 Biotransformations of benzaldehyde by single mutant TKs* 
 
WT-TK 
Yield % 
 (ee) 
D469E 
Yield %  
(ee) 
D469T 
Yield % 
(ee) 
D469K 
Yield % 
(ee) 
F434A 
Yield % 
(ee) 
0  
 
2 
 (0%) 
2 
 (70%, 3R) 
2 
(82%, 3R) 
10 
(82%, 3R) 
*Biotransformation of benzaldehyde by D469K was carried out by James Galman. 
Reaction conditions: 1.0 mmol aldehyde, 1.0 mmol LiHPA, 2 mL TK cell-free lysate, 
20 mL total volume, 48 hour reaction time. 
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WT-TK showed no activity, as expected, but isolated yields of 2-10% were observed 
for the mutant TKs. One major problem observed during the purification of 68 was 
the formation of the rearranged product 128 (Scheme 3.4), which was promoted by 
acidic or basic conditions or by extended reaction times,
[85]
 as previously observed 
for the biomimetic reaction (Chapter 2). 
 
 
Scheme 3.4 Proposed mechanism for the formation of undesired rearranged ketodiol (128) in 
the TK reaction 
 
Formation of the rearranged ketodiol (128) was prevented by keeping the pH of the 
reaction as close to neutral as possible by performing the biotransformations in an 
autotitrator programmed to add 1 M HCl in a controlled fashion, to prevent an 
increase in pH as the reaction progressed.
[26, 85]
 
F434A gave the highest isolated yield of ketodiol 68 (10%), with no double addition 
product observed. The D469 mutants however, each gave 5% of double addition 
product 144 and consequently lower yields of desired ketodiol 68. The lack of 
double addition product (144) observed for F434A could be due to the increased 
accessibility to the active-site that the alanine mutation confers, allowing the ketodiol 
product to exit the enzyme active-site more readily, preventing formation of any 
double addition product in the active-site region. Interestingly, analysis of 382 
ThDP-dependent enzyme sequences previously described,
[86]
 showed that the 
position equivalent to F434 was always phenylalanine or tyrosine, except for benzoyl 
formate decarboxylase and benzaldehyde lyase enzymes where this residue was 
found to be alanine. This seemed to suggest that the F434A mutation was indeed 
important for the acceptance of aromatic rings in the active site of TK.
[85]
 The 
stereoselectivities of the transformations were interesting, with both D469K and 
F434A forming the product (68) in 82% ee, D469T in 70% ee and D469E a 
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racemate, which is in contrast to the consistently high stereoselectivities observed for 
the linear and cyclic aliphatic aldehydes.
[26]
 It also appeared that the aromatic 
ketodiols were formed with the opposite stereocentre to the aliphatic series, with the 
absolute stereochemistry tentatively assigned as (3R), using the same Mosher’s ester 
analysis method as previously described.
[26, 83, 85]
  
With enzymes in hand that could accept benzaldehyde, attention was then turned to 
the heteroaromatic aldehydes, furfural (145) (Table 3.2, R = C4H3O) and 
thiophenecarboxaldehyde (146) (Table 3.2, R = C4H3S), which were screened for 
their conversion to the corresponding ketodiols 147 (Table 3.2, R = C4H3O) and 148 
(Table 3.2, R = C4H3S). 
 
Table 3.2 Biotransformation of heteroaromatic aldehydes by single mutant TKs* 
 
Aldehyde WT-TK 
Yield % 
 (ee) 
D469E 
Yield %  
(ee) 
D469T 
Yield % 
(ee) 
D469K 
Yield % 
(ee) 
F434A 
Yield % 
(ee) 
 
0 
 
5 (147) 
(ND) 
3 (147) 
(ND) 
3 (147) 
(ND) 
1 (147) 
(ND) 
 
0 2 (148) 
(ND) 
3 (148) 
(ND) 
2 (148) 
(ND) 
1 (148) 
(ND) 
*Biotransformations of these substrates were carried out by James Galman. Reaction conditions: 1.0 
mmol aldehyde, 1.0 mmol LiHPA, 2 mL TK cell-free lysate, 20 mL total volume, 24 hour reaction 
time. 
 
As observed for benzaldehyde, WT-TK showed no activity with these substrates. 
F434A and the D469 series of mutants gave low yields (<5%) of the desired ketodiol 
products 147 and 148 with small amounts (<2%) of rearranged product observed. No 
double addition product was observed for either substrate. Efforts to determine the 
stereoselectivities of these transformations failed, however, as rearrangement to the 
corresponding rearranged ketodiols occurred upon attempts to derivatise the ketodiol 
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products either as benzoate esters for chiral HPLC or Mosher’s esters for 1H-NMR 
analysis.
[85]
 
Since aromatic aldehydes had been shown to be accepted by mutant TKs, aliphatic 
aldehydes containing aromatic groups were then investigated. Phenylacetaldehyde 
(149) was studied for its conversion to ketodiol 150 and 2-methylphenylacetaldehyde 
(151) for its conversion to ketodiol 152 (Table 3.3).  
 
Table 3.3 Biotransformations of phenylacetaldehyde (149) and 2-methyl phenylacetaldehyde 
(151) by single mutant TKs* 
 
Aldehyde WT-TK 
Yield % 
 (ee) 
D469E 
Yield %  
(ee) 
D469T 
Yield % 
(ee) 
D469K 
Yield % 
(ee) 
F434A 
Yield % 
(ee) 
 
5 (150) 
(93%, 3S) 
50 (150) 
 (90%, 3S) 
50 (150) 
 (96%, 3S) 
50 (150) 
(95%, 3S) 
48 (150)  
(97%, 3S) 
 
35 (152) 
(88%, 3S,4R) 
(12%, 3S,4S) 
30 (152) 
(95%, 3S,4R) 
(5%, 3S,4S) 
40 (152) 
(96%, 3S,4R) 
(4%, 3S,4S) 
38 (152) 
(95%, 3S,4R) 
(5%, 3S,4S) 
35 (152) 
(85%, 3S,4R) 
(15%, 3S,4S) 
*Biotransformations of these substrates were carried out by James Galman prior to the start of this PhD 
project. Reaction conditions: 1.0 mmol aldehyde, 1.0 mmol LiHPA, 2 mL TK cell-free lysate, 20 mL 
total volume, 24 hour reaction time. 
 
The transformation of phenylacetaldehyde (149) (Table 3.3, R = PhCH2) by WT-TK 
gave the desired ketodiol product (150) with an isolated yield of 5% in 93% ee, 
which was an improvement over the previously reported transformation of 
phenylacetaldehyde by WT-TK, where a mixture of isomers was isolated.
[87]
 The 
mutant enzymes showed 10-fold increases in yield over WT and F434A showed the 
highest stereoselectivity (97% ee, 3S). 2-Methyl phenylacetaldehyde (151) (Table 
3.3, R = PhCHCH3) had not been previously reported as a substrate for TK, so the 
formation of ketodiol 152 from WT-TK was encouraging. The mutant TKs gave 
comparable yields to WT of 152 and were enantioselective for (2R)-2-
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phenylpropanal, stereoselectively forming the (3S)-isomer in both cases, as 
previously observed for other aliphatic aldehydes.
[26]
 2-Hydroxy-2-
phenylacetaldehyde has previously been used as a substrate for E.coli WT-TK, and 
was also observed to form the (3S,4R)-isomer selectively.
[87]
  
To further probe possible hydrogen bonding interactions in the active site, initial 
studies at the beginning of this PhD were carried out with 3-hydroxybenzaldehyde 
(93) (Table 3.4, R = 3-OHC6H4), 4-hydroxybenzaldehyde (118) (Table 3.4, R = 4-
OHC6H4) and 4-chlorobenzaldehyde (99) (Table 3.4, R = 4-ClC6H4) and the TK 
single mutants (Table 3.4). These substrates were also chosen to establish whether 
the yields of the TK biotransformations could be affected by the addition of electron 
withdrawing or donating groups onto the aromatic ring, hence activating or 
deactivating the aldehyde to nucleophilic attack by the ThDP-enamine intermediate 
in the enzyme active site. 
 
Table 3.4 Biotransformations of 3-hydroxybenzaldehyde (99), 4-hydroxybenzaldehyde (118) 
and 4-chlorobenzaldehyde (99)* 
 
Aldehyde WT-TK 
Yield % 
 (ee) 
D469E 
Yield %  
(ee) 
D469T 
Yield % 
(ee) 
D469K 
Yield % 
(ee) 
F434A 
Yield % 
(ee) 
 
0  
 
0 
  
4 (103) 
 (0%) 
0 
 
6 (103) 
(53%, 3R) 
 
0 0 0 0 0 
 
0 0 0 0 0 
*Reaction conditions: 1.0 mmol aldehyde, 1.0 mmol LiHPA, 2 mL TK cell-free lysate, 20 mL total 
volume, 48 hour reaction time. 
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Again, none of these substrates were accepted by WT-TK. Disappointingly, 4-
hydroxybenzaldehyde (118) and 4-chlorobenzaldehyde (99) were not accepted by 
any of the mutants tested. 3-Hydroxybenzaldehyde (93), however, was accepted by 
two of the single mutants forming ketodiol 103. D469T gave a 4% isolated yield of 
the ketodiol product (103), which was formed as a racemate. F434A gave a similar 
isolated yield of 103 of 6%, but some stereoselectivity was observed for this mutant, 
forming the ketodiol product in 53% ee. It is interesting that D469T and F434A 
accept 3-hydroxybenzaldehyde (93), but not 4-hydroxybenzaldehyde (118). This 
suggests that either the active site is not large enough to accommodate para-
substituted benzaldehydes, or there is a hydrogen bonding interaction which orients 
3-hydroxybenzaldehyde into an active conformation, allowing it to react with the 
ThDP enamine in the active site, forming the ketodiol product.  
 
3.3 Chiral analytical methods for determining the 
stereoselectivities of aromatic ketodiols 
 
Two complementary methods were used to determine the stereoselectivities and 
absolute stereochemistries of the aromatic ketodiol products formed by single mutant 
TKs. Firstly, a chiral HPLC method was developed. Unfortunately, despite 
containing a chromophore the aromatic ketodiols themselves could not be analysed 
directly using chiral HPLC, as the two enantiomers could not be separated. Previous 
work with ketodiols had relied upon making either acetate or benzoate ester 
derivatives,
[26, 75]
 so these methods were investigated. It quickly became clear that 
the derivatisation procedure would have to be altered due to the increased acidity of 
the α-proton adjacent to the aromatic ring, which was easily removed under existing 
protocols, giving rise to rearranged (Scheme 3.4) and racemised products. By using a 
hindered 2,4,6-collidine base it was possible to derivatise the aromatic ketodiols as 
either the mono- or di-benzoate esters without racemisation of the ketodiol product.  
Firstly, the racemic products were prepared by the NMM-catalysed biomimetic 
reaction (as in Chapter 2) and di-benzoylated, then used to develop an appropriate 
HPLC method (Figure 3.1, blue). Stereoselective products were then prepared using 
the TK mutants, purified, derivatised and analysed by chiral HPLC (Figure 3.1, 
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black). The traces of the racemic derivatives could then be compared to the 
stereoselective derivatives to determine the ee of the TK reaction (Figure 3.1).  
 
 
Figure 3.1 Overlaid chiral HPLC traces of dibenzoylated (68) from the biomimetic reaction 
(blue) and F434A (black) 
 
The absolute stereochemistry was then tentatively assigned by preparing Mosher’s 
ester derivatives of the biotransformation products as previously described.
[26, 83]
 The 
observed difference in chemical shifts between the diastereotopic protons was used 
to assign the absolute stereochemistry, with the syn-isomer demonstrating a large 
chemical shift difference and the anti-isomer demonstrating a small chemical shift 
difference (Figure 3.2). The integrations for each isomer were then used to determine 
the major isomer, confirm the approximate ee and indicate the absolute configuration 
(Figure 3.2).  
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Figure 3.2 
1
H NMR Mosher's ester analysis for identification of the unknown absolute 
stereocentre in (68)
*
  
 
For example, if the ketodiol was derivatised with the (S)-Mosher’s acid chloride, the 
new centre formed would be the (R)-isomer, and by looking at the chemical shift 
difference between the diastereotopic protons the absolute configuration of the 
unknown centre could then be elucidated. This method also used the hindered 2,4,6-
collidine base to avoid rearrangement and racemisation of the ketodiol. Mosher’s 
ester analysis had previously been validated using aliphatic substrates of known 
stereochemistry and used to determine the absolute stereochemistry of products from 
aliphatic aldehydes. The Mosher’s method was further validated for ketodiols 150 
and 152 from aliphatic aldehydes which contained aromatic groups 
(phenylacetaldehyde (149) and 2-hydroxy-2-phenylacetaldehyde (151))
†
 where the 
(S)-isomer was shown to be formed preferentially, in agreement with previous 
reports.
[87]
 However no standards with known stereocentres were available for 
 
 
* Data shown for (S)-Mosher’s acid chloride was obtained by James Galman 
† Chiral analysis of these compounds was carried out by James Galman 
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testing the method when applied to aromatic ketodiols.
[83]
 Since these compounds 
were novel the absolute stereochemistries were only tentatively assigned. 
[87]
 For the 
ketodiols 68 and 103 from benzaldehyde (8) and 3-hydroxybenzaldehyde (99) 
Mosher’s ester analysis suggested that the (3R)-centre was formed. If correct, this 
would mean that the aromatic TK products were formed with the opposite 
stereochemistry to all of the aliphatic series
[26]
 possibly indicating that the aromatic 
aldehydes bound in a different fashion to the aliphatic aldehydes, resulting in 
formation of the opposite stereocentre. However, subsequent work has suggested that 
the Mosher’s method may not be applicable to aromatic ketodiols and will be 
discussed further in Chapter 5. 
 
3.4 Docking of benzaldehyde into D469T 
 
In an attempt to gain more understanding into the biotransformation of benzaldehyde 
(8) by D469T TK, computational docking was performed using Autodock 4 
modelling software. Since a crystal structure for D469T has not been solved, the 
crystal structure of WT TK from E. coli was mutated in silico and the structure 
minimised using the CHARMM force field to give a D469T structure which could 
be used for docking.
*
 To gain a more complete picture of the interactions between 
benzaldehyde and the TK active site, the ThDP-enamine intermediate was included 
in the structure of the protein used for docking. To do this, a structure of the ThDP-
enamine was drawn in Chemdraw 10.0, subjected to an MM2 energy minimisation 
in Chem3D 10.0 and then docked into the D469T structure which had been 
generated in silico. The ThDP conformation obtained within the active-site of D469T 
(Figure 3.3, orange) very closely matched that found in the crystal structure of WT-
TK co-crystallised with the ThDP-enamine intermediate (1QGD) (Figure 3.3, green), 
validating this modelling approach. 
 
 
 
* In silico mutation was carried out by Panwajee Payongsri 
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Figure 3.3. Active site of D469T TK with the ThDP enamine from the crystal structure of WT-
TK (1QGD) (green) and the ThDP-enamine configuration obtained from docking into D469T 
(orange) overlaid. 
 
The conformation obtained for the ThDP-enamine intermediate was then added to 
the D469T structure and this complex used as the protein input file for docking with 
benzaldehyde. This allowed interactions between benzaldehyde and the ThDP-
enamine to be considered by the docking program. Benzaldehyde was prepared for 
the docking run in a similar fashion to the ThDP-intermediate; it was drawn in 
Chemdraw 10.0, the energy was then minimised and this was used as the ligand 
input file for Autodock 4. Three main clusters were obtained from the docking 
(Figure 3.4). 
 
 
Figure 3.4 Three binding clusters obtained from docking benzaldehyde into D469T TK with the 
ThDP-enamine intermediate (orange) 
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The first cluster (Figure 3.4, A) was the lowest in energy, containing 21 
conformations. Each of these conformations was bound as shown, with a hydrogen 
bonding interaction between the carbonyl oxygen of benzaldehyde and the D259 
residue. This interaction held the benzaldehyde molecule at the entrance to the active 
site, orienting the aldehyde away from the ThDP-enamine intermediate, at a distance 
of 12.2 Å, too far away for nucleophilic attack by the ThDP-enamine to occur. This 
conformation was therefore considered to be unproductive. The second cluster 
obtained (Figure 3.4, B) was the most highly populated cluster, and again showed 
the benzaldehyde molecule being held at the entrance to the active site, this time by 
hydrogen bonding with S24 and G25. This kept the aldehyde away from the ThDP-
enamine intermediate at a distance of 7.8 Å, which was closer than in the previous 
cluster, but still too far away to be considered productive. The final cluster (Figure 
3.4, C) was the least populated of the three, and the highest in energy. The 
conformations in this cluster demonstrated hydrogen bonding not with the enzyme 
itself, but with the ThDP-enamine intermediate. Here, the carbonyl oxygen hydrogen 
bonded to the two hydroxyl groups of the ThDP-enamine, at a distance of 4.6 Å 
making it the only potentially productive conformation.  
While these docking results only gave limited insights into the binding of 
benzaldehyde in the TK active site, they still provided some useful information. It 
was clear that the ThDP-enamine should be included in the enzyme structure for all 
future docking experiments, to allow interactions between the substrates and the 
active ThDP-enamine intermediate to be considered. They showed that benzaldehyde 
exhibits low affinity for the active-site of TK and does not display any specific 
binding to the active site, but instead seems to get ‘trapped’ by acidic residues on the 
entrance to the active site, or indeed by interactions with the protein backbone. This 
could account for the low yields observed for the single mutant TKs tested. The 
higher conversions previously observed for aliphatic aldehydes with single mutant 
TKs had been rationalised by hydrogen bonding interactions between the aldehyde 
oxygen atom and two histidine residues (H26 and H261) which held the aldehydes 
above the ThDP-enamine intermediate, allowing nucleophilic attack to occur.
[26]
 
Such interactions were not observed in the docking with benzaldehyde. This could 
be due to the increased steric bulk of the aromatic ring, or the reduced 
conformational flexibility of the aldehyde. Hence, to increase the activity of TK with 
aromatic aldehydes, such as benzaldehyde, a new binding mode would need to be 
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introduced, either by adding functionality to the aromatic ring to increase affinity of 
the substrate to the active site of TK, or by modifying the active site itself. For 
example, by introducing π-stacking interactions, or mutating residues on the entrance 
to the active site, such as D259, to prevent ‘trapping’ of the aldehyde before entering 
the active-site. 
 
3.5 Summary of chapter 3 
 
In conclusion, the transformation of aromatic aldehydes, and aliphatic aldehydes 
containing aromatic groups, by single mutant TKs has been studied. Mutants were 
identified using a colorimetric assay, the utility of which was shown to be limited 
due its inability to distinguish between the desired ketodiol product and the double 
addition side-product. Chiral analysis methods were developed and showed that the 
single mutant TKs were capable of forming ketodiols with high degrees of 
stereoselectivity.
[85]
 Computational docking studies were performed which suggested 
that the low yields observed for the transformation of benzaldehyde could be due to 
low affinity for the TK active-site, resulting in extensive non-specific binding of the 
substrate to residues outside the active-site. 
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4 Aliphatic aldehydes with single and combination 
mutant TKs 
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Aliphatic aldehydes had previously been studied with single mutant TKs and a 
library of D469 mutations were identified, via a colorimetric assay, which accepted a 
range of cyclic and linear aldehydes.
[26]
 The same colorimetric assay was then used 
to identify mutants with activity towards aromatic aldehydes (Chapter 3).
[85]
 The 
yields obtained for the transformations of aromatic aldehydes by these mutants were 
around 10-fold lower than the yields obtained for aliphatic aldehydes.
[26, 85]
 This was 
due in part to competing side reactions, but computational docking also suggested 
that low substrate affinity could be a factor (Chapter 3). Therefore, to successfully 
transform aromatic aldehydes a new library of mutants was needed. Unfortunately, 
the previously used colorimetric assay had already been shown to be misleading in 
screening for activity against aromatic aldehydes as it could not distinguish between 
the desired ketodiol (68) and the “double addition” side-product (144) (Figure 
4.1).
[85]
 
 
 
Figure 4.1 Structures of desired aromatic ketodiol product (68) and undesired double addition 
product (144) 
 
Therefore, in an attempt to create a new generation of TK mutants with improved 
activities toward both aliphatic and aromatic aldehydes, combination mutants were 
created by selecting and combining existing active single mutations in an effort to 
create mutants with further improved activities, stereoselectivities and stabilities.
[88]
 
 
4.1 Creation of combination mutant libraries[88]* 
 
The first library of double mutants was created by recombining single mutations 
which had shown increased activity towards propanal (24) compared to WT. A29E, 
 
 
* All of the mutants in this section were created and studied by John Strafford, Panwajee Payongsri, 
Edward Hibbert, Phattaraporn Morris and Sukhjeet Batth from the UCL Department of Biochemical 
Engineering. 
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H461S and R520V had all previously been shown to improve activity towards 
glycolaldehyde (26)  and propanal (24),
[46, 47]
 and so were recombined, by colleagues 
in the Department of Biochemical Engineering, as combinations of double mutants. 
D469T and D469A had also been shown to improve activity with propanal and so 
were recombined with D259A, D259G, D259S and D259Y which had been shown 
to improve activities with both propanal and glycolaldehyde.
[46, 47]
 The double 
mutants were expressed and the soluble TK expression levels and activities with 
propanal were determined from their clarified lysates after sonication (Figure 4.2, 
white squares),
[88]
 on a 225 µL scale using a previously published HPLC method to 
detect product formation.
[47]
  
  
 
Figure 4.2 Observed trade-off between specific activity and soluble TK concentration for a 
range of mutants with propanal. Diamonds-previously identified single mutants, squares-
combination mutants made from active single mutants, triangles-combination mutants created 
after guidance by statistical coupling analysis.
[88]
 (Used with permission from Elsevier). 
 
All of the double mutants (Figure 4.2, white squares) showed marked decreases in 
specific activity and expression levels compared to the single mutants (Figure 4.2, 
black diamonds).
[88]
 Indeed a dramatic loss of either soluble protein expression, 
specific activity, or both was observed for these double mutants. This indicated that 
simply combining active single mutations would not be an effective strategy to 
create active combination mutants, since all of the mutants created in this fashion 
gave enzymes with severely impaired function, due to decreased protein stability.
[88]
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TK protein stability and function is maintained through highly conserved residues in 
the active-site which have evolved over time to create synergistic networks 
responsible for maintaining correct folding, cofactor binding and efficient 
catalysis.
[89]
 Introducing random mutations into such regions can disrupt these 
synergistic networks and give enzymes with severely impaired stability and function, 
as was observed (Figure 4.2, white squares).
[88]
 To avoid disruption of these 
networks, statistical coupling analysis (SCA)
*
 was applied to 382 sequences of 17 
different ThDP dependent enzymes types to identify co-evolved sites that may have 
been disrupted in the combination mutants for which severely impaired protein 
stability and function had been observed.
[88]
  
The SCA method identified a cluster of nine residues (R520, G467, D469, G470, 
T472, P486, P493, E498 and D495) which formed a co-evolved network within the 
active-site (Figure 4.3). Within this cluster there were two major spatial groups, 
D495, E498 and P493, that were found to cap the N-terminus of an α-helix which 
was 9 Å from R520 in the second group which packed against an active-site loop 
containing G467, D469, G470 and T472. The remaining residue, P486, was not 
observed to directly interact with either of these two groups, but formed part of a 
hairpin turn which brought the two groups in close proximity to each other.
[88]
  
 
 
 
* SCA was carried out by John Strafford 
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Figure 4.3 The nine residues forming a co-evolved network within the active-site of TK.
[88]
 (Used 
with permission from Elsevier). 
 
Further analysis of the protein structure gave insights into why these residues may 
have co-evolved with each other. D469, for example, was observed to form an 
electrostatic interaction with R520, which in turn formed a salt bridge with E468 (not 
shown) which was adjacent to D469 and G467.  
The inactive double mutants which had been created contained at least one residue 
found in this co-evolved cluster. Also, in every case the networked residues were 
mutated to amino acids not naturally found at that position, based on the 382 
sequences analysed. With these results in mind, it seemed important that in order to 
create active double mutants, one position could be maintained as any beneficial 
single mutation (whether naturally found at that position or not), for example 
D469T, while the other residue could only be mutated to an alternative natural 
variation, based on the 382 ThDP-dependent enzyme sequences studied. To test this 
theory, and to probe potential synergies between groups of residues, four double 
mutant libraries (G467X/D495X, D469X/R520X, D469X/E498X, E498X/R520X) 
and one triple mutant library (D469X/E498X/R520X) were created and screened 
against propanal (Table 4.1, mutants with >70% of WT activity shown in bold), 
using the same HPLC assay as for the previous set of double mutants.
[47, 88]
 
 
92 
 
Table 4.1 Library of combination mutants made to residues with the co-evolved network in TK. 
Variants with >70% activity of WT shown in bold. 
Residues mutated Library of variants Best variants (activity 
>70% WT)  
G467/D495 DVSA/NQEL V/L, D/E 
D469/R520 LTSA/GKQA T/Q, A/G, S/Q, S/G 
D469/E498 LTSA/DAVI None 
E498/R520 DAVI/GKQA V/Q, D/K 
 
Only the D469/R520 library gave variants with activities greater than WT. The 
initial set of double mutants, created by combination of active single mutants without 
considering co-evolution of residues, had demonstrated a severe loss of activity due 
to protein instability (Figure 4.2, white squares). This new library of double mutants, 
however, showed no such trend (Figure 4.2, red triangles). The total amount of 
soluble protein for the double mutants was shown to trade-off in a similar fashion to 
the initial active single mutants, indicating that these combination mutants no longer 
lost both stability and function. Therefore, despite all of the mutations causing 
protein instability to a certain extent, the positive synergy between the networked 
residues was enough to ensure that severe disruption of stability and function did not 
occur.  
R520Q was shown to increase the expression level of TK when combined with 
D469S, so other D469 mutations were then recombined with R520Q to see whether 
more active combination mutants could be created. D469T/R520Q had been 
identified as an active mutant in the previous screen (Table 4.1), and so was 
investigated further. D469Y had previously been shown to reverse the 
stereochemistry of the biotransformation of  propanal (24),
[48]
 so this double mutant 
was also investigated (Figure 4.4). D469Y/R520Q demonstrated no synergy, but 
D469T/R520Q showed positive synergy, with the experimentally determined 
specific activity for propanal exceeding that expected from the additive accumulation 
of improvements for the single mutants (Figure 4.4).  
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Figure 4.4 Effect of recombining R520V and R520Q with D469 mutants. Experimental specific 
activities shown in black, expected specific activities from additive effects of single mutants 
shown in white.
[88]
 (Used with permission from Elsevier). 
 
Indeed, D469T/R520Q gave the highest specific activity that had been obtained for 
any TK mutant to date under the same conditions.
[88]
  
 
4.2 Biotransformations of aliphatic aldehydes with single 
and combination mutant TKs 
 
All of the combination mutants which had been created in the SCA study had only 
been investigated for their use as biocatalysts in terms of specific activities, which 
had been studied using HPLC analysis of 225 µL scale reactions by colleagues from 
the Department of Biochemical Engineering.
[88]
 No isolated yields or 
stereoselectivity data from scaled-up reactions had been established. Hence, a range 
of these combination mutants and their representative single mutants were used in 
scaled-up (20 mL) biotransformations with a range of aliphatic aldehydes, firstly 
with propanal (24) and LiHPA (Li-23) to form ketodiol 25 (Table 4.2). Products 
were isolated, purified and stereoselectivities determined using the previously 
described chiral HPLC analysis of mono-benzoate ester derivatives.
[26]
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Table 4.2 Isolated yield and stereoselectivity data obtained for the biotransformation of 
propanal by single, double and triple mutant TKs* 
 
Entry Mutant Yield ee 
1 WT
[26]
 36% 58% (3S) 
2 F434A 18% 63% (3S) 
3 D469E 70% 95% (3S) 
4 D469T
[26]
 68% 64% (3S) 
5 D469Y 11% 68% (3R) 
6 H461S 13% 64% (3S) 
7 A29E 7% 50% (3S) 
8 H26Y
[26]
 63% 88% (3R) 
9 A29E/H461S 3% 33% (3S) 
10 A29E/R520V 4% 40% (3S) 
11 A29E/H461S/R520V 4% 21% (3S) 
12 H26Y/D469Y 4% 38% (3S) 
13 D469Y/R520V  51% 85% (3R) 
14 F434A/R520Q 43% 63% (3S) 
15 D469Y/R520Q 42% 65% (3R) 
16 D469T/R520Q 32% 68% (3S) 
*All mutants in this section were created by Panwajee Payongsri. WT and single mutant data 
previously recorded is indicated. Reaction conditions: 50 mM aldehyde. 50 mM LiHPA, 2 mL TK 
cell-free lysate, 20 mL reaction volume, 24 hour reaction time. 
 
F434A (entry 2) was a mutant which had been previously engineered to be active 
towards aromatics,
[85]
 so the lower yield of ketodiol (25) formed compared to the 
best performing D469E and D469T mutants was not surprising. Interestingly though, 
the 18% yield of 25 produced by F434A was still higher than the yields observed for 
this mutant with aromatic aldehydes,
[85]
 indicating the general preference of TK for 
aliphatic aldehydes over aromatics, as reflected by the in vivo WT substrates. D469E 
(entry 3) was the best performing single mutant with propanal, giving a 70% yield of 
25 and comparable stereoselectivity to the 90% ee previously reported for this 
mutant.
[26]
 D469Y (entry 5) had been previously identified as a mutation which 
reversed the stereoselectivity of ketodiol 25.
[48]
 The biotransformation of propanal 
(24) by D469Y had not been scaled-up previously however, so an 11% isolated yield 
was slightly disappointing, however a reversal of stereochemistry was once again 
observed, with 68% ee for the 3R-isomer, compared to the 53% ee previously 
reported in the small-scale reaction for this mutant.
[48]
 This increase in ee could have 
been due to the pH of the reaction being carefully controlled throughout the reaction, 
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preventing racemisation of the ketodiol product (25). H461S and A29E were 
mutations which had previously been identified as increasing the specific activity of 
TK toward propanal on a 250 µL scale,
[47]
 but the scaled-up reactions had not been 
investigated. An isolated yield of 13% of 25 was observed for H461S (entry 6), with 
an ee of 64% for 3S-(25). A29E (entry 7) gave a lower isolated yield of 25 of 7% 
with an ee of 50% also for the 3S-product. Combining these two mutations to make 
A29E/H461S (entry 9) gave an enzyme with severely reduced activity. Only a 3% 
isolated yield of 25 was obtained, and an ee lower than both of the individual single 
mutations of 33% (3S) was observed. This is consistent with the impaired stability 
and function demonstrated by the soluble enzyme expression level and specific 
activity data obtained for A29E/H461S (Section 4.1, Figure 4.2).
[88]
 A mutant, 
R520V, had previously been shown to increase the activity of TK towards 
propanal,
[47]
 but combination of this mutant with A29E, in A29E/R520V (entry 10), 
did not improve the yields or stereoselectivities with propanal, with only a 4% yield 
and 40% ee of 3S-25 observed. Addition of R520V to A29E/H461S did not restore 
the function of this mutant either, with only a 4% yield of 25 obtained in 21% ee 
(3S) produced by A29E/H461S/R520V (entry 11). H26Y had previously been shown 
to be an effective reverser of stereochemistry in the formation of 25,
[26]
 and so was 
combined with D469Y to establish whether a more active double mutant could be 
made which further reversed the stereochemistry of 25. Interestingly though, this 
double mutant, H26Y/D469Y (entry 12), not only gave a lower isolated yield than 
both of the individual single mutants, but the observed stereochemistry was also 
opposite to what was expected, with 3S-(25) formed in 4% yield with 38% ee. This 
suggested that the structure of the enzyme must have been severely altered by the 
introduction of these two mutations, affecting not only the activity of the enzyme, 
giving greatly reduced yields, but changing the shape of the active-site such that the 
opposite enantiomer was formed compared to the individual single mutants.  
The combination mutants; A29E/H461S (entry 9), A29E/R520V (entry 10), 
A29E/H461S/R520V (entry 11) and H26Y/D469Y (entry 12) were all examples of 
combining two, or more, active single mutations in an attempt to create a more active 
double mutant, but obtaining an enzyme with drastically reduced function (Section 
4.1). This was demonstrated by the lower yields and ees observed for the 
combination mutants when compared to their parent single mutants. These results 
supported the hypothesis that blindly combining active single mutants was not an 
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effective strategy to develop new biocatalysts due to the disruption of the co-evolved 
network found in the TK active-site (Section 4.1).
[88]
  
Four mutants were tested which had been created to prevent disruption of the co-
evolved network of residues in the TK active site. D469Y/R520V was a mutant 
which had been shown to exhibit negative synergy, with a specific activity lower 
than expected from the accumulative effects of the two single mutants.
[88]
 However, 
the scaled-up biotransformation of propanal (24) by D469Y/R520V (entry 13) gave 
an almost 5-fold increase in isolated yield over D469Y and an excellent ee of 85% 
for the 3R-isomer. F434A/R520Q (entry 14) also gave an increased yield (43%) of 
ketodiol 25 over the parent mutant F434A, whilst not affecting the stereochemical 
outcome as both mutants formed the 3S-isomer in 63% ee. The increase in isolated 
yield for F434A/R520Q can be explained by R520Q stabilising the double mutant 
and increasing the expression level of TK, as previously observed for R520Q in 
combination with other mutations.
[88]
 The same can be said for D469Y/R520Q (entry 
15), where the yield of 25 was increased to 42%, nearly a 4-fold increase over the 
parent D469Y enzyme. However, D469T/R520Q gave a lower yield of ketodiol 25 
than the individual single mutant, D469T, despite D469T/R520Q exhibiting the 
highest specific activity toward propanal reported to date. The low yield could be 
explained by a decreased expression of soluble protein compared with D469T.
[88]
 
With several combination mutants identified which improved the biotransformation 
of propanal compared to WT,
[88]
 longer chain aliphatic aldehydes were investigated 
with the best combination mutants to establish the substrate scope of these new TK 
mutants. Firstly, the TK reaction of butanal (120) with LiHPA (Li-23) was 
investigated with D469Y (which had not been previously studied with this 
substrate), and the D469Y double mutants (Table 4.3). Stereoselectivities of ketodiol 
123 were once again assessed by chiral HPLC of mono-benzoate ester derivatives, 
using previously described methods.
[26]
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Table 4.3 Isolated yield and stereoselectivity data for single and double mutant TKs with 
butanal* 
 
Mutant Yield ee 
D469Y 9% 45% (3S) 
D469Y R520V 8% ND 
D469Y R520Q 10% 17% (3R) 
*Reaction conditions: 50 mM aldehyde. 50 mM LiHPA, 2 mL TK cell-free lysate, 20 mL reaction 
volume, 24 hour reaction time. 
 
The D469Y mutant gave only 9% isolated yield of ketodiol 123, formed with an ee 
of 45% in favour of the 3S-isomer. This was a similar yield as observed for the 
biotransformation of propanal (24) by D469Y, but with a lower ee in favour of the 
opposite stereoisomer. The best performing mutant with butanal was previously 
found to be D469E where a 44% yield and an ee of 98% was observed,
[26]
 D469Y 
compares unfavourably to this. Indeed, the combination mutants performed just as 
unfavourably, with 8% and 10% isolated yields observed for D469Y/R520V and 
D469Y/R520Q respectively.  
It seemed as if these combination mutants were less tolerant to longer chain aliphatic 
aldehydes, giving lower yields and stereoselectivities than for propanal (24). To 
further investigate this, pentanal (121) was then used as a substrate (Table 4.4) in the 
TK reaction with LiHPA (Li-23) to assess yields and stereoselectivities of resulting 
ketodiol 124. 
 
Table 4.4 Isolated yield and stereoselectivity data for single and double mutant TKs with 
pentanal* 
 
Mutant Yield ee 
D469Y 8% 50% (3S) 
D469Y R520V 10% ND 
D469Y R520Q 10% 44% (3S) 
*Reaction conditions: 50 mM aldehyde. 50 mM LiHPA, 2 mL TK cell-free lysate, 20 mL reaction 
volume, 24 hour reaction time. 
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A similar trend was observed for the transformation of pentanal (121) by these 
double mutants as for the transformation of butanal. A negligible increase in yield of 
124 was observed for D469Y/R520V and D469Y/R520Q, both giving 10% isolated 
yields of 124 compared to D469Y (8% yield), but the ee was not improved. 
Interestingly, while D469Y was shown to reverse the stereochemistry of the propanal 
transformation forming ketodiol (25) in 68% ee (3R), the transformation of the 
longer chain aldehydes, butanal (120) and pentanal (121), by D469Y gave the 3S-
isomer in both cases. This suggested that longer chain aliphatics were oriented 
differently within the active site, binding in a different conformation to propanal (24) 
and favouring formation of the opposite stereoisomer. Indeed, previous docking 
studies have suggested the presence of an alternative binding mode for propanal 
compared with longer chain aliphatics.
[26]
 
The fact that the combination mutants did not perform as well with the longer chain 
aliphatic aldehydes, butanal (120) and pentanal (121), compared to propanal (24) is 
perhaps not surprising, given that the screening of the combination mutant libraries 
was performed using propanal, and so only mutants that performed well with this 
substrate were selected. Also if the longer chain aliphatic aldehydes are indeed 
oriented differently within the TK active site, as previously suggested,
[26]
 then it is 
not surprising that mutants active towards propanal would not necessarily be active 
with longer chain aliphatic aldehydes. 
To further investigate the substrate scope of these combination mutants and to 
ascertain whether they would possibly be able to accommodate larger cyclic or 
aromatic substrates, a bulky cyclic aliphatic, 3,4-dimethylcyclohex-3-
enecarbaldehyde (122), was used as a substrate in the TK reaction with LiHPA (Li-
23) to form 125 (Table 4.5). This substrate had been previously investigated in the 
biomimetic reaction, and was prepared in the same fashion (Chapter 2). 
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Table 4.5 Isolated yield data for single, double and triple mutants with 3,4-dimethylcyclohex-3-
enecarbaldehyde* 
 
Mutant Yield 
F434A 11% 
D469T 10% (98% 1S,1’R)
†
 
D469Y 0% 
H461S Trace 
A29E 0% 
H26Y 0% 
A29E H461S 0% 
A29E R520V 0% 
A29E H461S R520V 0% 
H26Y D469Y 0% 
D469Y R520V  0% 
F434A R520Q Trace 
D469Y R520Q Trace 
*Reaction conditions: 50 mM aldehyde. 50 mM LiHPA, 2 mL TK 
cell-free lysate, 20 mL reaction volume, 24 hour reaction time. 
†Transformation of this substrate with D469T was performed 
previously by James Galman 
 
None of the combination mutant TKs formed isolable quantities of product with this 
substrate (122), which is not necessarily surprising given the complexity of the 
substrate compared to propanal (24), which the mutants had been screened against. 
Interestingly though, two of the single mutants, F434A and D469T, did accept the 
substrate with 11% and 10% isolated yields of 125 obtained, respectively. Both of 
these mutants had previously been shown to accept aromatic substrates,
[85]
 so their 
acceptance of the sterically-demanding 3,4-dimethylcyclohex-3-enecarbaldehyde 
(122) was pleasing. Given that R520Q had previously been shown to improve the 
specific activity of D469T/R520Q towards propanal (24) it is interesting to note that 
in combination with F434A in F434A/R520Q it did not increase the activity of this 
mutant towards 3,4-dimethylcyclohex-3-enecarbaldehyde (122) with only trace 
amounts of product observed (125). 
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4.3 Summary of chapter 4 
 
In conclusion, the transformation of aliphatic aldehydes by combination mutant TKs 
has been studied in detail. TK mutants made through the combination of active-
single mutant TKs showed dramatically impaired structure and function. Further 
investigation showed that only certain combinations of mutations could be made to 
avoid the disruption of a co-evolved network of residues within the TK active-site. 
Combination mutants made on this basis were shown to maintain structure and 
function. Isolated yield and stereoselectivity data supported these studies, with 
drastically reduced yields and stereoselectivities observed for combination mutants 
made from combinations of active single mutants. Combination mutants made 
considering the co-evolution of residues in the active-site showed greatly increased 
yields and stereoselectivities over the previous set of combination mutants, and 
indeed over WT and some existing single mutants. These combination mutants did 
not seem to exhibit a broad substrate scope however, with low yields and 
stereoselectivities observed for the transformation of other aliphatic aldehydes. The 
knowledge gained from the study of these combination mutants would prove 
invaluable in the creation of combination mutant TK libraries for the transformation 
of aromatic aldehydes (Chapter 5). 
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5 Aromatic aldehydes with combination mutant TKs 
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A range of combination mutant TKs had been created guided by a statistical 
coupling analysis method (Chapter 4).
[88]
 This involved taking into account the co-
evolution of certain active-site residues when creating combination mutants, to 
prevent the disturbance of a co-evolved network of residues crucial for enzyme 
structure and function.
[88]
 This method led to the generation of a mutant, 
D469T/R520Q, which had the highest specific activity reported for any mutant with 
propanal (Chapter 4).
[88]
 Since previous single mutant TKs had given low yields and 
variable stereoselectivities with aromatic aldehydes, it was hoped that combination 
mutant TKs might have increased activities with aromatic substrates. As a starting 
point, the previously prepared library of combination mutants, identified from 
screening propanal as a substrate, was tested with benzaldehyde (8) (Table 5.1) and 
LiHPA (Li-23) and isolated yields and stereoselectivities of the ketodiol 68 were 
determined (Table 5.1). Selected single mutants that were previously generated and 
incorporated into combination mutants were also tested. 
 
Table 5.1 Isolated yields and stereoselectivities for the transformation of benzaldehyde (8) by 
mutant TKs* 
 
Entry Mutant Yield ee 
1 F434A
[85]
 10% 82% (R) 
2 D469E
[85]
 2% 0 % 
3 D469T
[85]
 2% 70% (R) 
4 D469K
[85]
 2% 82% (R) 
5 D469Y 4% 0% 
6 H461S 4% 0%  
7 A29E 3% 0%  
8 A29E H461S 3% 0% 
9 H26Y D469Y 5% 0% 
10 A29E R520V 4% 0% 
11 D469Y R520V  3% 0% 
12 A29E H461S R520V 7% 0% 
13 F434A R520Q 3% 18% (R) 
14 D469Y R520Q 2% 0% 
15 D469T R520Q 3% 54% (R) 
*Mutant TKs were created by Panwajee Payongsri. Reaction conditions: 50 mM benzaldehyde, 50 
mM Li-HPA, 2 mL TK cell-free lysate, 20 mL total reaction volume, 48 hour reaction time. 
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Stereoselectivities were assessed by chiral HPLC analysis of the mono-benzoate 
ester derivatives of ketodiol products, and absolute stereochemistries were assigned 
based on previous chiral HPLC retention time data
[85]
, for which absolute 
stereochemistries had been tentatively assigned by a Mosher’s ester analysis.[85]  
No significant improvements were witnessed for any of the single or combination 
mutants. D469Y (entry 5), a mutation observed to reverse the stereoselectivity of the 
propanal reaction,
[48]
 gave rise to no stereoselectivity in the transformation of 
benzaldehyde and no improvements in the yield of ketodiol 68 over previous 
mutants. This is perhaps not surprising given that adding a tyrosine residue into the 
active-site of TK would restrict the access of benzaldehyde into the TK active-site 
because of increased steric hindrance. H461S (entry 6) and A29E (entry 7) had both 
been previously observed to increase the specific activity of TK towards propanal,
[47]
 
but did not increase the isolated yield or ee of 68, either as single mutants or double 
mutants (entry 8). H26Y, along with D469Y, had been shown to reverse the 
stereoselectivity of the TK reaction with propanal,
[26]
 but combining these mutants in 
H26Y/D469Y (entry 9) gave no stereoselectivity in the transformation of 
benzaldehyde. Combinations of these mutants, A29E, H461S and D469Y, with 
another mutant which had been shown to increase the activity of TK towards 
propanal, R520V (entries 10-12),
[47]
 gave no improvements in yield over the best 
performing single mutant, F434A. Interestingly, the yields observed for these 
mutants with benzaldehyde were similar to those for the reaction of the combination 
mutants with propanal (Chapter 4), again suggesting loss of enzyme stability and/or 
function. Since F434A was still the most active single mutant with benzaldehyde,
[85]
 
it was thought that by combining this mutant with R520Q, which had been shown to 
increase the expression level of soluble TK,
[88]
 that F434A/R520Q (entry 13) might 
increase the yields of ketodiol 68. Disappointingly however, this mutant only gave a 
3% isolated yield of 68 with only marginal stereoselectivity observed, forming 
ketodiol (68) in an 18% ee. It seemed that in this case adding the R520Q mutation 
was not beneficial, leading to a 7% lower yield of 68 and a major decrease in 
stereoselectivity from 82% to 18% ee when compared to F434A. In fact, adding 
R520Q to both D469T and D469Y gave no improvement in yield or stereoselectivity 
over the parent mutants either. D469Y/R520Q (entry 14) gave a comparable yield of 
68 as for D469Y, with both mutants forming racemic ketodiol 68. D469T/R520Q 
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(entry 15) gave a similar yield of 68 as D469T, but a lower ee of 54% was observed 
compared to 70% with D469T.  
By investigating these combination mutants in the transformation of benzaldehyde to 
68 it was clear, from the low yields and poor stereoselectivities observed, that these 
mutants gave no improvement over previously identified single mutants.
[85]
 The 
addition of mutations, such as R520Q, which had been proven to improve TK 
expression, stability and activity toward propanal (chapter 4),
[88]
 showed no 
improvement in the transformation of benzaldehyde. Therefore, a different approach 
was needed in order to identify combination mutants that would transform aromatic 
aldehydes in good yields and stereoselectivities. 
 
5.1 Probing TK active-site with formylbenzoic acid 
 
Previous docking studies with benzaldehyde (8) and the in silico generated variant 
D469T (Chapter 2) had shown only one productive conformation, where the 
aldehyde oxygen atom formed hydrogen bonding interactions with the ThDP 
intermediate in the active-site (Figure 5.1, C). The only other conformations 
identified from the docking experiment involved non-specific binding of the 
benzaldehyde molecule to acidic residues at the entrance to the active-site (Figure 
5.1, A), and to the protein backbone preventing entrance to the active-site (Figure 
5.1, B).  
 
 
Figure 5.1 Conformations obtained from the computational docking of benzaldehyde (8) into 
D469T. (ThDP-enamine intermediated shown in orange). 
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These docking results suggested that specific interactions between benzaldehyde and 
the TK active-site would have to be introduced in order to increase the activity of TK 
with aromatic substrates. It was therefore necessary to probe the active-site 
interactions with the natural substrate, ribose-5-phosphate further, to determine if 
any structural features could be exploited to improve the acceptance of aromatic 
substrates by TK. With this in mind, the X-ray crystal structure of TK with ThDP 
and the natural substrate, ribose-5-phosphate (R5P) (20), bound (2R5N)
[90]
 was 
analysed (Figure 5.2). 
 
Figure 5.2 Structure of R5P (20) and crystal structure of E. coli WT TK with R5P bound 
(2R5N)
[90]
  
 
Analysis of this structure showed two main binding regions, one region (H26, H261, 
S385, D469) responsible for binding the hydroxyl groups of R5P, and the other 
region (S385, R358, H461, R520) involved in binding of the phosphate group. 
Previous work directing TK activity towards hydroxylated aliphatic aldehydes has 
shown that D469, along with H26 and H261, is crucial for the binding of 
hydroxylated substrates,
[47]
 as observed in this crystal structure (Figure 5.2). Also, 
mutation of the phosphate binding region has been carried out to effectively improve 
the acceptance of non-phosporylated substrates by TK.
[46]
 Since docking studies had 
suggested that the acceptance of aromatic aldehydes by mutant TKs was poor 
potentially due to a lack of specific interactions between the substrate and the active-
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site, it was envisaged that the natural phosphate binding region could be exploited to 
increase specific interactions. If aromatic aldehyde substrates bearing a phosphate, or 
phosphate mimic, were used as substrates for TK, this moiety could interact with the 
phosphate binding region, potentially increasing the affinity of TK towards aromatic 
aldehydes. 
Since D469T had already been shown to be a useful mutation for increasing the 
acceptance of non-α-hydroxylated aldehydes, particularly cyclic aldehydes,[26, 47] this 
mutant was used as a starting point for computational docking studies. 
Formylbenzoic acids, such as 3-formylbenzoic acid (3-FBA) (97) (Figure 5.3) and 4-
formylbenzoic acid (4-FBA), bearing carboxylic acid functionalities at the meta  and 
para-positions respectively, were considered useful probes for studying active-site 
interactions with the phosphate binding region. 2-Formylbenzoic acid was 
considered to be too sterically hindered, and so was not investigated. 3-FBA was 
initially used as the substrate in docking studies with D469T.
[91]
 
 
 
Figure 5.3 3-Formylbenzoic acid (3-FBA) (97) with the phosphate mimic carboxylate group 
highlighted 
 
D469T was prepared in silico by mutation of the WT-TK crystal structure 2R5N.
*
 
The active enamine intermediate of ThDP and HPA was created in silico and docked 
separately into D469T. This complex was then used as the protein structure for 3-
FBA to be docked into, allowing the interactions between the substrate and the 
ThDP-enamine intermediate to be considered by the docking program, as described 
in Chapter 3.
[91]
 
The docking results were very encouraging. Whereas previous docking experiments 
with benzaldehyde had demonstrated the non-specific binding of benzaldehyde with 
the enzyme (Figure 5.1), with most conformations found at the entrance to the active 
 
 
* In silico mutation was carried out by Panwajee Payongsri 
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site (Figure 5.1 A and B), the results with 3-FBA were very different. The most 
populated cluster of conformations showed 97 bound by the phosphate binding 
region of S385, H461, R358 and R520 (Figure 5.4), in a similar docking 
conformation as observed for the natural substrate, R5P (20), in WT TK. (Figure 
5.2).
[90]
  
 
 
Figure 5.4 Most populated cluster obtained by docking of 3-FBA (97) into D469T. (ThDP-
enamine shown in orange) 
 
In addition to the carboxylate interactions with the phosphate binding region, the 
docking also showed a hydrogen bond between H26 and the aldehyde oxygen atom, 
holding it in an active conformation at a distance of 4.9 Å from the active ThDP-
enamine intermediate. While D469T has been shown to be an important mutation for 
the acceptance of non-α-hydroxylated substrates, as it prevents the burial of a 
positive charge upon substrate binding and removes a hydrogen bond,
[26]
 it also 
appeared that for aromatic aldehydes the D469T mutation was important on steric 
grounds to allow the entrance of bulky substrates into the active site. Alignment of 
the WT structure and D469T structure showed that D469 would be only 2.9 Å away 
from the aromatic ring of 3-FBA compared to 4.1 Å in D469T. 
[91]
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5.2 Screening of 3-formylbenzoic acid with TK mutants 
 
Encouraged by these docking results, 3-FBA (97) was screened against WT-TK, 
D469T, D469Y and F434A in small-scale biotransformations with LiHPA (Li-23) to 
form ketodiol (108) (Table 5.2). Aldehyde consumption was followed by HPLC 
analysis to allow preliminary conversion yields to be rapidly established without a 
pure product standard (Table 5.2).
[91]
  
 
Table 5.2 Conversions obtained for the transformation of 3-formylbenzoic acid (97) by mutant 
TKs* 
 
Mutant Isolated yield with benzaldehyde Conversion of 97 
WT 0%
[85]
 0% 
D469T 2%
[85]
 65% 
D469Y 4% 0% 
F434A 10%
[85]
 0% 
*Screening carried out by Panwajee Payongsri. Reaction conditions; 50 mM 3-FBA, 50 mM Li-
HPA, 30 µL TK cell-free lysate, 50 mM tris buffer (300 µL total volume). Conversion yields were 
determined after 24 hours. 
 
HPLC analysis showed that of all the mutants only D469T gave any observable 
product formation with a 65% conversion yield to ketodiol (108), representing a 
potential 30-fold increase in yield over the conversion of benzaldehyde by D469T.
[85]
 
Further HPLC analysis of the progression of the reaction showed that the reaction of 
97 with D469T reached its peak conversion of 65% after only 2 hours, compared to 
the 17 hours required to reach a 2% yield for the reaction of benzaldehyde with 
D469T, representing a 250-fold increase in specific activity for 3-FBA over 
benzaldehyde for D469T.
[91]
 
Interestingly, while D469T gave a 65% conversion yield of 108, D469Y showed no 
conversion whatsoever, suggesting steric hindrance was a key factor for the 
acceptance of 97 by D469T compared to D469Y. The tyrosine side chain would have 
a much greater steric bulk than aspartic acid or threonine, and could completely 
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restrict access of 3-FBA into the active site.
[91]
 Interestingly, F434A, which had been 
shown to be the most active mutant toward benzaldehyde,
[85]
 did not accept 3-FBA. 
This suggested that while the mutation of phenylalanine for alanine gave a 
hydrophobic pocket large enough to accommodate the steric bulk of the aromatic 
ring of benzaldehyde, it did not accept 3-FBA in a productive orientation to allow 
catalysis to occur.
[91]
 
In an effort to further understand the influence of the phosphate binding residues, 
R358, H461 and R520, on the conversion of 97, a series of mutations were made at 
these positions. These were based on previously identified functional mutations 
which had been shown to lower the affinity of TK for phosphorylated substrates,
[37]
 
and increase activity toward non-phosphorylated substrates.
[46]
 The influence of 
these residues on phosphorylated substrates made them ideal candidates for studying 
the binding of a phosphate mimic, such as a carboxylate group, in this case. These 
combination mutants were first screened with 3-FBA, in the same fashion as for the 
single mutants (Table 5.2). Conversions to 108 were again assessed by HPLC, based 
on the consumption of aldehyde 97 in the reaction after 24 hours.
[91]
 
 
Table 5.3 Conversions obtained for the transformation of 3-FBA (97) by TKs with mutations at 
phosphate binding residues* 
 
Mutant Conversion of 97 
[91]
 
WT 0% 
D469T 65% 
H461S/D469T 65% 
D469T/R520Q 65% 
H461S/D469T/R520Q 65% 
R358P/D469T 65% 
R358L/D469T <10% 
R358P/D469T/R520Q 14% 
*Screening carried out by Panwajee Payongsri after collaborative 
discussions. Reaction conditions; 50 mM 3-FBA, 50 mM Li-HPA, 30 
µL TK cell-free lysate, 50 mM tris buffer (300 µL total volume). 
Conversion yields were determined after 24 hours. 
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All of the mutants, except for R358L/D469T and R358P/D469T/R520Q, gave 
approximately 65% conversion yields of 108, even after multiple experimental 
repeats, suggesting product inhibition to the same extent for all mutants.  
The kinetic parameters for all of these mutants were obtained, to further investigate 
the effects of these mutations.
[91]*
 The results showed that affinity for 3-FBA (97) 
was increased by the removal of a positive charge from the phosphate-binding region 
in the TK active-site. This is plausible, given that the TK active-site has evolved to 
bind phosphate groups in the natural TK substrates such as, R5P, which has a charge 
of -2 (pKa1 1.2, pKa2 6.6) and the carboxylate functionality of 3-FBA has a charge of 
-1 (pKa 3.85). Since removal of a positive charge from the active-site increased its 
affinity for 3-FBA, it seemed that the close proximity of the two positively charged 
arginine residues, R358 and R520, interacting with the positively charged H461, 
might be destabilising when interacting with 3-FBA which has a single negative 
charge. Charge neutralising mutations such as R358P, H461S or R520Q would 
remove this destabilisation, caused by the burial of an additional positive charge, and 
hence increase the affinity of TK for 3-FBA. When both positive charges were 
removed the affinity increased again, potentially due to repositioning of 3-FBA in 
the active-site stabilised by an interaction with other positively charged active-site 
residues. Despite all of the charge-neutralising mutations increasing the affinity of 
TK for 3-FBA, the kinetics showed that the turnover for all combination mutants 
was decreased compared to D469T suggesting that removal of a positive charge from 
the active site, by mutation of R358, H461 or R520, resulted in unfavourable 
repositioning of the aldehyde relative to the ThDP-enamine intermediate.  
In order to understand the active-site interactions responsible for the increase in 
affinity but decrease in turnover for 3-FBA with the combination mutant TKs, 
computational docking was carried out with D469T/R520Q (Figure 5.5).
†
 This 
mutant had shown a 4-fold decrease in affinity and a corresponding 2-fold decrease 
in turnover compared to D469T.
[91]
 
 
 
 
* Kinetic studies were performed by Panwajee Payongsri 
† In silico mutation was carried out by Panwajee Payongsri after collaborative discussions 
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Figure 5.5 Results obtained for docking 3-FBA (97) into D469T/R520Q (ThDP-enamine shown 
in orange). 
 
Compared to the docking results obtained for 3-FBA with D469T (Figure 5.4), the 
binding with D469T/R520Q was slightly different. A small shift of 3-FBA towards 
R358 was observed, resulting in the removal of a hydrogen bond between the 
carboxylate group and S385 and the introduction of a new hydrogen bond between 
the aldehyde oxygen atom and S385. This interaction moved the aldehyde further 
away from the ThDP-enamine intermediate, to a distance of 6.6 Å, compared to a 4.9 
Å distance observed for 3-FBA and D469T. This increase in distance between the 
aldehyde moiety and the ThDP-enamine intermediate could help to explain the 2-
fold lower turnover observed for D469T/R520Q compared to D469T.
[91]
 
 
5.3 Screening of 4-formylbenzoic acid with TK mutants 
 
With the encouraging activities observed for TK mutants and 3-FBA, a related 
substrate, 4-formylbenzoic acid (153) (4-FBA), was investigated in the TK reaction 
with LiHPA (Li-23). The same range of mutants was screened as with 3-FBA, using 
the same conditions. The conversion yields to ketodiol 154 were assessed by HPLC 
analysis which was used to determine the consumption of 4-FBA (153) in the 
reactions after 24 hours (Table 5.4).
[91]
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Table 5.4 Conversions obtained for the transformation of 4-FBA (153) by mutant TKs* 
 
Mutant Conversion of 153 to 154 
WT 0% 
D469T 30% 
D469Y 0% 
D469K ND 
D469E ND 
F434A 0% 
*Screening carried out by Panwajee Payongsri. Reaction 
conditions; 50 mM 4-FBA, 50 mM Li-HPA, 30 µL TK 
cell-free lysate, 50 mM tris buffer (300 µL total volume). 
Conversion yields were determined after 24 hours. 
 
The results with 4-FBA (153) as a substrate followed a similar trend to those for 3-
FBA (97). Only D469T gave any observable product, with a conversion yield to 154 
of 30%. D469Y still gave no product (154), again possibly due to the extra steric 
bulk introduced to the active-site by the mutation of aspartic acid to tyrosine. While 
the conversion yield observed for D469T with 4-FBA (153) still represented a large 
increase in activity compared to D469T with benzaldehyde,
[85]
 the 30% conversion 
yield was less than half that observed for D469T with 3-FBA as the substrate. To 
investigate this 4-FBA was docked into the D469T structure containing the active 
ThDP-enamine intermediate (Figure 5.6), as carried out previously for 3-FBA 
(Figure 5.4). 
113 
 
 
Figure 5.6 Results obtained for docking 4-FBA (153) into D469T 
 
The docking results obtained were similar to those for the docking of 3-FBA (97) 
into D469T (Figure 5.4). The carboxylate group was bound by the phosphate binding 
region of R358, H461 and R520, orienting the aldehyde into an active conformation 
at a distance of 5.1 Å from the ThDP-enamine active intermediate, only 0.2 Å further 
away than found for 3-FBA when docked into D469T. Perhaps the most important 
result from this docking, however, was the loss of several hydrogen bonds to the 
carboxylate group compared to 3-FBA, notably between the carboxylic acid and 
S385. This, coupled with the slightly increased distance of the aldehyde from the 
ThDP enamine could help to explain the observed decrease in conversion from 65% 
for 3-FBA (97) to 30% for 4-FBA (153) with D469T.
[91]
 
Since many of the combination mutants had given good conversions with 3-FBA, a 
selection of these were also screened with 4-FBA (Table 5.5).
[91]*
 
  
 
 
* Mutants were created by Panwajee Payongsri  
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Table 5.5 Conversions obtained for the transformation of 4-FBA by TKs with mutations at 
phosphate binding residues
†
 
 
Mutant Conversion of 153 to 154 
WT 0% 
D469T 30% 
D469T/R520Q 13% 
R358P/D469T 1% 
R358L/D469T 5% 
R358P/D469T/R520Q <1% 
†Screening carried out by Panwajee Payongsri. Reaction 
conditions; 50 mM 4-FBA, 50 mM Li-HPA, 30 µL TK cell-free 
lysate, 50 mM tris buffer (300 µL total volume). Conversion 
yields were determined after 24 hours. 
 
The conversion yields for all of the combination mutants with 4-FBA were lower 
than those observed for D469T. This is in contrast with the results obtained when 3-
FBA was used as a substrate, where the majority of the combination mutants gave 
similar conversion yields compared to D469T (Table 5.3).  
Kinetic parameters for the combination mutants with 4-FBA were obtained where 
possible to investigate why lower conversion yields were observed for 4-FBA 
compared to 3-FBA.
*
 Only the kinetic parameters for the two best performing 
mutants, D469T and D469T/R520Q, could be obtained. Interestingly, although 
D469T/R520Q gave a 2-fold lower conversion yield for 4-FBA than D469T, this 
was not due to impaired affinity. In fact, D469T/R520Q had a 10-fold higher affinity 
for 4-FBA than D469T.
[91]
 This is consistent with the hypothesis that there is an 
increase in stability when a positive charge is removed from the active site, bringing 
the active-site closer to neutral when binding these single negatively charged 
substrates.
[91]
 While affinity was shown to increase 10-fold for 4-FBA with 
D469T/R520Q, a 20-fold decrease in turnover was observed suggesting that this 
increase in affinity resulted in a repositioning of the substrate to a less-productive 
conformation. Computational docking of 4-FBA with D469T/R520Q supported this 
hypothesis. 4-FBA was docked into D469T/R520Q with the ThDP-enamine 
 
 
* Kinetic parameters were obtained by Panwajee Payongsri 
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intermediate already bound. No single productive conformations were obtained, in 
contrast to the docking of 3-FBA with D469T/R520Q, which showed specific 
interactions between the substrate carboxylate group and H461, R358 and R520Q 
(Figure 5.5). These results are consistent with the 30-fold lower turnover observed 
for 4-FBA compared to 3-FBA with D469T/R520Q.
[91]
  
 
5.4 Creation of a new mutant library to improve the 
bioconversions with aromatic aldehydes 
 
To further investigate the importance of the key electrostatic interactions between 
the phosphate binding region and carboxylate substituents of 3-FBA and 4-FBA, a 
range of other meta and para-substituted benzaldehydes were screened with D469T 
(Figure 5.7) to determine whether neutral substitutents would be accepted. 3-
Methylbenzaldehyde (155), 4-methylbenzaldehyde (132), 3-methoxybenzaldehyde 
(134), 4-methoxybenzaldehyde (133), 3-isopropylbenzaldehyde (156), 4-
isopropylbenzaldehyde (157) were all individually screened at a 50 mM 
concentration in scaled-up (20 mL) biotransformations with Li-HPA (50 mM) and 
D469T. Product formation was followed by TLC analysis. 
 
 
Figure 5.7 Additional substituted benzaldehydes screened with D469T 
 
No product formation was observed for any of these substrates even after extended 
(48 hour) reaction times. This was in stark contrast to the 65% conversion yield 
observed for D469T with 3-FBA (97),
[91]
 suggesting that the binding of the 
carboxylate groups in 3-FBA and 4-FBA was indeed responsible for the high 
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activities observed for these substrates with D469T.
[91]
 Considering that the removal 
of a positive charge from the TK active-site in D469T/R520Q might potentially 
provide a better microenvironment for benzaldehyde, the conversion of 
benzaldehyde by D469T/R520Q was also investigated. Disappointingly, only a 3% 
isolated yield of ketodiol product was obtained, in 55% ee, representing no 
improvement over D469T.
[85]
 These studies confirmed the importance of the charged 
carboxylate functionality on 3-FBA and 4-FBA for efficient binding and catalysis, 
and showed that hydrophobic interactions alone were not sufficient to obtain high 
turnover for benzaldehyde and other functionalised derivatives.
[91]
 With this in mind, 
it was clear that while rational design targeted toward the phosphate binding site was 
effective at increasing the activity of TK toward certain aromatic aldehydes, further 
work focused on the TK active-site was needed to improve the biotransformations of 
benzaldehyde and other aromatic aldehydes in general.  
Previous work had shown that saturation mutagenesis at residues close to the active-
site had more potential to improve enzyme activities and stereospecificities than 
mutation of residues at positions further from the enzyme active-site.
[92]
 Therefore, 
to develop a strategy to improve activities of TK with aromatic aldehydes, first shell 
residues within 4 Å of the active-site, which had been previously identified as targets 
for mutation,
[46]
 were targeted, and mutants created based on the knowledge gained 
from studying the co-evolution of certain active-site residues
[88]
 and the subsequent 
acceptance of formylbenzoic acids by certain TK mutants.
[91]
 
D469T had been shown to be the most active mutant towards 3 and 4-formylbenzoic 
acids,
[91]
 while the combination mutant D469T/R520Q was also active to both of 
these substrates, albeit it to a lesser extent.
[91]
 However, the R520Q mutation had 
previously been shown to stabilise the combination mutants containing D469T and 
other D469 mutations,
[88]
 so D469T/R520Q was used as the initial TK template for 
saturation mutagenesis. The other residues were chosen for mutation based on their 
position in the active-site and the knowledge gained from previous protein 
engineering studies.
[88, 91]
  
F434A had previously been shown to be the most active single mutant for the 
transformation of benzaldehyde.
[85]
 This activity was rationalised by the removal of 
steric bulk within the active site, allowing benzaldehyde to enter.
[85]
 However, the 
activities observed for D469T with the more sterically-demanding 3 and 4-
formylbenzoic acids showed that sterics were not a limiting factor for the acceptance 
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of aromatic aldehydes, and that the low affinity of benzaldehyde for the active-site of 
TK seemed more likely a reason for the low yields observed for this substrate. This 
hypothesis was supported by docking experiments where non-specific binding of 
benzaldehyde had been observed (Figure 5.1). Also, since F434A is more than 4 Å 
from the TK active-site, it was not chosen for further study. 
To increase affinity for aromatic substrates the natural phosphate binding region 
seemed a logical area to target for mutation. H461, a positively charged residue 
responsible for phosphate binding of the TK natural substrates, was considered as a 
target for mutagenesis to potentially improve the affinity of the TK active-site 
towards neutral substrates, such as benzaldehyde. However, previous mutation of 
this residue, for example to H461S, had shown that the stability and function of the 
resulting mutant was severely affected and only partially restored by the addition of 
the stabilising R520Q mutation.
[88]
 H461 was therefore considered integral to the 
structure and function of TK, and so not targeted for mutagenesis.  
R358 had previously been successfully targeted for mutation to remove a positive 
charge from the phosphate binding region of TK, and as such had only been mutated 
to neutral residues.
[91]
 Therefore, this residue was targeted for saturation 
mutagenesis, using the D469T/R250Q template, to obtain R358X/D469T/R520Q.  
The remaining residue in the phosphate binding region, S385, had previously been 
identified as a residue suitable for mutation to improve activity toward non-
phosphorylated substrates.
[46]
 Though no active single mutations of this residue were 
reported,
[46]
 the resulting mutants maintained structure and function, unlike H461 
mutants.
[88]
 This residue was therefore also chosen for saturation mutagenesis in 
combination with D469T/R520Q to obtain a library of S385X/D469T/R520Q 
mutants.
*
 
Mutant libraries were screened with 3-FBA (97), 4-FBA (153) and 3-
hydroxybenzaldehyde (93) (3-HBA) (Figure 5.8). 3-FBA and 4-FBA were chosen 
since they had already been shown to be well tolerated by D469T,
[91]
 whereas 3-
HBA was chosen as it had been previously shown to be poorly accepted by 
D469T.
[85]
 Screening the mutants with these substrates would therefore give an 
indication of whether the mutant libraries were merely binding the carboxylate 
 
 
* All TK mutant libraries were created by Panwajee Payongsri after collaborative discussions 
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functionality of 3-FBA and 4-FBA in a more productive conformation, or whether 
mutants were being created which were generally more active towards aromatic 
aldehydes. Screening was carried out using an HPLC assay to assess aldehyde 
consumption and hence rapidly identify active mutants.
*
 
 
 
Figure 5.8 Substrates used for screening of R358X/D469T/R520Q and S385X/D469T/R520Q 
mutant libraries 
 
The initial screening of the R358X/D469T/R520Q library showed that half of the 
library maintained activity toward 3-HBA, but variations in activity with 3-FBA and 
4-FBA were observed. All of the mutants were less active towards 4-FBA, and only 
one mutant, R358T/D469T/R520Q maintained activity towards 3-FBA. However, 
none of these mutants increased activity towards any of the substrates compared to 
D469T and more than a third of the colonies lost activities towards all three 
substrates, indicating a complete loss of catalytic function or enzyme stability. The 
R358X/D469T/R520Q library was therefore not considered to be useful for the 
conversion of aromatic aldehydes and not investigated further.  
In contrast to the R358X/D469T/R520Q library, the S385X/D469T/R520Q library 
was much more interesting. The majority of the mutants showed a marked increase 
in activity for 3-HBA compared to D469T, whilst maintaining activity towards 3-
FBA. Some of the mutants also showed increased activities towards 4-FBA. Only 
one fifth of the mutants showed no activity toward any of the substrates, far fewer 
than the number of inactive mutants found for the R358X/D469T/R520Q library, 
indicating that while S385 is a highly conserved residue, it may be more stable 
towards mutation then R358. Of all of the mutations in the S385X/D469T/R520Q 
library, S385T/D469T/R520Q, S385Y/D469T/R520Q and S385E/D469T/R520Q 
were the most active mutants identified by the initial screening. 
S385T/D469T/R520Q showed a 2.5-fold increase in 4-FBA conversion yield, a 5.5-
 
 
* Screening was carried out by Panwajee Payongsri 
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fold increase in 3-HBA conversion yield whilst only halving the activity with 3-FBA 
compared to D469T. S385Y/D469T/R520Q showed a similar trend, halving activity 
with 3-FBA while giving a 1.5-fold increase in conversion yield for 4-FBA and a 5-
fold increase in conversion yield for 3-HBA compared to D469T. Finally, 
S385E/D469T/R520Q maintained the conversion yield for 4-FBA, but gave a 1.5-
fold increase in activity with 3-FBA and a 2.5-fold increase in conversion yield for 
3-HBA.  
As S385T/D469T/R520Q, S385Y/D469T/R520Q and S385E/D469T/R520Q were 
the best performing mutants, they were chosen for detailed kinetic analysis.
*
 The 
most interesting results were found for S385E/D469T/R520Q with 3-FBA, 
S385Y/D469T/R520Q with 4-FBA and S385Y/D469T/R520Q with 3-HBA. 
S385E/D469T/R520Q showed a 2.5-fold increase in turnover and a 3-fold increase 
in affinity for 3-FBA, and showed no substrate inhibition even at high substrate 
concentrations (up to 90 mM). This suggested a different binding mode compared to 
D469T, so docking studies with the in silico generated mutant were carried out with 
3-FBA as the substrate.
†
  
The docking experiment gave two different clusters. The first cluster was the lowest 
in energy but had a small population, while the second cluster was higher in energy 
but had a large population. The first cluster (Figure 5.9) showed two different 
conformations, both considered to be unproductive due to the distance of the 
aldehyde functionalities from the ThDP-enamine intermediate. One conformation 
(Figure 5.9, red) brought the aldehyde to 7.1 Å away from the ThDP-enamine, and 
the other conformation (Figure 5.9, green) showed the aldehyde at a greater distance 
of 9.0 Å. In both cases the carboxylate group was bound by the phosphate binding 
residues of R358 and H461, and in the conformation where the aldehyde was 9.0 Å 
from the ThDP-enamine (Figure 5.9, green), the position of the aldehyde was 
stabilised by hydrogen bonding interactions with D469T.  
 
 
 
* Kinetic parameters obtained by Panwajee Payongsri 
† In silico mutagenesis was carried out by Panwajee Payongsri 
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Figure 5.9 Lowest energy, non-productive cluster found for docking 3-FBA (97) into 
S385E/D469T/R520Q. (Two non-productive conformations shown in red and green, ThDP-
enamine shown in orange). 
 
The second cluster (Figure 5.10) found by the docking program had a higher 
population, and demonstrated a more productive conformation.  
 
 
Figure 5.10 Productive cluster found for docking 3-FBA (97) into S385E/D469T/R520Q. (ThDP-
enamine shown in orange). 
 
In this second cluster (Figure 5.10) the aldehyde was positioned at a closer distance 
of 4.6 Å from the ThDP-enamine intermediate. This is a similar distance as found in 
the docking of 3-FBA with D469T (4.9 Å), however this cluster showed a different 
binding mode than that found for D469T (Figure 5.4) or D469T/R520Q (Figure 5.5), 
as the carboxylate group was not bound by the phosphate binding residues of R358 
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or H461 but rather by S24, G25, H26 and R91. Also, in this case, the aldehyde 
moiety was held in a productive conformation directly above the ThDP-enamine 
stabilised by hydrogen bonding interactions with H26 and H261. The increased 
number of hydrogen bonding interactions and shorter distance between the 3-FBA 
aldehyde moiety and ThDP-enamine found for S385E/D469T/R520Q could help to 
explain the increased affinity and turnover observed for this mutant compared to 
D469T. 
Compared to D469T, S385Y/D469T/R520Q showed a 17-fold increase in affinity 
and only a 2.5-fold decrease in turnover for 4-FBA, making it the most active mutant 
towards this substrate. S385Y/D469T/R520Q was also the most active mutant for 3-
HBA showing a similar turnover as for 4-FBA but demonstrating a much lower 
affinity. To try and understand these results, both 4-FBA and 3-HBA were used as 
substrates for computational docking with S385Y/D469T/R520Q.
*
 
 Docking of 4-FBA with S385Y/D469T/R520Q gave only one cluster (Figure 5.11), 
in which the carboxylate group was bound by the phosphate binding residues of 
R358 and H461. This brought the aldehyde to a distance of 5.1 Å from the ThDP-
enamine, the same distance as docking had predicted for 4-FBA with D469T (Figure 
5.6). The docking also suggested possible π-stacking interactions of the aromatic 
ring with S385Y, which would further stabilise this binding conformation. However, 
it was not clear from the docking results why such an increase in affinity (>16-fold) 
was observed for 4-FBA with S385Y/D469T/R520Q compared to D469T. 
 
 
 
* In silico mutation was carried out by Panwajee Payongsri 
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Figure 5.11 Results found for docking 4-FBA (153) into S385Y/D469T/R520Q. (ThDP enamine 
shown in orange). 
 
The docking of 3-HBA into S385Y/D469T/R520Q predicted four major clusters, 
again demonstrating the difficulty in obtaining clear docking results for substrates 
where low affinities are observed, as non-specific binding around the TK active-site 
is favoured. Of these four clusters only one was considered to be productive (Figure 
5.12). In this cluster the hydroxyl group of the substrate formed hydrogen bonding 
interactions with both H261 and S385Y and the aldehyde moiety was bound by the 
ThDP-enamine at a distance of 4.6 Å. The number of different binding clusters 
predicted by Autodock suggests the prevalence of non-specific binding in and 
around the TK active-site, which helps to explain the low affinities observed for 
S385Y/D469T/R520Q with 3-HBA. 
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Figure 5.12 Productive cluster found for docking 3-HBA (93) into S385Y/D469T/R520Q. 
(ThDP-enamine shown in orange). 
 
Through knowledge gained from previous investigation into the co-evolution of 
active-site residues,
[88]
 and mutation of the phosphate binding residues H461, R520, 
and R358,
[91]
 three mutants were identified which showed increased activity towards 
an aromatic aldehyde not bearing a phosphate mimic, with up to 13-fold increased 
specific activities for 3-HBA observed compared to D469T (0.0071 µmol/mg/min)
*
. 
These mutants, S385E/D469T/R520Q (0.0426 µmol/mg/min)
*
, 
S385Y/D469T/R520Q (0.0884 µmol/mg/min)
*
 and S385T/D469T/R520Q (0.0902 
µmol/mg/min)
*
 could now be tested with other aromatic aldehydes in scaled-up 
biotransformations, to allow stereoselectivities and isolated yields to be obtained and 
to assess the value of these mutants as biocatalysts in a two-step pathway towards 
aromatic aminodiols. 
 
5.5 Biotransformation of aromatic aldehydes with 
combination mutant TKs 
 
In previous work with TK and aromatic aldehydes, the concentration of aldehyde 
substrate used was 50 mM.
[85]
 While assessing the activities of newly created triple 
 
 
* Specific activities for TK mutants towards 15 mM 3-HBA/50 mM HPA, as determined by Panwajee 
Payongsri. 
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mutants with 3- and 4-FBA, it was noted that most of the mutants were inhibited by 
substrate concentrations over 40 mM.
[91]
 With this in mind, when scaling-up the 
biotransformation of aromatic aldehydes, a lower concentration of 25 mM was used 
to avoid inhibition of TK. Biotransformations were carried out using 4 mL of TK 
cell-free lysate, with a protein concentration of approximately 1 mg/mL.
*
 
Benzaldehyde (8) was tested with the S385X/D469T/R520Q combination mutants 
and the isolated yields and stereochemistry of ketodiol 68 were assessed (Table 5.6). 
The previous highest yielding mutant with benzaldehyde was F434A, which gave an 
isolated yield of ketodiol 68 of 10% and an ee of 70%,
[85]
 at 50 mM concentration of 
benzaldehyde. D469T previously gave a yield of 2% at 50 mM concentration of 
benzaldehyde.
[85]
 Testing D469T at a lower substrate concentration of benzaldehyde 
of 25 mM, but maintaining the concentration of HPA at 50 mM, gave an isolated 
yield of 12% of 68 without affecting the stereoselectivity. Stereoselectivities were 
assessed by chiral HPLC analysis of mono-benzoate ester derivatives. 
 
Table 5.6 Isolated yields and stereoselectivities obtained for the transformation of benzaldehyde 
by S385X/D469T/R520Q†  
 
F434A
[85]
 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
‡
10% 
(70%) 
12% 
(70%) 
‡
2%
[85]
 
7% 
(54%) 
34% 
(98%) 
30% 
(97%) 
33% 
(37%) 
†Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 25 mM benzaldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 
20 mL total reaction volume, 18 hour reaction time. ‡50 mM concentration of aldehyde. 
 
D469T/R520Q had not previously been studied with benzaldehyde as a substrate, 
and gave a 7% isolated yield of 68 formed with an ee of 54%, both values lower than 
for D469T. Interestingly, D469Y/R520Q had only given a 2% yield of the racemic 
 
 
* Protein concentrations were determined by Panwajee Payongsri who also created all of the TK 
mutants used in this chapter. 
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ketodiol 68 (Table 5.1), so some stereoselectivity with D469T/R520Q was 
encouraging. S385T/D469T/R520Q, which was shown to be the most active mutant 
when screened with 3-HBA, gave a dramatically increased isolated yield of 68 of 
34%, representing a 3-fold increase in yield over D469T. This triple mutant also 
gave an unprecedented level of stereoselectivity, forming ketodiol 68 in an excellent 
98% ee. S385Y/D469T/R520Q had displayed a similar activity as 
S385E/D469T/R520Q for 3-HBA, and indeed performed similarly with 
benzaldehyde, with an isolated yield of 68 of 30%. This mutant was also highly 
stereoselective forming the product (68) in an excellent 97% ee. The final triple 
mutant, S385E/D469T/R520Q had shown half the specific activity of the other two 
triple mutants for 3-HBA, however with benzaldehyde this mutant gave a 
comparable isolated yield of ketodiol 68 of 33%. Disappointingly, however, this 
mutant lost the high degree of stereoselectivity shown by the other two triple 
mutants, forming the product (68) in only 37% ee. 
The stereoselectivity of these reactions was assessed by chiral HPLC analysis of the 
mono-benzoate ester derivatives (68-B) (Scheme 5.1) of the reaction product. A 
racemic standard was prepared using the previously reported biomimetic reaction, 
and then mono-benzoylated in the same fashion as previously described (Scheme 
5.1).
[79, 85]
  
 
 
Scheme 5.1 Monobenzoylation of ketodiol (68) for chiral HPLC analysis 
 
Good separation of both enantiomers was achieved using a Chiralpak AD column 
with a solvent system of 90:10 (n-hexane:isopropanol, 1 mL/min) and detection at 
214 nm. The purified biotransformation products (68) from all mutants were then 
derivatised in the same fashion and analysed using the chiral HPLC method 
developed for the racemic sample. HPLC traces of 68-B derived from the racemic 
reaction (Figure 5.13. A), and the two best performing mutants, are shown (Figure 
5.13, B and C). 
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Figure 5.13 Chiral HPLC traces for mono-benzoate derivatives (68-B) of ; A - racemic product, 
B - S385T/D469T/R520Q product, C - S385Y/D469T/R520Q product. (Elution time shown in 
minutes). 
 
The exquisite stereoselectivities demonstrated by S385T/D469T/R520Q and 
S385Y/D469T/R520Q for the formation of ketodiol (68) from benzaldehyde were 
very pleasing, especially since these triple mutants had been engineered and selected 
solely to improve the activity of TK toward aromatic substrates, and not to improve 
stereoselectivity. 
In an attempt to rationalise the dramatic increases in yield and stereoselectivity 
observed for these mutants with benzaldehyde, computational docking of 
benzaldehyde was carried out with S385T/D469T/R520Q, which was created by in 
silico mutagenesis.
*
 Unfortunately, the docking results were similar to previous 
results obtained from docking with benzaldehyde. Extensive non-specific binding 
was observed, with 12 different clusters found by Autodock, the most populated of 
which showed benzaldehyde docked in a non-productive conformation (Figure 5.14). 
 
 
 
* In silico mutagenesis was performed by Panwajee Payongsri 
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Figure 5.14 Most populated conformation found for docking of benzaldehyde into 
S385T/D469T/R520Q. (Non-productive conformation shown in white, ThDP-enamine shown in 
orange). 
 
This cluster showed non-specific binding of the benzaldehyde molecule with the 
protein backbone at residues G161 and I162, approximately 12 Å behind the ThDP-
enamine, far from the active-site. This again demonstrated the limitations of using 
computational docking when studying molecules which exhibit low affinity for the 
TK active-site. The increased activity of these triple mutants with benzaldehyde 
might therefore be due to more efficient catalysis, and faster turnover rather than 
increased affinity, although this cannot be concluded definitively without further 
kinetic data. 
The next substrate tested in scaled-up biotransformations with these triple mutants 
was 3-HBA (93, Table 5.7). This substrate had been used to screen this mutant 
library, and largely increased specific activities were noticed compared to D469T. 
Previous work had identified F434A as the most active single mutant towards 3-
HBA with a yield of 6% forming the ketodiol product (103) in 53% ee.
[85]
 D469T 
had given 4% yield of racemic 103.
[85]
 Both of these reactions had been performed at 
50 mM concentration of 3-HBA. Performing the reaction with D469T at 25 mM 
concentration of 3-HBA gave no product whatsoever, so all the other mutants were 
tested at the higher concentration of 50 mM of 3-HBA and isolated yields and 
stereoselectivities obtained (Table 5.7).  
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Table 5.7 Isolated yields and stereoselectivities obtained for the transformation of 3-HBA (93) 
by S385X/D469T/R520Q mutants* 
 
F434A
[85]
 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
6% 
(53%) 
3% 
(0%) 
4%
[85]
 
5% 
(0%) 
7% 
(50%) 
3% 
(55%) 
2% 
(60%) 
*Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 50 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 
mL total reaction volume, 18 hour reaction time. 
 
S385T/D469T/R520Q had been shown to give a 12-fold increase in specific activity 
with 3-HBA compared to D469T. However, only a slightly increased isolated yield 
was observed of 7% compared to 3% for D469T. However, whereas D469T formed 
the product as a racemic mixture, S385T/D469T/R520Q formed the ketodiol product 
(103) in 50% ee. The other triple mutants behaved similarly to 
S385T/D469T/R520Q, albeit with slightly lower yields. S385Y/D469T/R520Q had 
been shown to increase the specific activity with 3-HBA 12-fold compared to 
D469T, but gave ketodiol 103 in an isolated yield of only 3%. However, this mutant 
showed some stereoselectivity forming the product (103) in 55% ee, slightly 
increased from S385T/D469T/R520Q. S385E/D469T/R520Q showed the lowest 
specific activity of the triple mutants, with only a 6-fold increase compared to 
D469T, however it gave a comparable isolated yield of 2%. This triple mutant was 
the most stereoselective for 3-HBA, forming the product in 60% ee. 
The stereoselectivity of these transformations was once again assessed by chiral 
HPLC analysis of benzoate ester derivatives. In this case since the phenolic proton 
was more acidic than the primary alcohol so the dibenzoate ester was prepared (103-
B), (Scheme 5.2). The racemic standard was prepared using the biomimetic TK 
reaction, and dibenzoate ester prepared as previously described.
[85]
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Scheme 5.2 Di-benzoylation of ketodiol (103) for chiral HPLC analysis. 
 
Good separation of both enantiomers was achieved with a Chiralpak AD column, 
with a solvent system of 20:80 (n-hexane:isopropanol, 1 mL/min). HPLC traces of 
the racemic product and the product from S385T/D469T/R520Q are shown (Figure 
5.15). 
 
 
Figure 5.15 Chiral HPLC traces of di-benzoylated derivatives (103-B) of; A - racemic product, 
B - S385T/D469T/R520Q product. Elution times are shown in minutes. 
  
Previous docking of 3-HBA into S385Y/D469T/R520Q had not been productive, 
with non-specific binding of the substrate to the protein backbone, and to residues 
outside of the enzyme active-site extensively demonstrated. Hence, this substrate 
was not investigated in any further computational docking. 
Whilst these triple mutants did not increase the isolated yields with 3-HBA, it should 
be noted that initial studies with 3-HBA and single mutants required 48 hour reaction 
times,
[85]
 whereas the triple mutant reactions were run for only 18 hours. Also, while 
not increasing isolated yields the triple mutants were far more stereoselective than 
previous single mutants,
[85]
 giving products with ees >50%. This was very 
encouraging, so a further range of functionalised benzaldehydes were assessed in 
scaled-up biotransformations. 
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3-Fluorobenzaldehyde (94) (Table 5.8) had not been previously investigated with 
transketolase, but had been investigated in the asymmetric biomimetic reaction 
where low yields (<5%) were observed (Chapter 2).
[79]
 The yields and 
stereoselectivities of ketodiol 105 from a range of single and combination mutant 
TKs were obtained (Table 5.8). Since the use of 25 mM concentration of 
benzaldehyde had been shown to reduce substrate inhibition for the 
S385X/D469T/R520Q mutants a 25 mM concentration of 3-fluorobenzaldehyde was 
used for all of the biotransformations. 
 
Table 5.8 Isolated yields and stereoselectivities obtained for the transformation of 3-
fluorobenzaldehyde (93) by S385X/D469T/R520Q mutants* 
 
F434A 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
ND 12% 
(20%) 
8% 
(78%) 
12% 
(70%) 
10% 
(64%) 
11% 
(90%) 
*Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 25 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 
mL total reaction volume, 18 hour reaction time. 
 
D469T gave a 12% isolated yield of ketodiol (105), the same yield as obtained for 
the transformation of benzaldehyde by this mutant (Table 5.6). However, a much 
lower stereoselectivity of 20% ee was observed compared to the transformation with 
benzaldehyde. D469T/R520Q gave a slightly reduced yield of 105 of 8%, but gave a 
large increase in stereoselectivity to 78% ee. This was greater than when the same 
mutant was used to transform both benzaldehyde (Table 5.6) and 3-
hydroxybenzaldehyde (Table 5.7). S385T/D469T/R520Q gave the same isolated 
yield of 105 as for D469T, but again gave a large increase in stereoselectivity 
compared to D469T, with a product ee of 70%, though this was slightly 
disappointing given the 98% ee for this mutant when benzaldehyde was used as the 
substrate (Table 5.6). S385Y/D469T/R520Q performed similarly to 
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S385T/D469T/R520Q, with a slightly reduced product (105) yield of 10%, and 
slightly reduced stereoselectivity of 64% ee. S385E/D469T/R520Q gave a similar 
yield as the other two triple mutants, with an isolated yield of ketodiol (105) of 11%. 
Interestingly, although this mutant was not highly stereoselective with benzaldehyde, 
forming ketodiol 68 with an ee of only 37%, with 3-fluorobenzaldehyde 
S385E/D469T/R520Q was highly stereoselective, forming 105 with an ee of 90%. 
This suggests that 3-fluorobenzaldehyde could adopt a different binding mode to 
benzaldehyde with S385E/D469T/R520Q, giving rise to a much higher degree of 
stereoselectivity. It is also possible that the electron withdrawing effects of the 3-
fluoro substitutent could be responsible for tighter binding, increasing the 
stereoselectivity of the transformation. 
Stereoselectivities were determined by chiral HPLC analysis of mono-benzoate ester 
deriviatives (105-B) of biotransformation product (105) and racemic 105 as carried 
out as for benzaldehyde, and as previously described (Chapter 2).
[79]
 Benzoylated 
derivatives (105-B) from the biomimetic reaction (Figure 5.16, A) and 
S385Y/D469T/R520Q and S385E/D469T/R520Q reaction products (Figure 5.16, B 
and C) are shown below. 
 
 
 
Figure 5.16 Chiral HPLC traces of mono-benzoylated derivatives (105-B) of; A - Racemic 
product, B - S385Y/D469T/R520Q product, C – S385E/D469T/R520Q product. Elution times 
are shown in minutes. 
 
A more lipophilic substrate was then tested with these combination mutants. 3-
Vinylbenzaldehyde (96) (Table 5.9) had not been previously reported as substrate for 
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the TK reaction. It is an interesting substrate as it contains a vinyl group which can 
act as a synthetic handle, for example, in cross metathesis reactions. This substrate 
was at a concentration of 25 mM and isolated yields and stereoselectivities of 
ketodiol 107 were obtained where possible (Table 5.9). 
 
Table 5.9 Isolated yields and stereoselectivities obtained for the tranformation of 3-
vinylbenzaldehyde (96) by S385X/D469T/R520Q mutants* 
 
F434A 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
ND 2% 
(0%) 
4% 
(0%) 
4% 
(84%) 
5% 
(90%) 
Trace 
*Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 25 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 
mL total reaction volume, 18 hour reaction time. 
 
All of the mutants gave comparable yields of product (107) of <5%. D469T showed 
least activity toward the substrate, with only a 2% yield of racemic 107 isolated. 
D469T/R520Q showed a similar activity with a 4% yield of racemic product (107) 
isolated. However, S385T/D469T/R520Q and S385Y/D469T/R520Q both exhibited 
some stereoselectivity giving isolated yields of 4% and 5% of ketodiol 107 
respectively, with product ees of 84% and 90%. S385E/D469T/R520Q only showed 
traces of 107 by TLC analysis, and no product could be isolated. The low isolated 
yields observed for all mutants are perhaps not surprising, given that this substrate 
was poorly soluble in water even at 25 mM concentration. However, the 
stereoselectivities exhibited by S385T/D469T/R520Q and S385Y/D469T/R520Q 
were once again very encouraging.  
Since ketodiol 107 was a new analogue, chiral HPLC analysis methods had to be 
established. The same HPLC method as used for both the benzaldehyde and 3-
fluorobenzaldehyde mono-benzoylated products (68-B, 105-B) gave good separation 
of both enantiomers of the mono-benzoylated derivative (107-B) of ketodiol 107. 
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The chiral HPLC traces of both the racemic mono-benzoylated biomimetic product 
(Figure 5.17, A) and S385Y/D469T/R520Q product (Figure 5.17, B) are shown. 
 
 
 
Figure 5.17 Chiral HPLC traces of mono-benzoylated derivatives (107-B) of; A - Racemic 
product, B - S385Y/D469T/R520Q product. 
 
It appeared that meta-substituted benzaldehydes were well tolerated by this family of 
S385X/D469T/R520 mutant enzymes, whether in terms of isolated yields, 
stereoselectivities, or both. To probe this tolerance further, a more bulky substrate, 
methyl-3-formylbenzoate (95), which had been investigated in the asymmetric 
biomimetic TK reaction,
[79]
 was tested as a substrate (Table 5.10). Since these 
mutants were developed based on phosphate binding interactions with 3-
formylbenzoic acid, it was thought that the methyl ester variant of this substrate 
should be tolerated, albeit to a lesser extent due to the absence of an acid group. 
Isolated yields and stereoselectivities were established at 25 mM concentration to 
avoid substrate inhibition (Table 5.10). 
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Table 5.10 Isolated yields and stereoselectivities obtained for the transformation of methyl-3-
formylbenzoate (95) by S385X/D469T/R520Q mutants* 
 
F434A 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
ND Trace Trace 34% 
(96%) 
9% 
(72%) 
Trace 
*Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 25 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 
mL total reaction volume, 18 hour reaction time. 
 
D469T and D469T/R520Q gave only trace amounts of 106, observed by TLC 
analysis, and no product could be isolated for either mutant. This was disappointing, 
given that D469T had one of the highest observed specific activities towards the 
related substrate, 3-FBA,
[91]
 suggesting that in this case the methyl ester did not 
interact productively with the phosphate binding region. Interestingly, 
S385T/D469T/R520Q gave a large increase in isolated yield, giving a 34% yield of 
ketodiol product (106). This mutant was also highly stereoselective, forming 106 in 
96% ee. S385Y/D469T/R520Q on the other hand only gave a 9% isolated yield of 
106, and showed a decrease in stereoselectivity, with a product ee of 72%. Once 
again, as for 3-vinylbenzaldehyde (96), S385E/D469T/R520Q formed only trace 
amounts of product, indicating that this mutant was not as tolerant to meta-
substituents as the other triple mutants. 
The chiral analysis of these compounds was carried out as previously described 
(Chapter 2).
[79]
 Good separation of enantiomers was achieved using a chiralpak AD 
column with a solvent system of 90:10 (n-hexane:isopropanol, 1 mL/min) with 
detection at 214 nm. Racemic 106 was prepared using the biomimetic reaction. 
HPLC traces of the mono-benzoate esters (106-B) of racemic 106 (Figure 5.18, A) 
and 106 from the S385T/D469T/R520Q reaction (Figure 5.18, B) are shown. 
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Figure 5.18 Chiral HPLC traces of mono-benzoylated derivatives (106-B) of; A - racemic 
product, B - S385T/D469T/R520Q product 
 
The increases in yield and stereoselectivity observed for methyl-3-formylbenzoate 
with S385T/D469T/R520Q compared to all of the other mutants was very interesting 
and so further investigation with computational docking was carried out. Firstly, 
methyl-3-formylbenzoate was docked into the structure of D469T with the ThDP-
enamine intermediate already in place. D469T had only formed trace amounts of 
product with this substrate, and four main clusters were observed, with the lowest in 
energy being the most populated. This cluster contained the only productive 
conformations, where the ester group formed hydrogen bonding interactions with 
R358, S385 and R520 (Figure 5.19, A). These interactions held the aldehyde in a 
productive conformation pointing toward the ThDP enamine at a distance of 4.1 Å 
from the ThDP enamine, which was closer than computationally predicted for this 
mutant and 3-FBA, for which excellent conversions were observed.
[91]
 The second 
cluster found by the docking program showed similar interactions as the first cluster, 
but in this case the aldehyde was flipped into a non-productive conformation where 
it was stabilised by L466 (Figure 5.19, B). The third cluster showed similar 
interactions to the previous two clusters, but the hydrogen bond between the 
substrate and S385 was lost, pointing the aldehyde away from the ThDP enamine at 
an increased distance of 8.1 Å (Figure 5.19, C). The final cluster showed the ester 
group of the methyl-3-formylbenzoate substrate forming hydrogen bond interactions 
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with H26 and one of the diols on the ThDP-enamine intermediate, pointing the 
aldehyde out of the active-site where it formed a hydrogen bond interaction with the 
protein backbone of G25 (Figure 5.19, D). The existence of so many non-productive 
binding modes could explain the low product yield observed for D469T. 
 
 
Figure 5.19 Results obtained for docking of methyl-3-formylbenzoate (95) into D469T. A-
Lowest energy, most highly populated cluster showing productive conformation, B-Second 
cluster showing non-productive conformation, C-Third cluster showing non-productive 
conformation, D-Fourth cluster showing non-productive conformation. 
 
Computational docking of methyl-3-formylbenzoate (95) into S385T/D469T/R520Q 
was then carried out, to try to rationalise such an improved tolerance with this 
mutant. The docking program gave two highly populated, low energy clusters, both 
of which showed productive conformations (Figure 5.20). 
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Figure 5.20 Results obtained for docking of methyl-3-formylbenzoate into 
S385T/D469T/R520Q. A - First low-energy, highly populated cluster, showing productive 
conformation, B - Second low-energy, highly populated cluster showing productive 
conformation 
 
In contrast to the productive cluster found when docking methyl-3-formylbenzoate 
into D469T (Figure 5.19, A), in S385T/D469T/R520Q the first productive cluster 
showed hydrogen bonding interactions not between the ester group of the substrate 
and the phosphate binding region, but between the ester group and G25 (Figure 5.20, 
A). The aldehyde moiety also formed additional hydrogen bonds with H26 and 
H261, holding it in position directly above the ThDP-enamine at a distance of 4.8 Å. 
Interestingly, studies of WT-TK with aliphatic aldehydes had given similar yields as 
S385T/D469T/R520Q and methyl-3-formylbenzoate, and computational docking 
studies of aliphatic aldehydes with WT-TK had identified a similar binding mode, 
with the aldehyde oxygen atom held in position by H26 and H261.
[26]
 This 
interaction could therefore be responsible for the increase in yield for methyl-3-
formylbenzoate with S385E/D469T/R520Q. In the other productive cluster (Figure 
5.20, B) the ester group was directed towards the phosphate binding region, but at 
too great a distance to form hydrogen bonding interactions. However, the aldehyde 
was again held directly above the ThDP-enamine intermediate, stabilised by a 
hydrogen bond with H261, at a slightly reduced distance of 4.7 Å. It is possible that 
the existence of these two productive binding modes for S385T/D469T/R520Q could 
explain the increased isolated yields for methyl-3-formylbenzoate compared to 
D469T, where only 1 productive cluster was found. Also, the interactions of the 
aldehyde with H26 and H261, as found for aliphatic aldehydes, may activate the 
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aldehyde moiety for nucleophilic attack by the ThDP-enamine intermediate, 
increasing turnover of the substrate. 
Both D469T and D469T/R520Q had been observed to have good activities with 3-
FBA (97).
[91]
 This substrate had then been used to screen the S385X/D469T/R520Q 
library (Section 5.4), and so was used as a substrate in scaled-up biotransformations 
(Table 5.11). Despite substrate inhibition being observed above 40 mM, good 
conversions were still observed at 50 mM, and so this concentration of substrate was 
used. It was observed that ketodiol 108 was difficult to isolate and prone to 
rearrangement. Hence, for ease of isolation, conversion yields were assessed by the 
1
H-NMR spectroscopy analysis of peaks corresponding to 108 formation and the 
crude product was then subjected to the standard benzoylation procedure. Here, the 
di-benzoate esters were formed and then isolated and analysed by chiral HPLC to 
determine stereoselectivities (Table 5.11). 
 
Table 5.11 Conversions and stereoselectivities obtained for the transformation of 3-FBA (97) by 
S385X/D469T/R520Q mutants* 
 
F434A 
Conv. 
(ee) 
D469T 
Conv. 
(ee) 
D469T 
R520Q 
Conv. (ee) 
S385T 
D469T/R520Q 
Conv. (ee) 
S385Y 
D469T/R520Q 
Conv. (ee) 
S385E 
D469T/R520Q 
Conv. (ee) 
ND 100%
†
 
(62%) 
70% 
(56%) 
78% 
(49%) 
87% 
(45%) 
73% 
(0%) 
*Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 50 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 
mL total reaction volume, 18 hour reaction time.† No aldehyde proton could be 
observed 
 
The conversion yields obtained were excellent for all of the mutants (Table 5.11). 
After 18 hours no starting aldehyde could be observed when using D469T, which 
was consistent with the high activities for this mutant with 3-FBA (section 5.2). 
D469T/R520Q gave a conversion yield of 108 of 70%, consistent with the lower 
specific activity reported compared to D469T.
[91]
 S385T/D469T/R520Q and 
S385Y/D469T/R520Q gave comparable conversion yields of 108 of 78% and 87%, 
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again consistent with their lower specific activities compared to D469T. 
S385E/D469T/R520Q had an almost 2-fold higher specific activity than D469T for 
3-FBA, so was expected to perform well. Disappointingly, however, this mutant 
gave a lower conversion yield of 108 of 73%. This was not due to substrate 
inhibition, as S385E/D469T/R520Q had been screened with aldehyde concentrations 
up to 90 mM and no substrate inhibition had been observed (Section 5.4). Also, 
S385E/D469T/R520Q was shown to give a nearly 6-fold increase in turnover 
compared to D469T, so reaction time should not have been an issue. The limited 
yield could potentially have been caused by lower expression levels of 
S385E/D469T/R520Q. The stereoselectivities for all of the mutants were very 
disappointing, especially considering the excellent conversions. This could possibly 
be due to analytical methods and rearrangement of the product during derivatisation, 
as previously observed for several other aromatic ketodiols.
[85]
 Indeed, the electron 
withdrawing effects of the carboxylate substituent would be expected to promote 
rearrangement of these products, causing racemisation. Rearranged products were 
indeed observed in 
1
H-NMR spectra of crude biotransformation reactions, especially 
after extended reaction times. Dibenzoylated products (108-B) were used in chiral 
HPLC analyses, using a method developed by analysis of the dibenzoylated racemate 
generated from the biomimetic reaction. Good separation of isomers was achieved 
using a Chiralpak AD column and a solvent system of 77:23 (n-hexane:isopropanol, 
1 mL/min, 214 nm). The chiral HPLC traces of the racemate (Figure 5.21, A) and 
S385Y/D469T/R520Q product are shown (Figure 5.21, B). 
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Figure 5.21 Chiral HPLC traces of di-benzoylated derivatives (108-B) of; A - Racemic product, 
B - S385Y/D469T/R520Q product 
 
3-Formylbenzonitrile (18) (Table 5.12) had not been previously studied with TK and 
so was investigated with the new combination mutants and isolated yields and 
stereoselectivities of ketodiol (110) were determined (Table 5.12). 
 
Table 5.12 Isolated yields and stereoselectivities obtained for the transformation by 
S385X/D469T/R520Q mutants* 
 
Aldehyde F434A 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
R=3-CN ND Trace Trace 10% 
(90%) 
26% 
(91%) 
Trace 
*Reactions were performed in duplicate and consistent yields and ees were observed. Reaction 
conditions: 25 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 mL total reaction volume, 
18 hour reaction time. 
 
Neither D469T, D469T/R520Q, or S385E/D469T/R520Q gave any isolable 
quantities of ketodiol product (110), with only trace amounts seen by TLC analysis. 
S385T/D469T/R520Q however, gave 10% yield of product (110), and demonstrated 
excellent stereoselectivity with an ee of 90%. S385Y/D469T/R520Q performed even 
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better, with an isolated yield of 26% of ketodiol 110 and again excellent 
stereoselectivity with a product ee of 91%. Racemic 110 was prepared using the 
biomimetic reaction, mono-benzoylated (110-B) and then used to develop a chiral 
HPLC method. Good separation of both enantiomers was achieved using a Chiralpak 
AD column and a solvent system of 90:10 (n-hexane:isopropanol , 1mL/min, 214 
nm). The chiral HPLC traces of racemic product 110-B (Figure 5.22, A) and 110-B 
derived from S385T/D469T/R520Q and S385Y/D469T/R520Q products (Figure 
5.22, B and C) are shown below. 
 
 
 
Figure 5.22 Chiral HPLC traces of monobenzoylated derivatives (110-B) of; A - Racemic 
product, B - S385T/D469T/R520Q product, C - S385Y/D469T/R520Q product 
 
The acceptance of this substrate was interesting, especially since the nitrile moiety 
could act as a synthetic handle to introduce more functionality to the ketodiol 
product (110). 
A wide-range of meta-substituted benzaldehydes had been screened, so it was 
decided to also test some para-substituted benzaldehydes as substrates in the TK 
reaction with these combination mutants. 4-Formylbenzoic acid (153) (Table 5.13) 
had initially been screened with the library of triple mutants and >3 fold increases in 
specific activity were observed compared to D469T, so scaled-up biotransformations 
with 4-FBA to form ketodiol 154 were investigated (Table 5.13). The 
biotransformation product (154) was also found to be difficult to isolate due to its 
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high polarity, so conversion yields were calculated by 
1
H-NMR spectroscopy 
analysis. 
 
Table 5.13 Conversions obtained for the biotransformation of 4-FBA (153) by 
S385X/D469T/R520Q mutants* 
 
F434A 
Conversion  
D469T 
Conversion 
D469T 
R520Q 
Conversion 
S385T 
D469T/R520Q 
Conversion 
S385Y 
D469T/R520Q 
Conversion 
S385E 
D469T/R520Q 
Conversion 
ND 31% 42% 78% 56% 17% 
*Reactions were performed in duplicate and consistent yields and ees were observed. Reaction 
conditions: 50 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 mL total reaction 
volume, 18 hour reaction time. 
 
D469T had already been reported to give a 30% conversion yield to 154 in small-
scale biotransformations monitored by HPLC,
[91]
 which was comparable to the 31% 
conversion yield of 153 observed for D469T upon scale-up. Interestingly, while 
D469T/R520Q was observed to decrease the conversion yield of 153 in the small-
scale transformations, at a 20 mL scale an increased conversion yield to 154 of 42% 
was observed. S385T/D469T/R520Q was previously shown to give a 2-fold increase 
in specific activity with 4-FBA compared to D469T, and this was also represented 
by an increase in conversion yield of 153 to 78%, more than twice the conversion 
yield of D469T. S385Y/D469T/R520Q was shown to give the largest increase in 
specific activity for 4-FBA compared to D469T, but while the conversion yield 
observed was greater than that for D469T, at 56%, this was lower than that for 
S385T/D469T/R520Q. S385E/D469T/R520Q was previously shown to have 
severely impaired activity toward 4-FBA, with a 5-fold decrease in specific activity 
observed (Section 5.4). This decreased activity was also observed in a larger scale 
biotransformation, giving a conversion yield of 17%, lower than any of the other 
mutants.  
Unfortunately, all attempts to derivatise the biotransformation product to allow 
purification and analysis of the stereoselectivities failed (Scheme 5.3). Standard acid 
catalysed ester formation was avoided to prevent the racemisation of the 
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stereocentre, which had been observed to be sensitive to acidic and basic conditions 
(Chapter 2). TMS-diazomethane has been shown to be an effective method to 
prepare methyl esters from carboxylic acids under mild conditions.
[93, 94, 95]
 This 
method was attempted using crude biotransformation product but numerous attempts 
to protect the acid functionality of the ketodiol product (154) in this manner failed, 
despite using increasing amounts of reagent. Lipases have been identified as useful 
biocatalysts for the reversible formation of esters from carboxylic acids under mild 
conditions.
[96]
 To assess the use of Candida antarctica lipase B (CAL-B) to protect 
the acid functionality of ketodiol 154, it was first tested with 4-formylbenzoic acid. 
By stirring 50 mg of immobilized CAL-B in methanol with 20 mM concentration of 
4-formylbenzoic acid, a quantitative conversion to methyl-4-formylbenzoate was 
observed. This was encouraging, and so the same procedure was used with crude 
biotransformation material. Unfortunately this was unsuccessful, and despite 
numerous repeats of the experiment with increased enzyme loadings no ester 
formation was observed, only formation of the rearranged ketodiol and methyl-4-
formylbenzoate (formed from 4-FBA remaining in the crude biotransformation 
mixture) was observed. Attempts to derivatise the alcohol functionalities using 
standard benzoylation methods were also unsuccessful (Scheme 5.3). Since writing 
this thesis a trimethylsilyl derivatisation method for polyol TK products has been 
published by the Hanefeld group, however the harsh conditions required would not 
be suitable for sensitive products such as 154.
[44]
 
 
 
Scheme 5.3 Attempts to derivatise 4-FBA biotransformation product (154) 
The stereoselectivities in the 3-FBA biotransformation reaction had been observed to 
be fairly low (<65% ee), potentially due to the racemisation of product in situ or 
when derivatised, due to the electron withdrawing effects of the carboxylic acid 
functionality. The 4-FBA product (154) would be expected to racemise even more 
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readily, due to the position of the carboxylic acid functionality, increasing the acidity 
of the proton adjacent to the aromatic ring and making the product more susceptible 
to rearrangement. Thus, even if derivatisation had been possible, it is likely that the 
stereoselectivities that could be monitored would be even lower than those observed 
for the biotransformations of 3-FBA. 
The final substrate investigated with these mutants was 4-
(methylsulfonyl)benzaldehyde (158) (Table 5.14), a substrate which, if accepted by 
TK, would furnish a direct precursor to the antibiotic, thiamphenicol. Once again, the 
increased polarity of the ketodiol product (159) made it difficult to purify, so 
conversion yields were assessed by 
1
H-NMR (Table 5.14) and crude material 
brought through to the benzoylation reaction. Di-benzoate ester derivatives (159-B) 
were then isolated and analysed by chiral HPLC to determine the stereoselectivity of 
the ketodiol product (159). 
 
Table 5.14 Conversion yields and stereoselectivities obtained for the biotransformation of 4-
methylsulfonylbenzaldehyde by S385X/D469T/R520Q mutants* 
 
F434A 
Yield 
(ee) 
D469T 
Yield 
(ee) 
D469T 
R520Q 
Yield (ee) 
S385T 
D469T/R520Q 
Yield (ee) 
S385Y 
D469T/R520Q 
Yield (ee) 
S385E 
D469T/R520Q 
Yield (ee) 
ND Trace Trace *49% 
(90%) 
*20% 
(70%) 
Trace 
*Reactions were performed in duplicate and consistent yields and ees were observed. 
Reaction conditions: 50 mM aldehyde, 50 mM Li-HPA, 4 mL TK cell-free lysate, 20 
mL total reaction volume, 18 hour reaction time. 
 
When both D469T and D469T/R520Q variants were used, only traces of 159 were 
observed by TLC analysis. S385T/D469T/R520Q had so far been the best 
performing mutant for benzaldehyde (34% yield of (68) in 98% ee), 3-
hydroxybenzaldehyde (7% yield of (103) in 50% ee), 3-fluorobenzaldehyde (12% 
yield of (105) in 70% ee) and methyl-3-formylbenzoate (34% yield of (106) in 96% 
ee), and was also found to be the best performing mutant for 4-(methylsulfonyl) 
benzaldehyde with a 49% conversion yield and high degree of stereoselectivity 
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forming the product (159) in 90% ee. S385Y/D469T/R520Q had performed similarly 
to S358T/D469T/R520Q for most of the substrates, with similar yields and 
stereoselectivities observed, and this was also the case with 4-
(methylsulfonyl)benzaldehyde where a slightly reduced conversion yield of 20% was 
observed along with a slightly reduced ee of (159) of 70%. S385E/D469T/R520Q 
had not been as tolerant as the other two triple mutants towards substituted 
benzaldehydes, and this was again observed with 4-methylsulfonylbenzaldehyde 
where only trace amounts of product were observed by TLC analysis. 
In an attempt to rationalise the large variation in activity observed for these mutants 
with 4-methylsulfonyl benzaldehyde, computational docking was performed with 
this substrate and D469T, S385E/D469T/R520Q and S385T/D469T/R520Q with the 
ThDP-enamine already docked in all structures (Figure 5.23). D469T gave only trace 
amounts of product with 4-(methylsulfonyl)benzaldehyde and the computational 
docking results supported the experimental data, with one major binding cluster 
predicted by the docking program, which appeared to be non-productive. In this 
cluster (Figure 5.23, A) the sulfonyl functionality formed hydrogen bonding 
interactions with H258 and D259 at the entrance to the active-site, pointing the 
aldehyde away from the ThDP-enamine intermediate at a distance of 8.7 Å. 
S385E/D469T/R520Q demonstrated a low energy cluster (Figure 5.23, B) where the 
sulfonyl group was bound by R358, S385E and H461, pointing the aldehyde towards 
the ThDP-enamine, at a distance of 6.0 Å. It is possible that this distance is too far 
away for nucleophilic attack to occur, which could explain why only trace amounts 
of product were observed. 
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Figure 5.23 Results obtained for the docking of 4-methylsulfonylbenzaldehyde. A – Non-
productive cluster found for docking into D469T. B – Non-productive, lowest energy cluster 
found for docking into S385E/D469T/R520Q. C – Productive cluster found for docking into 
S385T/D469T/R520Q. D - Productive cluster found for docking into S385T/D469T/R520Q 
 
For S385T/D469T/R520Q two major binding clusters were predicted, with very 
similar populations and energies. The first cluster (Figure 5.23, C) showed the 
sulfonyl group bound by S24 and G25, holding the aldehyde directly above the 
ThDP-enamine at a distance of 3.9 Å. The other cluster (Figure 5.23, D) showed the 
sulfonyl group bound by D469T and R520Q, again holding the aldehyde above the 
ThDP-enamine intermediate at a slightly increased distance of 4.6 Å. The presence 
of two low energy binding clusters for S385T/D469T/R520Q with 4-
(methylsulfonyl) benzaldehyde supports the high conversion yields observed for this 
mutant as both clusters show potentially productive orientation of the aldehyde in 
relation to the ThDP-enamine, at short distances (<5 Å). 
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5.6 Aromatic substrates not accepted by combination 
mutant TKs 
 
Since these triple mutants, especially S385T/D469T/R520Q, showed good tolerances 
towards substituted aromatic aldehydes, a more sterically demanding substrate, 1,8-
naphthalaldehydic acid (160) (Figure 5.24) was investigated. This substrate was 
chosen as it would investigate whether fused aromatic rings would be accepted by 
the mutant TKs, and also because it maintained the 1,3 relationship between the 
aldehyde and acid functionalities which had been observed to increase the activity of 
TKs with 3-FBA (Section 5.3), albeit in a different orientation. 
 
 
Figure 5.24 Structure of 1,8-naphthaldehydic acid (160) 
 
Unfortunately, no product was seen with this substrate for any of the mutants at 
either 25 mM or 50 mM concentrations, even with extended reaction times (up to 48 
hours). This is perhaps not surprising given the size of the substrate, and indicated 
that while these mutants showed a good tolerance for several aromatic aldehydes, 
there was a steric limit to the aldehydes that they would accept. 
A range of more functionalised benzaldehydes was also tested with these mutants, to 
see whether they would be tolerated. Vanillin (4-hydroxy-3-methoxybenzaldehyde, 
161, Figure 5.25), ortho-vanillin (2-hydroxy-3-methoxybenzaldehyde, 162, Figure 
5.25) and iso-vanillin (3-hydroxy-4-methoxybenzaldehyde, 163, Figure 5.25) were 
all used at 25 mM concentrations. Reactions were followed by TLC analysis but no 
product formation was observed for any of the mutants even after extended reaction 
times (48 hours). 
 
 
Figure 5.25 Range of Vanillin analogues tested with TK mutants. 
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Given that 3-hydroxybenzaldehyde (93) was accepted by all of the mutants, albeit 
with low yields and moderate stereoselectivities (Table 5.7), the lack of product 
formation observed for these vanillin derivatives (Figure 5.25) was disappointing. It 
is possible that the presence of two electron donating groups renders the aldehyde 
less reactive towards nucleophilic attack by the ThDP-enamine intermediate. It is 
also possible that the presence of additional substituents at either the 2- or 4-position 
of the aromatic ring create unfavourable steric hinderence which restrict access of 
these vanillin derivatives into the TK active-site. 
Another substrate which was investigated with these mutants was 3-
nitrobenzaldehyde (98, Figure 5.26). 
 
 
Figure 5.26 Structure of 3-nitrobenzaldehyde (98) 
 
Unlike the vanillin derivatives where no products of any kind were formed, the 
formation of multiple products was observed by TLC analysis for all mutants, 
however no ketodiol product was observed in the 
1
H-NMR spectra of crude 
biotransformation reaction mixtures, so this substrate was not investigated further.  
 
5.7 Aminodiol synthesis with TAm 
 
The acceptance of 4-methylsulfonyl benzaldehyde (158) in good yield and with 
excellent stereoselectivity by S385T/D469T/R520Q (Table 5.14), was very exciting, 
since this gave access to a direct precursor (159) of thiamphenicol (70) which could 
be used in a second-step with transaminase (Scheme 5.4) to give the aminodiol core 
(164) of thiamphenicol in a total of two enzymatic steps. 
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Scheme 5.4 Approach to thiamphenicol using TAm 
 
A TAm from Chromobacterium violaceum, CV2025, had already been reported to 
accept the racemic product (68) of the biomimetic TK reaction with benzaldehyde. 
This TAm accepted both enantiomers of racemic 68, but formed the new 
stereocentre (69) with S-configuration exclusively (Scheme 5.5).
[75]
 
 
Scheme 5.5 Stereoselectivity of aromatic aminodiol synthesis by CV2025
[75]
 
 
A number of substrates could now be transformed with high degrees of 
stereoselectivity (>90% ee) using mutant TKs, so it was possible to investigate the 
synthesis of optically pure aminodiols using a TK/TAm approach. 
Since the ketodiol product (68) formed by the TK reaction with benzaldehyde had 
been shown to be accepted by TAm,
[75]
 and this substrate could be prepared by 
S385T/D469T/R520Q with 98% ee, this was the first substrate tested with CV2025 
(Scheme 5.6). The TK reaction with benzaldehyde (8) was performed with 
S385E/D469T/R520Q as previously described, and a portion of the product (68) was 
benzoylated, analysed by chiral HPLC and the ee confirmed to be >95%, in 
accordance with the data already gathered for this mutant. The remaining product 
was used as the acceptor substrate for TAm, using reaction conditions previously 
described, with S-α-methylbenzylamine as the amine donor. TAm cell-free lysate 
was prepared as previously described with a protein concentration of approximately 
4 mg/mL.
[75]
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Scheme 5.6 Combined TK and TAm strategy to an aromatic aminodiol (69) starting from 
benzaldehyde (8) 
 
The reaction was followed by TLC analysis, until no starting material could be 
observed after 24 hours. Difficulty isolating these aminodiols has been reported,
[75]
 
so the reaction was concentrated to dryness under reduced pressure, and the crude 
reaction mixture subjected to the acetylation conditions of acetic anhydride, DMAP 
and pyridine.
[75]
 The 
1
H-NMR spectrum of the crude material showed two products, 
which were identified as acetylated S-α-methylbenzylamine (165) (Figure 5.27), the 
amine donor which had been used in excess, and the desired acetylated aminodiol 
(69-B) (Figure 5.27). 
 
 
Figure 5.27 Two major products isolated after acetylation of the crude TAm reaction 
 
These two compounds were separated by flash silica chromatography, and the pure 
acetylated aminodiol was isolated in low yield (<5% yield based on starting amount 
of ketodiol). However, the TLC analysis of the TAm reaction had shown no ketodiol 
remaining, so the low yield was not due to the inefficiency of the TAm reaction, but 
more likely loss of product during the acetylation and subsequent purification. This 
compound was then used to determine the absolute stereochemistry of the starting 
ketodiol, as discussed later (section 5.8). 
The conversion to aminodiol 69 was encouraging, and so other ketodiols which had 
been generated in high yields and/or stereoselectivities by the combination mutant 
TKs were prepared and investigated as substrates for CV2025 (Figure 5.28). 3-
Fluorobenzaldehyde had been converted by S385E/D469T/R520Q to ketodiol 105 
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with 10% yield and 90% ee and so was used as a substrate. Methyl-3-formylbenzoate 
had been transformed by S385T/D469T/R520Q to 106 in 34% yield and 96% ee, the 
good yield and excellent stereoselectivity making this an interesting substrate to 
investigate with TAm. 3-Formylbenzoic acid was converted quantitatively to 108 by 
D469T, but with disappointing ee. Swift conversion of the ketodiol product (108) to 
the corresponding aminodiol would hopefully prevent racemisation, maintaining any 
stereoselectivity and so using this ketodiol as a substrate for TAm would hopefully 
give insights into the stereoselectivity of the intial TK step. This was also the case 
for the ketodiol product (154) from 4-formylbenzoic acid (153) for which 
stereoselectivity data could not be obtained, despite excellent conversion yields to 
154 of 78% observed for S385T/D469T/R520Q. The final substrate of interest was 
the ketodiol (159) from 4-methylsulfonyl benzaldehyde which was transformed with 
49% conversion yield and 90% ee by S385T/D469T/R520Q. This was possibly the 
most interesting substrate, since performing the transaminase reaction on this 
substrate would give access to the core structure (164, Scheme 5.4) of thiamphenicol 
(Scheme 5.4). 
. 
 
Figure 5.28 Range of aromatic ketodiols investigated with CV2025 
 
All ketodiols were isolated and purified for use in the transaminase reaction, except 
for ketodiol products 154 and 159 from 4-FBA and 4-methylsulfonyl benzaldehyde 
which were isolated as mixtures of the ketodiols and their respective aldehydes. In 
these cases conversion yields from the TK reaction were assessed by 
1
H NMR 
analysis and found to be in accordance with previous data. TAm reactions were then 
performed as for the benzaldehyde ketodiol product (68), and as previously 
described.
[75]
 Reactions were followed by TLC analysis to monitor the consumption 
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of ketodiol substrate, and also by reverse phase HPLC analysis to screen for 
acetophenone production, which is  generated upon consumption of the amine donor, 
S-α-methylbenzylamine.[66] 
After 24 hours, TLC analysis of the TAm reactions of all of the ketodiol substrates 
showed large amounts of starting ketodiol remaining. To each reaction more cell-free 
TAm lysate was added and reactions left for a further 24 hours at 37 
o
C. After this 
time TLC analysis once again showed large amounts of starting ketodiol for each 
case. However, HPLC analysis showed generation of acetophenone in each case, 
indicating the consumption of some amine donor, and thus potential turn-over of 
ketodiol. It was decided that even though reactions had not gone to completion, the 
generation of acetophenone was encouraging, and so reactions were concentrated to 
dryness and the crude reaction mixtures subjected to acetylation conditions to enable 
more facile product purification. Analysis of the 
1
H-NMR spectra for all crude 
reaction mixtures revealed no acetylated aminodiols for any of the transaminase 
reactions with these substituted aromatic ketodiols. Only acetylated 
methylbenzylamine (165) was observed. This was very disappointing, especially 
given the good acceptance of the benzaldehyde TK product (68) by CV2025.  
The non-acceptance of substituted aromatic ketodiols was interesting, especially 
since relatively small substituents such as fluorine, were not accepted. The active site 
of transaminases have been shown to have two binding pockets, a large pocket and a 
small pocket.
[97]
 The aromatic ring of the aromatic ketodiols would be expected to 
occupy the large pocket of the enzyme, which seems to accept a non-substituted 
benzene ring, but will not accept any substitutents on meta or para-positions. It 
seems possible that to increase the activity of CV2025 with these substrates 
mutations would need to be introduced into the large pocket to increase its size, thus 
increasing its acceptance of larger aromatic substrates. A library of CV2025 mutants 
has subsequently been generated by the Dalby group to address this problem, and 
can be explored with these substrates in future work.
*
 
  
 
 
*CV2025 mutants have been created by Dawid Deszcz in UCL Dept. Of Biochemical Engineering 
153 
 
5.8 Assignment of absolute stereochemistry of aromatic 
ketodiols using transaminase 
 
Previous work with aromatic ketodiols had tentatively assigned their absolute 
stereochemistry based on a modified Mosher’s ester analysis method which had been 
developed using aliphatic ketodiols (Figure 5.29).
[79, 83, 85]
 This method was 
particularly useful as only small amounts of material (<5 mg) were required for 
derivatisation. 
 
 
 
 
Figure 5.29 Assignment of absolute stereochemistry of aliphatic ketodiols based on a modified 
Mosher's analysis method. (Used with permission from Elsevier).
[83]
 
 
The absolute stereochemistries of the ketodiols were assigned based on previously 
published absolute stereochemistries, either from synthesis of chiral standards, or 
established stereochemistries of, for example, L-erythrulose.
[48, 83]
 When this 
Mosher’s method was applied to ketodiols 150 and 152 formed from 
phenylacetaldehyde and 2-phenylpropanal, it indicated the formation of the (3S)-
isomer, which was also in agreement with the absolute stereochemistry already 
reported for the transformation of the structurally related 2-hydroxy-2-
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phenylacetaldehyde (Figure 5.30).
[87]
 On this basis, application of the Mosher’s 
method to aromatic compounds was a logical extension. 
 
 
Figure 5.30 Aliphatic ketodiols containing aromatic groups used to prove validity of modified 
Mosher's ester analysis method 
 
Crucially, however, an aromatic ketodiol standard of known stereochemistry was 
never tested with this method to confirm the assignment of absolute stereochemistry 
for aromatic ketodiols, because no synthetic methods exist to produce these 
compounds with known stereochemistry.
[83]
  
While no chiral aromatic ketodiol standards are available, chiral aminodiol standards 
do exist. Both (1S,2S)-2-amino-1-phenyl-1,3-propanediol (1S,2S-69) (Figure 5.31) 
and (1R,2R)-2-amino-1-phenyl-1,3-propanediol (1R,2R-69) (Figure 5.31) are 
commercially available. 
 
 
Figure 5.31 Structures of both syn-diastereomers of 69 
 
In previous work examining the stereoselectivity of the transformation of the 
benzaldehyde TK product (68) by CV2025, these two commercially available syn-
isomers were triacetylated and analysed by chiral HPLC. One of the two remaining 
anti-isomers, (1R,2S) was then synthesised, tri-acetylated and also studied by chiral 
HPLC.
[75]
 Analysis of the racemic product gave the elution times of the four 
diasteroisomers, three of which could be directly correlated to available standards, 
and the remaining diasteroisomer was assigned as (1S,2R) (Table 5.15).
[75]
 
Benzaldehyde was accepted by S385T/D469T/R520Q in 98% ee and CV2025 had 
been shown to exclusively form the (S)-isomer at the new stereocentre (69). This 
product had been triacetylated (69-B) to allow easy isolation of product from the 
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TAm reaction, so this gave the opportunity, for the first time, to assign the 
stereocentre from the TK reaction by direct correlation to known chiral standards 
(Scheme 5.7). Therefore, commercially available (1S,2S)-69 and (1R,2R)-69 were 
triacetylated, and chiral HPLC analysis was performed, using a Chiralpak AD 
column and a solvent system of 97:3 (n-hexane:isopropanol, 0.8 mL/min, detection 
at 214 nm),
[75]
 on these two samples and the triacetylated biotransformation sample 
(69-B).  
 
 
Scheme 5.7 69-B of known stereochemistry, and formation of 69-B derived from the two-step 
biotransformation procedure 
 
Table 5.15 Previously reported elution times for all four diasteroisomers of triacetylated 
aminodiol 69
[75]
 
Diastereoisomer of 69-B Elution time (min) 
1R,2R 74.4 
1S,2S 77.1 
1R,2S 99.8 
1S,2R 105.4 
 
The chiral HPLC profile for the biotransformation product (69-B) showed a major 
peak at 77 minutes and a minor peak at 93 minutes. The major peak corresponded to 
(1S,2S)-69 which was confirmed by analysis of acetylated (1S,2S)-69-B and 
comparison of the HPLC traces (Figure 5.32). This confirmed for the first time that 
the TK reaction was (S)-selective in the reaction with benzaldehyde to form ketodiol 
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68, with the minor diastereomer assigned as (1R,2S) based on the previously reported 
retention time for this isomer, and the highly S-selective nature of CV2025.
[75]
 This 
confirmed that the combined TK and TAm strategy using benzaldehyde as the 
starting substrate gave an overall 95% selectivity in favour of (1S,2S)-69-B with the 
minor (1R,2S) isomer present at a level of 5%. The slight loss in de was probably 
due to a slight amount of racemisation during the TAm step with ketodiol 68, as this 
reaction required elevated temperatures of 37 
o
C and a slightly elevated pH, 
conditions which have previously been shown to erode the optical purity of aromatic 
ketodiols.
[85]
  
 
 
Figure 5.32 Overlaid chiral HPLC profiles of 69-B from the TK/TAm strategy and (1S,2S)-69-
B. Elution times shown in minutes. 
 
Previous work with aromatic ketodiols and TK had assigned absolute 
stereochemistries as 3(R) based on the extension of the modified Mosher’s method 
(Figure 5.29).
[79, 83, 85]
 However, the chiral HPLC data for aminodiol 69, based on the 
correlation of stereochemistry to known standards, showed that TK was (S)-selective 
in the formation of ketodiol 68, the same stereoselectivity as observed for aliphatic 
ketodiols formed by TK.
[26]
 This indicates that the Mosher’s method cannot be 
applied in the same way for aliphatic and aromatic ketodiols with stereocentres at the 
C-3 position. It is possible that ring current effects from the presence of the aromatic 
ring affect the shift patterns of the diastereotopic protons misleadingly indicating the 
formation of the opposite stereoisomer. Indeed, problems have previously been 
reported in assigning the absolute stereochemistry of some aromatic compounds 
157 
 
using this method.
[98]
 To date, all available Mosher’s and chiral HPLC data for 
aromatic ketodiols has consistently indicated the formation of the same stereocentre 
in all cases. Since the HPLC data for aminodiol 69-B formed from the combined 
TK/TAm strategy definitively showed that the 3(S) isomer was formed by TK 
(Figure 5.32), the absolute stereochemistry of all aromatic ketodiols can now be 
assigned as 3(S) by analogy (Table 5.16). 
 
Table 5.16 Summary of stereoselectivities obtained for mutant TKs with aromatic aldehydes. 
Absolute stereochemistries based on the observed selectivity for TK with benzaldehyde, from 
study of acetylated aminodiol from combined TK/TAm approach 
 
 
Aldehyde 
(R=) 
F434A 
 
D469T D469T 
R520Q 
S385T 
D469T 
R520Q 
S385Y 
D469T 
R520Q 
S385E 
D469T 
R520Q 
H (8) 82%
[85]
  
(3S) (68) 
70% (3S) 
(68) 
54% (3S) 
(68) 
98% (3S) 
(68) 
97% (3S) 
(68) 
37% (3S) 
(68) 
3-OH 
 (93) 
53%
[85]
 
(3S) (103) 
0%  
(103) 
0%  
(103) 
50% (3S) 
(103)  
55% (3S)  
(103)  
60% (3S) 
(103)  
3-F  
(94) 
ND  20% (3S) 
(105) 
78% (3S) 
(105) 
70% (3S) 
(105) 
64% (3S) 
(105) 
90% (3S) 
(105) 
3-vinyl 
 (96) 
ND 0%  0% 84% (3S) 
(107) 
90% (3S) 
(107) 
ND 
3-CO2Me 
(95) 
ND ND ND% 96% (3S) 
(106) 
72% (3S) 
(106) 
ND 
3-CO2H  
(97) 
ND% 62% (3S) 
(108) 
56% (3S) 
(108) 
49% (3S) 
(108) 
45% (3S) 
(108) 
0% 
3-CN 
(18) 
ND ND ND 90% (3S) 
(110) 
91% (3S) 
(110) 
ND 
4-SO2Me 
(158) 
ND ND ND 90% (3S) 
(159) 
70% (3S) 
(159) 
ND 
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These results indicate that the predominant isomer formed in all cases is (S), as 
found for the aliphatic series of ketodiols.
[26, 85]
 It should be noted that the initial 
absolute stereochemistries of aromatic ketodiols were only ever tentatively assigned 
by the Mosher’s method,[79, 85] as at the time it was the only method available. Also, 
the absolute stereochemistries of the aromatic ketodiols prepared by the asymmetric 
biomimetic TK reaction were also assigned using the Mosher’s method (Chapter 2), 
and so should be re-assigned as 3(S) by analogy to the formation of (1S,2S)-69. 
 
5.9 Analysis of docking results to support assignment of 
absolute stereochemistry 
 
In an attempt to support the assignment of the stereocentre formed by the mutant 
TKs with aromatic aldehydes as 3S, the docking experiments performed with these 
mutants and some of the aromatic aldehydes were studied in more detail. The most 
productive docking experiments came from the docking of 3-FBA (97) into D469T, 
4-(methylsulfonyl)benzaldehyde (158) into S385T/D469T/R520Q and methyl-3-
formylbenzoate (95) into S385T/D469T/R520Q, so these docking experiments were 
chosen for further analysis. 
The productive conformation obtained by docking 3-FBA into D469T showed the 
carboxylate group bound by the phosphate binding region, with hydrogen bonding 
interactions with R358, S385, H461 and R520. This held the aldehyde almost 
perpendicular to the ThDP-enamine intermediate, exposing neither face of the 
aldehyde preferentially to nucleophilic attack (Figure 5.33). This is in contrast to the 
62% ee 3(S) which was experimentally determined for the ketodiol 108 from the 
reaction of 3-FBA with D469T (Table 5.16).  
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Figure 5.33 Productive conformation found for docking 3-FBA (97) into D469T, where neither 
face of the substrate is preferentially exposed to the ThDP-enamine intermediate. 
 
A very similar binding mode was observed for the docking of 4-
(methylsulfonyl)benzaldehyde (158) into S385T/D469T/R520Q (Figure 5.34). The 
sulfonyl group was bound by D469T and R520Q, placing the aldehyde in a position 
perpendicular to the ThDP-enamine intermediate with neither face of the substrate 
preferentially exposed to nucleophilic attack. This was again in contrast to the 90% 
ee (3S) which was determined experimentally for ketodiol 159 (Table 5.16). 
 
 
Figure 5.34 Productive conformation found from docking of 4-(methysulfonyl)benzaldehyde 
into S385T/D469T/R520Q, where neither face of the aldehyde is preferentially exposed to the 
ThDP-enamine intermediate. 
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The results obtained for the docking of methyl-3-formylbenzoate (95) into 
S385T/D469T/R520Q were very different. The ester group was bound by G25 and 
the aldehyde functionality held in place by interactions with H26 and H261. In this 
case the re-face of the substrate was preferentially exposed to attack by the ThDP-
enamine intermediate (Figure 5.35), which would lead to formation of the 3S-
ketodiol product. This result supports the experimentally determined formation of 
the 3S-106 in 96% ee. 
 
 
Figure 5.35 Productive conformation found from docking of methyl-3-formylbenzoate into 
S385T/D460T/R520Q, with the re-face preferentially exposed to the ThDP-enamine 
intermediate attack. 
 
These results show the difficulty in using computational docking to analyse the 
stereoselectivity of reactions, since two of the docking experiments showed 
conformations that would lead to no stereoselectivity in the products, despite 
stereoselectivity being observed experimentally. However, the result obtained from 
docking methyl-3-formylbenzoate into S385T/D469T/R520Q supported the 
experimentally determined absolute stereochemistry as 3S. It would seem that 
computational docking in this case is not a reliable method for assessing 
stereochemistry, but may be a useful tool for supporting some experimental 
observations. 
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5.10 Summary of chapter 5 
 
In conclusion, the transformation of aromatic aldehydes by combination mutant TKs 
has been extensively studied. 3 And 4-formylbenzoic acids were used as molecular 
probes to investigate interactions between these substrates and the TK active-site. 
The natural phosphate binding region within the active-site was shown to be 
effective at binding the carboxylic acid groups of these substrates, leading to 
dramatically increased activities compared to previous work with mutant TKs and 
aromatic aldehydes. Mutant TK libraries were then created by focussing on this 
phosphate binding region and from knowledge gained from previous studies on the 
co-evolution of active-site residues in TK.
[88]
 The most active combination mutants 
were then used to transform a range of aromatic aldehydes and dramatic increases in 
yield and stereoselectivity over previous single mutant TKs were observed, with 
aromatic ketodiols formed in up to 98% ee. A two enzyme strategy was then 
investigated using the best performing combination mutant TK, 
S385T/D469T/R520Q and CV2025 TAm, to access an aromatic aminodiol in 90% 
de. By correlation with optically pure reference standards this aminodiol was shown 
to be predominantly the (1S,2S) isomer. This conclusively showed that the Mosher’s 
ester analysis method which had been used to tentatively assign the absolute 
stereochemistry of aromatic ketodiols as 3(R) was incorrect and as a result all 
compounds were re-assigned as 3(S). The molecular basis for the increased activities 
of these mutant TKs with aromatic aldehydes was extensively investigated using 
computational docking studies, which helped to explain the increases in isolated 
yield over previously studied single mutant TKs. While the docking results were not 
conclusive in rationalising observed stereoselectivities, some of the results helped to 
support the assignment of absolute stereochemistry and the conversions observed for 
aromatic aldehydes. 
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6 Novel donor substrates with transketolase 
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Much of the work with transketolase has been focussed on increasing the substrate 
scope of the enzyme with respect to the acceptor substrate. As such, mutant enzymes 
have been developed which accept a broad range of aliphatic, cyclic, and aromatic 
aldehydes.
[26, 85, 91]
 However, the substrate scope of the donor substrate has been 
poorly studied, presumably due to the high specificity that TK exhibits towards its 
natural phosphorylated subtrates (Figure 6.1) and hydroxypyruvate.
[99, 100, 101]
 
Analysis of the active-site of WT E.coli TK with two of these natural phosphorylated 
substrates, xylulose-5-phosphate (19) and fructose-6-phosphate (166), bound shows 
the origin of this specificity (Figure 6.2).
[90]
 
 
 
Figure 6.1 Structures of two of the natural substrates for TK, xylulose-5-phosphate (19) and 
fructose-6-phosphate (166) 
 
Figure 6.2 Crystal structures of WT-TK (2R5N) with; A - xylulose-5-phosphate (19) and B - 
fructose-6-phophate (166), bound. 
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In both cases the same interactions are observed. The ketol moiety is stabilised by 
interactions with H473 and H100, while the 3-hydroxyl group interacts with H261 
and H26, and the 4-hydroxyl group is bound by D469. It is reasonable to suppose 
that if the key interactions with the ketol group and H100 and H473 can be 
maintained, then other ketol donors could be accepted by TK.  
Recently the use of halogenated pyruvate derivatives as donor substrates for yeast 
TK has been reported (23, 167-171) (Figure 6.3).
[102]
 
 
Figure 6.3 Pyruvate derivatives studied as donor substrates for yeast TK
[102]
 
 
These substrates were studied by circular dichroism for their reaction with ThDP in 
the active site of TK to form the active ThDP-enamine intermediate. The further 
reaction of the enamine with an acceptor substrate was not studied. Nevertheless, 
some kinetic parameters for these donors were obtained (Table 6.1).
[102]
 
 
Table 6.1 Kinetic parameters obtained for pyruvate derivatives and their reaction with ThDP in 
the active-site of yeast TK
[102]
 
Substrate kcat (%) KM (mM) 
Hydroxypyruvate (23) 100 0.05 
Bromopyruvate (167) 130 0.13 
Dibromopyruvate (170) 90 2.0 
Chloropyruvate (168) 80 0.4 
Dichloropyruvate (171) 100 1.1 
Fluoropyruvate (169) 30 2.5 
 
Interestingly, while hydroxypyruvate (23) showed the highest affinity for yeast TK 
with the lowest KM value of 0.05 mM, bromopyruvate (167) actually showed the 
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highest kcat, with a kcat value 1.3 fold higher than that obtained for 
hydroxypyruvate.
[102]
 
This work was performed with yeast TK and no products were isolated or 
characterised,
[102]
 as only the formation of the active ThDP-enamine was studied by 
circular dichroism. However, this suggested that transketolase could potentially 
accept different donor substrates, providing a suitable leaving group on the α-
position of the ketol donor was present. The leaving group is crucial for the 
formation of the active ThDP-enamine intermediate (Scheme 6.1), as this renders the 
reaction irreversible, driving the reaction to completion, as in the case of pyruvate 
derivatives where the leaving group is CO2.
[100]
 
 
 
Scheme 6.1 Formation of the active ThDP-enamine intermediate in the active site of TK with 
pyruvate derivatives 
 
Therefore, modifying the R’’ group (Scheme 6.1) of the α-ketoacid should not affect 
the catalytic mechanism of TK, and if key active-site interactions are maintained, 
different groups should be tolerated. Novel ketol donors would be beneficial to 
investigate, especially in terms of increasing the synthetic use of transketolase in 
preparing a more diverse range of compounds. This is especially true given that the 
ketol products, which could be accessed by theTK reaction with pyruvate (7) and 2-
ketobutyric acid (172) as donors substrates (Figure 6.4), have not been accessed 
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asymmetrically using standard synthetic techniques, and only lipase catalysed kinetic 
resolutions have previously been reported to prepare such compounds.
[103]
 
 
 
Figure 6.4 Potential novel donor substrates for TK 
 
6.1 Sodium pyruvate as a donor in the TK reaction 
 
The investigation into novel donors was started by using pyruvate (7) as the ketol 
donor (Scheme 6.2) using the same conditions as previously reported for standard 
biotransformations.
[26, 85]
 Sodium pyruvate (Na-7) was first used as a donor with WT 
TK and with aliphatic aldehydes that had been shown to be tolerated by the WT 
enzyme. Low boiling points had been reported for the corresponding ketol 
compounds,
[104, 105]
 so longer chain aliphatics were used to enhance the ease of 
isolating any resulting products. Initially, sodium pyruvate was investigated with 
pentanal (121) (R = C4H9) and hexanal (173) (R = C5H11) as the acceptor substrates, 
to form ketols 174 (R = C4H9) and 175 (R = C5H11). 
 
 
Scheme 6.2 TK reaction using sodium pyruvate as the donor substrate 
 
No product formation was observed for either of these substrates, in contrast to the 
16% and 25% isolated yields previously reported for WT TK using HPA (23) as the 
ketol donor with 121 and 173 respectively.
[26]
  
A mutant TK, D469E, had been shown to lead to increased yields with HPA (23) as 
the donor and pentanal and hexanal as acceptor substrates,
[26]
 so this mutant was then 
investigated with sodium pyruvate (Scheme 6.2, Table 6.2) and a larger range of 
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acceptor aldehydes, including cyclohexanecarboxaldehyde (143, R = cyclohexyl) 
and benzaldehyde (8, R = Ph). 
 
Table 6.2 Yields obtained for D469E with sodium pyruvate (Na-7) as the donor substrate* 
Substrate Yield 
Pentanal (121) (R = C4H9) 5% (174) 
Hexanal (173) (R = C5H11) 4% (175) 
Cyclohexanecarboxaldehyde (143) (R = cyclohexyl) No reaction 
Benzaldehyde (8) (R = Ph) No reaction 
*D469E TK was made by Panwajee Payongsri. Reaction conditions: 50 mM aldehyde. 50 mM 
sodium pyruvate, 2 mL TK cell-free lysate, 20 mL reaction volume, 24 hour reaction time. 
 
Interestingly, after 18 hours, TLC analysis of the reactions with both pentanal and 
hexanal showed the formation of products with lower polarities than the 
corresponding ketodiols. To investigate these products further they were isolated and 
purified by flash silica chromatography. Column fractions were carefully 
concentrated in vacuo to prevent evaporation of any ketol products. 
1
H-NMR 
analysis of both products showed that the corresponding ketols 174 and 175 had 
been formed in each case, with isolated yields of 5% for 174 and 4% for 175. 
The formation of ketol products, and the acceptance of pyruvate by TK, was 
completely unprecedented, so two other aldehydes, cyclohexanecarboxaldehyde 
(143) (Scheme 6.2, R = cyclohexyl) and benzaldehyde (8) (Scheme 6.2, R = Ph) 
were investigated. The potential for TK to form ketol 5 from benzaldehyde and 
sodium pyruvate was particularly interesting as this would represent transketolase 
acting in a similar fashion to pyruvate decarboxylase, forming the 
phenylacetylcarbinol 5 (Scheme 6.3).
[15]
 
 
 
Scheme 6.3 Phenylacetylcarbinol (5) formation by pyruvate decarboxylase and transketolase 
 
D469E had been reported to transform both cyclohexanecarboxaldehyde (143) and 
benzaldehyde (8) using HPA as the ketol donor, though <5% isolated yields were 
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reported in both cases.
[26, 85]
 Disappointingly, no reaction was observed with sodium 
pyruvate as the donor substrate. 
D469T was another TK mutant which had been shown to be useful in the 
transformation of aliphatic aldehydes with HPA (23),
[26]
 and so this was also 
investigated for its acceptance of sodium pyruvate (Na-7), with the same range of 
acceptor substrates as D469E (Scheme 6.2, Table 6.3). 
 
Table 6.3 Yields obtained for D469T with sodium pyruvate (Na-7) as the donor substrate* 
 
Aldehyde Yield 
Pentanal (121) 5% (174) 
Hexanal (173) 4% (175) 
Cyclohexanecarboxaldehyde (143) Trace 
Benzaldehyde (8) Trace 
*D469T TK was made by Panwajee Payongsri. Reaction conditions: 50 mM aldehyde. 50 mM 
sodium pyruvate, 2 mL TK cell-free lysate, 20 mL reaction volume, 24 hour reaction time. 
 
Interestingly, D469T performed similarly to D469E with pentanal and hexanal, with 
isolated yields of 5% of (174) and 4% of (175) obtained for these two substrates. 
Trace amounts of product with comparable Rf values were observed by TLC analysis 
of the reactions with cyclohexanecarboxaldehyde and benzaldehyde, but not enough 
product was formed in either case to allow isolation of these products. Since 
cyclohexanecarboxaldehyde and benzaldehyde were poorly tolerated in the TK 
reaction with sodium pyruvate, they were not investigated further as acceptor 
substrates. 
D469Y was a TK mutant which had been shown to be active towards aliphatic 
aldehydes, forming the opposite stereoisomer compared to other TK mutants,
[47, 48]
 
and so was investigated with sodium pyruvate as the ketol donor (Table 6.4). 
Combination mutant TKs had already been shown to increase the activity of TK 
toward a range of aliphatic and aromatic aldehydes,
[88, 91]
 and so were also 
investigated with sodium pyruvate as the donor substrate in an attempt to increase 
the isolated yields of ketols 174 and 175 obtained. R520Q was a mutation which had 
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previously been shown to increase the activity of certain TK mutants towards 
propanal.
[88]
 Since D469E had given the highest isolated yields with sodium 
pyruvate as the donor, these two mutants were recombined to give D469E/R520Q 
and tested with sodium pyruvate and pentanal and hexanal (Table 6.4). Another 
combination mutant, S385T/D469T/R520Q, had been shown to be the most active 
TK mutant towards a range of aromatic aldehydes (Chapter 5) and so was also used 
(Table 6.4).  
 
Table 6.4 Yields obtained for D469Y, D469E/R520Q and S385T/D469T/R520Q with sodium 
pyruvate (Na-7) as the donor substrate* 
 
Aldehyde D469Y 
Yield 
D469E/R520Q 
Yield 
S385T/D469T/R520Q 
Yield 
Pentanal (121) Trace Trace Trace 
Hexanal (173) Trace Trace Trace 
*D469Y, D469E/R520Q and S385T/D469T/R520Q TK mutants were made by Panwajee Payongsri. 
Reaction conditions: 50 mM aldehyde. 50 mM sodium pyruvate, 2 mL TK cell-free lysate, 20 mL 
reaction volume, 24 hour reaction time. 
 
Despite D469E and D469T giving isolatable quantities of product with sodium 
pyruvate as the donor substrate, D469Y only formed trace amounts of ketols 174 and 
175. Disappointingly this was also the case for both of the combination mutants 
where only trace amounts of product were observed once again. Nevertheless, two 
TK mutants, D469E and D469T, accepted sodium pyruvate as the donor substrate 
with both pentanal and hexanal. With this in mind, a further novel donor substrate 
was investigated. 
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6.2 2-Ketobutyric acid as a donor in the TK reaction 
 
2-Ketobutyric acid (172) (Scheme 6.4), is structurally similar to sodium pyruvate 
(Na-7), but with an extra methylene group. Given the structural similarity of these 
substrates it was hoped that the TK mutants might show similar activities with 2-
ketobutyric acid as for sodium pyruvate. 
 
 
Scheme 6.4 TK reaction with 2-ketobutyric acid as the donor substrate 
 
D469E had been the best performing mutant using sodium pyruvate as the donor, 
and so was the first mutant to be investigated with 2-ketobutyric acid (172) (Table 
6.5). 
 
Table 6.5 Yields obtained for D469E with 2-ketobutyric acid as the donor substrate* 
Aldehyde Yield 
Pentanal (121) Trace 
Hexanal (173) 7% (177) 
*D469E was made by Panwajee Payongsri. Reaction conditions: 50 mM aldehyde. 50 mM 2-
ketobutyric acid, 2 mL TK cell-free lysate, 20 mL reaction volume, 24 hour reaction time. 
 
Only trace amounts of product were observed when pentanal was used as the 
acceptor substrate. When hexanal was used as the acceptor substrate, however, a 7% 
yield of ketol 177 was obtained. Despite bearing an extra methylene group compared 
to ketol 175, 177 was still observed to be highly volatile and product isolation was 
once again difficult.  
The acceptance of 2-ketobutyric acid (172) by D469E was encouraging, so a range 
of other TK mutants were tested with this donor (Table 6.6).  
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Table 6.6 Yields obtained for D469T, D469Y, D469E/R520Q and S385T/D469T/R520Q with 2-
ketobutryic acid as the donor substrate* 
 
Aldehyde D469T 
Yield 
D469Y 
Yield 
D469E/R520Q 
Yield 
S385T/D469T 
R520Q 
Yield 
Pentanal (121) 4% (176) Trace (176) 6%(176) 4% (176) 
Hexanal (173) Trace (177) 8% (177) 3% (177) Trace (177) 
*TK mutants were made by Panwajee Payongsri. Reaction conditions: 50 mM aldehyde. 50 
mM 2-ketobutyric acid, 2 mL TK cell-free lysate, 20 mL reaction volume, 24 hour reaction 
time. 
 
D469T had formed isolatable quantities of product with sodium pyruvate (Na-7) 
(Table 6.3) and in this case, using pentanal as the acceptor substrate gave a 4% 
isolated yield of 176 while hexanal gave only trace amounts of 177. D469Y had not 
formed any products with sodium pyruvate as a donor substrate, yet showed more 
activity towards 2-ketobutyric acid (172) (Table 6.6). Trace amounts of 176 were 
observed but an 8% isolated yield of ketol 177 (Scheme 6.4, R = C5H11) was 
obtained when using hexanal. Combination mutants had not increased the yields of 
ketol products 173 or 175 (Scheme 6.2) with sodium pyruvate as the donor, yet they 
performed better with 2-ketobutyric acid. D469E/R520Q gave isolated yields of 6% 
of 176 and 3% of 177 for pentanal and hexanal, respectively. S385T/D469T/R520Q 
had only formed trace amounts of product with sodium pyruvate as the donor with 
both aldehyde acceptors. However, it performed slightly better with 2-ketobutyric 
acid (Table 6.6), with a 4% isolated yield of 176 (Scheme 6.4, R = C4H9), but 
forming only trace amounts of 177. 
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6.3 2-ketoglutaric acid as a donor in the TK reaction 
 
One final donor substrate was briefly investigated with D469E. α-Ketoglutaric acid 
(178) is a substrate for another ThDP-dependent enzyme, 2-succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate synthase (menD), which has been reported to accept a 
range of aromatic and aliphatic aldehydes with variable yields and stereoselectivities 
observed.
[106]
 Thus, acceptance of α-ketoglutarate by TK as an acceptor substrate 
would represent TK mimicking the function of menD (Scheme 6.5). 
 
 
Scheme 6.5 Potential use of α-ketoglutaric acid as a donor substrate for TK 
 
D469E was one of the best performing mutants with the other two novel donors, 
sodium pyruvate and 2-ketobutyric acid, and so was chosen for investigation with α-
ketoglutaric acid (Scheme 6.5, Table 6.7). 
 
Table 6.7 Yields obtained for D469E with α-ketoglutaric acid as the donor substrate* 
Aldehyde Yield 
Pentanal (121) No reaction 
Hexanal (173) No reaction 
*Reaction conditions: 50 mM aldehyde. 50 mM α-ketoglutaric acid, 2 mL TK cell-free lysate, 20 mL 
reaction volume, 24 hour reaction time. 
 
Disappointingly, no product formation was observed for either of the acceptor 
aldehydes, not even trace amounts by TLC analysis. Since D469E had been one of 
the most tolerant mutants towards novel donors, this substrate was not investigated 
further. 
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6.4 Determination of stereoselectivity of TK with novel 
donors 
6.4.1 Determination of stereoselectivity of TK reaction with 
sodium pyruvate as donor substrate 
 
While the ketol products (174-177) from the TK reaction with sodium pyruvate and 
2-ketobutryic acid had been isolated and fully characterised, the stereoselectivity of 
these reactions had not yet been established. Ketols 174 and 175 formed when using 
sodium pyruvate as a donor (Scheme 6.2) have been previously reported as 
compounds present in the pheromones of various longhorn beetle species.
[104]
 
Several chiral analytical methods have been reported for these compounds, mainly 
relying on chiral gas chromatography analysis.
[105]
 However, facile isomerisation of 
these compounds has been observed upon heating, making GC methods 
unreliable.
[105]
 A method has also been reported which involves the preparation of 
Mosher’s ester derivatives of the ketol compounds.[104] The coupling of the chiral 
auxiliary affected the signal of the terminal methyl triplet in each enantiomer (δ 0.83 
for (S,S) and δ 0.87 for (S,R)), which could be easily distinguished from each other. 
It also caused a shift in the signal of the singlet methyl peak (δ 2.22 for (S,S) and δ 
2.12 for (S,R)) which were also easily distinguishable. The relative integrations of 
each signal would therefore give the enantiomeric excess and absolute 
stereochemistry of the starting ketol compound. As each peak had been 
unambiguously confirmed by the synthesis of chiral standards,
[104]
 this method 
would allow assignment of the absolute stereochemistries and ees (Figure 6.5). 
Previous optical rotations had also been reported for each enantiomer, so the 
absolute stereochemistries assigned by the Mosher’s method could be re-affirmed by 
measurement of the optical rotations for the ketol compounds.
[105]
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Figure 6.5 Use of Mosher's ester analysis to determine the absolute stereochemistry of ketol 
products (175)
[104]
 (Used with permission from Elsevier). 
 
Of all the mutants tested with sodium pyruvate as a donor substrate, only D469E and 
D469T had given any isolatable products, with both enzymes producing ketols 174 
and 175 from pentanal (121) and hexanal (173). Therefore, purified samples of 
ketols 174 and 175 from both enzymes were derivatised with R-Mosher’s acid 
chloride, using an analogous procedure as previously described for ketodiols,
[26, 85]
  
to make the S-Mosher’s esters (174-B and 175-B). The peaks of the singlet methyl 
groups were then analysed to determine which enantiomers were being formed 
(Scheme 6.2). The resulting 
1
H-NMR spectrum of 175-B is shown in Figure 6.6.  
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Figure 6.6 
1
H-NMR of S-Mosher's derivative (175-B) of ketol (175) from D469E reaction with 
hexanal and sodium pyruvate, with terminal methyl singlet region expanded 
 
Pleasingly, comparison of the singlet methyl signals at δ 2.21 and δ 2.13 and the 
integrations for each signal showed that the S-enantiomer of 175 was formed almost 
exclusively by D469E in > 95% ee. This method was then extended to ketol 174 
from the D469E TK reaction of pentanal and sodium pyruvate (Figure 6.7). 
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Figure 6.7 
1
H-NMR of S-Mosher's derivative (174-B) of ketol (174) from D469E reaction with 
pentanal and sodium pyruvate, with terminal methyl singlet region expanded 
 
Once again, analysis of the singlet methyl signals at δ 2.20 and δ 2.13 showed that 
D469E formed the S-enantiomer almost exclusively with a product ee > 95%. The 
optical rotation values of both ketol compounds supported the 
1
H-NMR data in the 
assignment of the absolute stereochemistry, with both exhibiting positive optical 
rotations as previously reported for the S-enantiomers of these compounds.
[104, 105]
 
Ketol products 174 and 175 from D469T were then subjected to the same Mosher’s 
derivatisation method, and the singlet methyl regions in each 
1
H-NMR spectrum 
analysed as before. Once again, exquisite selectivity was observed with products 
formed with >95% ee for the (S)-enantiomer. The absolute stereochemistry was 
confirmed by the optical rotation values for all compounds.
[104, 105]
 The results with 
sodium pyruvate as the donor substrate for both D469E and D469T are summarised 
below (Table 6.8).  
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Table 6.8 Isolated yields and stereoselectivities obtained for D469E and D469T with sodium 
pyruvate as the donor substrate 
 
Substrate 
(R=) 
D469E 
Yield (ee) 
D469T 
Yield (ee) 
C4H9 (121) 5% (>95% 3S) (174) 5% (>95% 3S) (174) 
C5H11 (173) 6% (>95% 3S) (175) 4% (>95% 3S) (175) 
 
6.4.2 Determination of stereoselectivity of TK reaction with 2-
ketobutyric acid as donor substrate 
 
While the ketol products (174, 175, Scheme 6.2) from the TK reaction with aliphatic 
aldehydes and sodium pyruvate had been previously reported, along with chiral 
analysis methods,
[104, 105]
 no such methods had been reported for products 176 and 
177 formed from 2-ketobutyric acid as the donor substrate. However, it was 
considered that the Mosher’s ester analysis method could once again be applied 
using an analogous approach. The 2-ketobutyric acid products (176 and 177) 
contained an extra methylene group, changing both the shift and multiplicity of the 
singlet methyl signal used to assign the stereochemistry in 174-B and 175-B. 
However, as previously mentioned, the terminal triplet methyl signal can also be 
used to assign absolute stereochemistries.
[104]
 The shift of this proton would be 
unaffected by using 2-ketobutyric acid as the donor substrate, so this signal could be 
used to assign the absolute stereochemistry.  
To confirm that this approach was feasible, the 
1
H-NMR spectrum of the Mosher’s 
ester derivative of the D469E TK product of 175 was analysed again (Figure 6.8), 
focusing on the terminal methyl triplet signal (Figure 6.6).  
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Figure 6.8 
1
H-NMR spectrum of S-Mosher's derivative (175-B) of ketol (175) from the D469E 
reaction of hexanald with sodium pyruvate, with terminal methyl triplet region expanded 
 
The triplet methyl signals for each isomer at δ 0.83 and δ 0.93 were in good 
agreement with previously reported chemical shift data (Figure 6.5),
[104]
 and 
confirmed the stereoselectivity as >95% (3S), the same as found by analysing the 
singlet methyl signal of this Mosher’s ester derivative (Figure 6.6). 
The Mosher’s ester derivative of ketol 177 from the S385T/D469T/R520Q TK 
reaction product of hexanal and 2-ketobutyric acid was then prepared as previously 
described and studied by 
1
H-NMR spectroscopy, focusing on the triplet methyl 
signals (Figure 6.9). 
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Figure 6.9 Formation of S-Mosher's ester derivative (177-B) of ketol (177) from the 
S385T/D469T/R520Q TK reaction with hexanal and 2-ketoglutaric acid. The resulting 
1
H-NMR 
is shown, with the terminal methyl triplet region expanded 
 
Integration of the triplet methyl signals at δ 0.82 and δ 0.94 indicated that 
S385T/D469T/R520Q gave the same selectivity with 2-ketobutyric acid as D469E 
and D469T did with sodium pyruvate, forming the 4(S)-enantiomer exclusively with 
>95% ee. In addition ketol 177 from S385T/D469T/R520Q gave a positive optical 
rotation, as did ketols 176 and 177 from the other mutants, which were therefore all 
assigned as 4(S), as summarised below (Table 6.9). 
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Table 6.9 Isolated yields and stereoselectivities obtained for mutant TKs with 2-ketobutyric acid 
(172) as the donor substrate 
 
Aldehyde 
(R=) 
D469E 
Yield (ee) 
D469T 
Yield (ee) 
D469Y 
Yield (ee) 
D469E 
R520Q 
Yield (ee) 
S385T 
D469T 
R520Q 
Yield (ee) 
C4H9 (121) Trace 
(176) 
4% (4S) 
(176) 
Trace 
(176) 
6% (4S) 
(176) 
4% (>95% (4S)) 
(176) 
C5H11 (173) 7% (4S) 
(177) 
Trace 
(177) 
8% (4S) 
(177) 
3% (4S) 
(177) 
Trace 
(177) 
 
6.5 Summary of chapter 6 
 
The unprecedented acceptance of novel donor substrates by mutant TKs has been 
investigated. Sodium pyruvate was accepted by a range of mutant TKs with aliphatic 
acceptor substrates, and low yields but excellent stereoselectivities were observed. 2-
Ketobutyric acid was also accepted by a range of mutant TKs, forming ketol 
products with a similar degree of stereoselectivity. There have been no reports of E. 
coli TK accepting non-natural donor substrates (other than HPA), and only one 
report of yeast TK accepting non-natural substrates.
[102]
 In this study, circular 
dichroism was used to prove that novel donor substrates bound to ThDP in the TK 
active-site, but did not indicate whether the donors were turned over to generate 
products. The work presented in this chapter therefore represents the first conclusive 
report of TK accepting novel donor substrates. Ketol products were isolated and 
fully characterised and chiral analysis methods were developed and used to prove 
that the products were formed with exquisite stereoselectivity in all cases.  
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7 Conclusions and future work 
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This thesis has described detailed investigations into ketodiol synthesis using both 
organocatalytic (Chapter 2) and biocatalytic (Chapters 3-5) strategies. Initial 
investigations into the transformation of some aromatic ketodiols by CV2025 TAm 
have also been conducted (Chapter 5) and a proof-of-concept two-step TK/TAm 
pathway to aromatic aminodiols has been demonstrated using benzaldehyde as the 
starting substrate (Figure 7.1). The absolute stereochemistry of the TK-catalysed 
conversion of benzaldehyde was shown to be (S)-selective by correlation to optically 
pure aminodiol reference compounds, and all other ketodiols have been assigned as 
3(S) by extension and based on previous chiral data. The acceptance of several novel 
donor substrates by TK has also been investigated (Chapter 6), and the reaction 
shown to be highly (S)-selective. While this thesis describes the first in-depth studies 
into the acceptance of aromatic acceptor substrates and novel donor substrates by 
TK, there is much future work still to be carried out. 
Firstly, it would be beneficial to solve crystal structures of the mutant TKs, 
especially those which showed excellent activity towards aromatic aldehydes 
(Chapter 5). This would allow more detailed modelling experiments to be performed 
to account for enzyme activities, stereoselectivities and also to aid the design of more 
active biocatalysts.  
Secondly, in order to fully recognise one of the main goals of this project, namely 
the enzymatic synthesis of antibiotic molecules such as thiamphenicol and 
chloramphenicol (Figure 7.1), the use of mutant TKs which reverse the 
stereoselectivity of the reaction with aromatic aldehydes needs to be investigated. 
Since both of the target compounds exhibit (1R,2R)-stereochemistry, these new TK 
mutants would have to be combined with an (R)-selective transaminase. Since R-
selective transaminases which accept aromatic susbtrates have been reported in the 
literature,
[107]
 if mutant TKs can be created which reverse the stereochemistry of 
aromatic ketodiols then the biocatalytic synthesis of molecules such as 
thiamphenicol and chloramphenicol should be possible (Figure 7.1). 
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Figure 7.1 Approach to biocatalytic aminodiol synthesis; above route using currently available 
enzymes, below ideal route using (R)-selective enzymes 
 
Thirdly, CV2025 TAm was shown to be poorly tolerant of aromatic ketodiols, 
transforming only the TK product of benzaldehyde, and none of the other aromatic 
ketodiols tested (Chapter 5). It is clear that in order to prepare a diverse range of 
aromatic aminodiols more work is required to find a TAm which accepts substituted 
aromatic ketodiol substrates. A library of mutant CV2025 TAms has been created, 
by colleagues in biochemical engineering, which can now be studied in further 
detail. 
Finally, three pyruvate derivatives were tested with a range of mutants, and two of 
these substrates were transformed with high stereoselectivities (>95% (S)). It would 
be of great interest to investigate this area more comprehensively with a wider range 
of both donor and acceptor substrates, to further assess the donor substrate scope of 
mutant TKs. Also, while the stereoselectivity of these reactions was shown to be 
excellent the isolated yields were rather low (<10%). This is perhaps due, in part, to 
the volatility of the ketol products, however there is plenty of scope to optimise the 
reaction conditions of these biotransformations to generate products in higher yields. 
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8 Experimental 
8.1 General experimental 
 
1
H NMR and 
13
C NMR spectra were recorded using Bruker AMX 300 MHz, Avance 
500 MHz and 600 MHz machines. 
19
F NMR spectra were recorded using a Bruker 
AMX 300 MHz machine. All NMR spectra were recorded at 298 K. Chemical shifts 
are given in ppm (δ), relative to tetramethylsilane as reference. IR spectra were 
recorded neat using Nicolet FT-IR and Shamadzu FTIR-8700 machines. ES
+
 mass 
spectra were recorded using Thermo Finnigan MAT 900XP and Micro Mass QC. CI 
spectra and HRMS were obtained using Fisons VG70-SE and LTQ orbitrap XL 
(EPSRC National Mass Spectrometry Service Centre, Swansea University). Chiral 
HPLC was performed with a Varian Prostar machine fitted with a UV detector 
prostar/dynamic system 24 (2 volts) absorbance at 214 nm. Ees were determined 
using Chiralcel OD and Chiralpak AD columns (Daicel; Chiral Technologies 
Europe, France) 25 cm x 0.46 cm. Polar mobile phase (isopropanol) and non-polar 
mobile phase (n-hexane) were used with the indicated methods. TLC was carried out 
on pre-coated aluminium backed silica plates (Merck 60 F254 normal phase) and 
examined under UV fluorescence at 254 nm and stained using phosphomolybdic 
acid. Chemicals were used as received from Aldrich Chemical Company or Fisher 
Chemical Company without further purification. Solvents used were of analytical 
and HPLC grade. Optical rotations were recorded on a Perkin Elmer 343 model 
polarimeter at 589 nm, at the indicated temperature, using the indicated solvent and 
quoted in deg cm
2
 g
-1
 and concentration (c) in g/100 mL. Melting points (m.p) were 
established using a Gallenkamp apparatus and measured in 
o
C. 
 
8.2 Preparation of TK cell-free lysate 
 
Glycerol stocks of TK mutants were obtained from Panwajee Payongsri (25% v/v 
glycerol) and stored at -80 
o
C until needed. These were then used to inoculate 250 
mL shake flasks containing 50 mL LB broth containing ampicillin (150 µg/mL) and 
incubated overnight at 37 
o
C and 160 rpm using an SI 50 orbital shaker (Stuart 
Scientific, Redhill, UK.) This culture was then used to inoculate a 1 L shake flask 
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containing 200 mL LB-Amp media and incubated at 37 
o
C and 200 rpm. The culture 
was then centrifuged at 4400 rpm for 20 minutes at 4 
o
C and approximately 4 g of 
cell paste was obtained and subsequently re-suspended in cold sodium phosphate 
buffer (5 mM, pH 7) to a final concentration of 1 g of cell paste per 10 mL buffer. 
The cells were then lysed by sonication for 4 minutes (cycles of 10 seconds on, 10 
seconds off) using a Soniprep 150 sonicator (MSE, Sanyo, Japan), and centrifuged at 
4400 rpm for 20 minutes at 4 
o
C. Supernatant cell-free lysate (approximately 40 mL 
total) was stored in 2 mL eppendorf tubes and kept at -20 
o
C until needed. TK 
protein concentration was determined to be approximately 1 mg/mL.  
 
8.3 Representative biotransformation procedure 
 
MgCl2 (0.390 mL of 0.10 g/mL solution, 0.40 mmol) was added to ThDP (0.022 g, 
48 mmol) in water (10 mL) at pH 7. TK cell-free lysate (2 mL or 4 mL, as indicated) 
was added and the mixture incubated for 20 minutes. In a separate flask, Li-HPA 
(0.110 g, 1.0 mmol) was dissolved in water (10 mL) and the pH adjusted to 7 with 
NaOH (1 M), this was then added to the enzyme mixture along with the desired 
aldehyde (25 mM or 50 mM as indicated). Reactions were then stirred at room 
temperature for 24 hours or 48 hours, as indicated, in an autotitrator programmed to 
add 1 M HCl when the pH increased above 7. 
 
Lithium hydroxypyruvate (Li-23)[26] 
 
 
 
Bromopyruvic acid (10.0 g, 60.0 mmol) was dissolved in water (100 mL) and LiOH 
solution (1 M) was added until the pH was 9.5. Then, glacial acetic acid was added 
until the pH reached 5. The solvent was then removed under reduced pressure to a 
final volume ~20 mL and the product was left to crystallise out of solution overnight 
at 4 
o
C. The crude off-white precipitate was then washed with ethanol and collected 
by suction filtration. The crude solid was then  re-suspended in ethanol (50 mL) and 
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stirred at 40 
o
C for 30 min before being collected by suction filtration and washed 
with more ethanol (50 mL) to give Li-23 (4.42 g, 70%) as a white powder. 
mp (decomposed before melting); νmax/cm
-1
 (neat): 3340, 1595, 1532, 1377; 
1
H NMR 
(300 MHz; D2O) δ: 4.61 (2H, s, CH2 gem diol), 3.60 (2H, s, CH2 ketone) 
13
C NMR 
(125 MHz; CDCl3) δ: 203.0 (C=O), 177.0 (C=O), 167.9 (C=O), 94.7 (C(OH)2), 66.5 
(CH2), 65.8 (CH2). 
 
Rac-1,3-dihydroxypentan-2-one (Rac-25)[26] 
 
 
 
Li-HPA (1.10 g, 10.0 mmol) was dissolved in water (300 mL) at room temperature. 
Propanal (0.72 mL, 10.0 mmol) and N-methylmorpholine (1.10 mL, 1.0 mmol) were 
added and the pH was adjusted to 8 with hydrochloric acid (1 M). The reaction 
mixture was stirred overnight at room temperature and monitored by TLC analysis. 
The crude reaction mixture was then dry-loaded onto silica and purified by flash 
silica chromatography (EtOAc:hexane, 3:7) to give rac-25 as an orange oil (0.21 g, 
17%), Rf = 0.20 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3412, 2957, 2934, 2874, 1720; 
1
H NMR (300 MHz; CDCl3) δ: 4.40 
(1H, d, J = 19.7 Hz, CHHCO), 4.38 (1H, d, J = 19.7 Hz, CHHCO), 4.20 (1H, m, 
CH2CHOH), 3.60 (2H, br s, OH), 1.80-1.72 (1H, m, CH3CHH), 1.61-1.52 (1H, m, 
CH3CHH), 0.91 (3H, t, J = 7.2 Hz, CH3); 
13
C NMR (125 MHz; CDCl3) δ: 213.0 
(C=O), 76.0 (CHOH), 65.8 (CH2OH), 27.4 (CH2), 9.4 (CH3); m/z (HR ES+) found 
[MH]
+ 
119.0703. C5H11O3
 
requires 119.0630. 
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(3S)-1,3-Dihydroxypentane-2-one (S-25)[26] 
 
 
 
The standard biotransformation procedure was performed with D469Y TK cell-free 
lysate (2 mL) and propanal (50 mM) for 48 hours. The crude reaction mixture was 
then dry-loaded onto silica and purified by flash silica chromatography 
(EtOAc:hexane, 3:7) to give S-25 as a colourless oil (0.013 g, 11%), Rf = 0.20 
(EtOAc:hexane, 1:1).  
Characterisation data was as found for the racemic product (rac-25). 
 
3-Hydroxy-2-oxopentyl benzoate (25-B) 
 
 
 
To a stirred solution of 25 (0.013 g, 0.11 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.014 mL, 0.11 mmol) and benzoyl chloride (0.021 mL, 0.11 mmol). The 
reaction was followed by TLC analysis and stirred overnight at room temperature. 
The reaction was then washed with HCl (2 M, 25 mL) and extracted with CH2Cl2 
(20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9) to give 25-B as a colourless oil (0.022g, 91%), 
Rf = 0.17 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3482, 2930, 1720, 1273; 
1
H NMR (500 MHz; CDCl3) δ: 8.07 (2H, 
m, Ar H), 7.59 (1H, m, Ar H), 7.46 (2H, t, J = 7.8 Hz, Ar H), 5.15 (1H, d, J = 17.2 
Hz, COCHH), 5.04 (1H, d, J = 17.2 Hz, COCHH), 4.36 (1H, dd, J = 8.0 Hz, 3.9 Hz, 
CHOH), 1.94 (1H, m, CH3CHH), 1.71 (1H, m, CH3CHH), 1.02 (3H, t, J = 7.4 Hz, 
CH3); 
13
C NMR (125 MHz; CDCl3) δ: 206.0 (C=O), 171.1 (C=O), 133.7, 129.8 
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(Signals overlapping), 128.5, 76.2 (CHOH), 66.3 (CH2), 27.1 (CH2), 9.0 (CH3); m/z 
(HR ES+) found [MH]
+ 
223.0964. C12H15O4 
 
requires 223.0970. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 5:95, 0.8 mL/min) gave 
retention times of 22.0 minutes (R-isomer) and 24.5 minutes (S-isomer). 
 
Rac 1,3-dihydroxy-1-phenylpropan-2-one (Rac-68)[85] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 3:2 (5 mL total), at 
room temperature. Benzaldehyde (0.102 mL, 1.0 mmol) and N-methylmorpholine 
(0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 with hydrochloric 
acid (1 M). The reaction was stirred overnight at room temperature and monitored by 
TLC analysis. The crude reaction mixture was then dry-loaded onto silica and 
purified by flash silica chromatography (EtOAc:hexane, 1:4) to give rac-68 as a 
colourless oil (0.025 g, 15%), Rf = 0.34 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3400, 2925, 1724; 
1
H NMR (300 MHz; CDCl3) δ: 7.60-7.30 (5H, Ar 
H), 5.23 (1H, d, J = 3.9 Hz, CHOH), 4.35 (1H, dd, J = 19.1 Hz, 4.4 Hz, COCHH), 
4.25 (1H, dd, J = 19.1 Hz, 4.4 Hz, COCHH), 3.88 (1H, d, J = 3.9 Hz, OH), 2.76 (1H, 
t, J = 4.4 Hz, OH); 
13
C NMR (125 MHz; CDCl3) δ: 209.0 (C=O), 137.4, 129.3, 
128.7, 127.0, 77.8 (CHOH), 65.2 (CH2OH); m/z (HR ES+) found [MH]
+ 
167.0712. 
C9H11O3 requires 167.0630.  
  
189 
 
(3S)-1,3-Dihydroxy-1-phenylpropan-2-one (S-68) 
 
 
 
The standard biotransformation procedure was performed with F434A TK cell-free 
lysate and 50 mM benzaldehyde for 48 hours. Solvent was then removed and the 
crude product purified by flash silica chromatography (EtOAc:hexane, 1:4) to give 
S-68 (0.016 g, 10%) as a colourless oil.  
[α]20D = + 74.0
 
(c
 
0.5, CHCl3) 
Characterisation data was as found for the racemic product (rac-68). 
 
3-Hydroxy-2-oxo-3-phenylpropyl benzoate (68-B) 
 
 
To a stirred solution of 68 (0.025 g, 0.15 mmol) in CH2Cl2 (20 mL) was added 
benzoyl chloride (0.019 mL, 0.16 mmol) and 2,4,6-collidine (0.023 µL, 0.16 mmol). 
The reaction was stirred at room temperature overnight, then washed with HCl (50 
mL, 2M) and extracted with CH2Cl2 (100 mL). The organic layer was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 5:95) 
to give 68-B as a colourless oil (0.001 g, 2%), Rf = 0.26 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3020, 2836, 2676, 2565, 1685, 1326, 1292; 
1
H NMR (300 MHz; 
CDCl3) δ: 8.10-8.00 (2H, m, Ar H), 7.62-7.30 (8H, m, Ar H), 5.34 (1H, s, CHOH), 
5.00 (1H, d, J = 16.9 Hz, COCHH), 4.25 (1H, d, J = 16.9 Hz, COCHH); 
13
C NMR 
(125 MHz; CDCl3) δ: 203.2 (C=O), 168.9 (C=O) 137.1, 133.8, 130.3, 130.0, 129.4, 
128.9, 128.7, 127.5, 78.4 (CHOH), 65.7 (CH2OH); m/z (HR ES+) found [MH]
+ 
271.0961. C16H15O4 requires 271.0970. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 10:90, 1 mL/min) gave 
retention times of 13.4 minutes (S-isomer) and 15.2 minutes (R-isomer). 
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2-Oxo-1-phenylpropane-1,3-diyl dibenzoate (68-C)[85] 
 
 
 
To a stirred solution of 68 (0.025 g, 0.15 mmol) in CH2Cl2 (20 mL) was added 2,4,6-
collidine (0.040 mL, 0.34 mmol) and benzoyl chloride (0.038 mL, 0.32 mmol). The 
reaction was stirred at room temperature overnight, then washed with HCl (50 mL, 2 
M) and extracted with CH2Cl2 (50 mL). The organic layer was dry-loaded onto silica 
and purified by flash silica chromatography (EtOAc:hexane, 1:9) to give 68-C as a 
colourless oil (0.001 g, 1%), Rf = 0.4 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 2921, 2851, 1726, 1272; 
1
H NMR (300 MHz; CDCl3) δ: 8.10-8.05 
(4H, m, Ar H) 7.63-7.41 (11H, m, Ar H), 6.43 (1H, s, CHO), 5.17 (1H, d, J = 16.9 
Hz, COCHH), 4.25 (1H, d, J = 16.9 Hz, COCHH); 
13
C NMR (125 MHz; CDCl3) δ: 
197.9 (C=O), 165.8 (C=O), 165.7 (C=O), 133.8, 133.6, 132.9, 130.6, 130.3, 130.1, 
130.0, 129.9, 129.5, 128.7, 128.6, 128.3, 79.0 (CHOH), 66.3 (CH2OH); m/z (HR 
ES+) found [MH]
+ 
375.1221. C23H19O5 requires 375.1232.  
HPLC analysis (Chiralcel OD column, isopropanol:hexane, 18:82, 1 mL/min) gave 
retention times of 10.5 minutes (R-isomer) and 13.4 minutes (S-isomer). 
 
(2S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid 3-
hydroxy-2-oxo-3-phenyl-propyl ester (68-D)[85] 
 
 
 
To a stirred solution of rac-68 (0.005 g, 0.03 mmol) in CH2Cl2 was added 
triethylamine (0.010 mL, 0.07 mmol) and (R)-MTPA-Cl (0.010 mL, 0.05 mmol) and 
the reaction stirred at room temperature overnight. The crude reaction mixture was 
dry-loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 
1:9) to give 68-E as a colourless oil (0.001 g, 9%), Rf = 0.63 (EtOAc:hexane, 1:1). 
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νmax/cm
-1
 (neat): 3420, 2930, 2855, 1734; 
1
H NMR (300 MHz; CD3OD) δ: 7.80-7.30 
(10H, m, Ar H), 5.26 (1H, s, CHOH), 5.01 (0.5H, d, J = 17.0 Hz, COCHH), 4.91 
(0.5H, d, J = 17.0 Hz, COCHH), 4.86 (0.5H, d, J = 17.0 Hz, COCHH), 4.70 (0.5 H, 
d, J = 17.0 Hz, COCHH), 3.62 (3H, s, COCH3); 
13
C NMR (150 MHz; CDCl3) δ: 
201.7 (C=O), 166.3 (C=O), 133.8, 130.1, 129.6, 129.2, 128.7, 128.5, 127.6, 126.4, 
77.1 (CHOH), 71.6 (OCH3),  66.5 (CH2OH); 
19
F NMR (300 MHz; CDCl3) δ: -77.2 
(CF3); m/z (HR ES+) found [MH]
+
 383.1109. C19H18F3O3 requires 383.1106.  
 
(1S,2S)-2-Acetamido-1-phenylpropane-1,3-diyl diacetate 
((1S,2S)-69-B)[75] 
 
 
 
To a stirred solution of (1S,2S)-2-amino-1-phenyl-1,3-propanediol (0.050 mg, 0.30 
mmol) in pyridine (1.0 mL, 12.0 mmol) was added acetic anhydride (1.0 mL, 13.0 
mmol) and N’, N’-dimethylaminopyridine (0.025 g, 0.20 mmol). The reaction was 
stirred at room temperature for 18 hours and then concentrated under vacuum. The 
crude mixture was then redissolved in water and the product extracted with CH2Cl2 
(2 x 25 mL). The organic layer was dried over magnesium sulfate, filtered and 
concentrated under vacuum to give the title compound as a light yellow oil (0.085 g, 
97%), Rf = 0.30 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3289, 3065, 1739, 1659; 1540; 
1
H NMR (600 MHz; CDCl3) δ: 7.50-
7.32 (5H, m, Ar H), 5.93 (1H, d, J = 7.2 Hz, CHOAc ), 5.89 (1H, d, J = 9.3 Hz, 
NHAc ), 4.63 (1H, m, CHNHAc); 4.05 (1H, dd, J = 11.6 Hz, 5.0 Hz, CHHOAc), 
3.84 (1H, dd, J = 11.6 Hz, 4.8 Hz, CHHOAc), 2.09 (3H, s, CH3), 2.05 (3H, s, CH3), 
1.94 (3H, s, CH3) 
13
C NMR (150 MHz; CDCl3) δ: 170.7 (C=O), 170.5 (C=O), 170.0 
(C=O), 136.6, 128.9 (signals overlapping), 126.9, 74.3 (CHOAc), 63.3 (CH2OAc), 
52.3 (CHNAc), 23.3 (CH3), 21.2 (CH3), 20.9 (CH3); m/z (HR CI+) found [MH]
+ 
294.1324. C15H19NO5 requires 294.1336. 
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HPLC analysis (Chiralpak AD column, isopropanol:hexane, 3:97, 0.6 mL/min) gave 
a retention time of 77.9 minutes. 
 
Biotrans-2-acetamido-1-phenylpropane-1,3-diyl diacetate (69-
B) 
 
 
 
To a sample of 68 (0.016g, 0.10 mmol) dissolved in HEPES buffer (7.5 mL, 100 
mM, pH 8, 0.2 mM PLP) was added CV2025 cell-free lysate (5 mL) and S-α-
methylbenzylamine (0.026 mL, 0.20 mM). The reaction was adjusted to pH 8 and 
the mixture incubated at 37 
o
C and followed by TLC analysis until no starting 
material could be observed. The reaction was then concentrated to dryness and 
acetylation performed as for (1S,2S)-69-B. 
Spectroscopic data was as found for (1S,2S)-69-B. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 3:97, 0.6 mL/min) gave 
retention times of 77.9 mins (1S,2S)-major isomer and 92.9 mins (1R,2S)-minor 
isomer. 
 
Rac-1-(3-fluorophenyl)-1,3-dihydroxypropan-2-one (Rac-94)[79] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total), 
at room temperature. 3-Fluorobenzaldehyde (0.106 mL, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction mixture was stirred at room temperature 
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overnight and monitored by TLC analysis. The crude reaction mixture was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 3:7) 
to give rac-94 as a colourless oil (42 mg, 23%), Rf = 0.29 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3440, 2938, 1721, 1272; 
1
H NMR (600 MHz; CDCl3) δ: 7.38-7.05 
(4H, m, Ar H), 5.25 (1H, d, J = 4.2 Hz, CHOH), 4.35 (1H, dd, J = 19.8 Hz, 5.2 Hz, 
COCHH), 4.25 (1H, dd, J = 19.8 Hz, 5.2 Hz, COCHH), 3.80 (1H, d, J = 4.2 Hz, 
OH), 2.67 (1H, t, J = 5.2 Hz, OH); 
13
C NMR (150 MHz; CDCl3) δ: 208.5 (C=O), 
163.2 (C-F, d, 
1
JCF = 248.7 Hz), 139.7  (d, 
3
JCF = 6.6 Hz), 131.1 , (d, 
3
JCF = 8.8 Hz,) 
122.7 (d,
4
JCF = 2.2 Hz), 116.3 (d, 
2
JCF = 20.9 Hz), 114.0 (d, 
2
JCF = 21.9 Hz) 76.9 
(CHOH), 65.2 (CH2OH); 
19
F NMR (300 MHz; CDCl3) δ: - 111.6; m/z (HR ES+) 
found [MH]
+ 
185.0610. C9H10O3F requires 185.0614.  
 
(3S)-1-(3-Fluorophenyl)-1,3-dihydroxypropan-2-one (S-94) 
 
 
 
The standard biotransformation procedure was performed with 
S385T/D469T/R520Q TK cell-free lysate (4 mL) and 3-fluorobenzaldehyde (25 
mM) for 24 hours. The crude reaction mixture was then dry-loaded onto silica and 
purified by flash silica chromatography (EtOAc:hexane, 1:4) to give S-94 as a 
colourless oil (0.011 g, 12 %). 
Characterisation data was as found for the racemic product (rac-94). 
 
3-(3-Fluorophenyl)-3-hydroxy-2-oxopropyl benzoate (94-B)[108] 
 
 
 
To a stirred solution of 94 (0.040 g, 0.20 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.026 mL, 0.20 mmol) and benzoyl chloride (0.023 mL, 0.20 mmol). The 
194 
 
reaction was stirred overnight at room temperature and monitored by TLC analysis. 
The reaction was then washed with HCl (2 M, 25 mL) and extracted with CH2Cl2 
(20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9) to give 94-B as a colourless oil (0.020 g, 
35%), Rf = 0.21 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3440, 3073, 2938, 1721, 1272; 
1
H NMR (600 MHz; CDCl3) δ: 8.10-
8.00 (2H, m, Ar H), 7.63-7.40 (7H, m, Ar H), 5.34 (1H, s, CHOH), 5.02 (1H, d, J = 
16.9 Hz, COCHH), 4.83 (1H, d, J = 16.9 Hz, COCHH); 
13
C NMR (150 MHz; 
CDCl3) δ: 202.7 (C=O), 171.4 (C=O), 163.1 (d, 
1
JCF = 249.8 Hz), 139.4 (d, 
3
JCF = 
10.3 Hz), 133.9 (d, 
3
JCF = 11.0 Hz,), 131.6, 130.3, 129.2, 128.1, 123.1 (d, 
4
JCF = 3.3 
Hz), 116.3 (d, 
2
JCF = 21.5 Hz), 114.0 (d, 
2
JCF = 20.8 Hz), 76.9 (CHOH), 65.2 
(CH2OH); 
19
F NMR (300 MHz; CDCl3) δ: - 111.6; m/z (HR ES+) found [MH]
+
 
289.0871. C16H14O4F requires 289.0876. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 10:90, 1 mL/min) gave 
retention times of 10.9 minutes (S-isomer) and 13.1 minutes (R-isomer). 
 
Rac-1,3-dihydroxy-1-(3-hydroxyphenyl)propan-2-one (Rac-
103)[85] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 3:2 (10 mL total), 
at room temperature. 3-Hydroxybenzaldehyde (0.122 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred overnight at room 
temperature and monitored by TLC analysis. The crude reaction mixture was then 
dry-loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 
1:1) to give rac-103 as a colourless oil (0.010 g, 6%), Rf = 0.31 (EtOAc:hexane, 
3:1). 
νmax/cm
-1
 (neat): 3350, 2925, 2497, 1731, 1592; 
1
H NMR (300 MHz; CDCl3) δ: 7.18-
7.10 (1H, m, Ar H), 6.87-6.73 (3H, m, Ar H), 5.39 (1H, s, CHOH), 4.45 (1H, d, J = 
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19.1 Hz, COCHH), 4.30 (1H, d, J = 19.1 Hz,  COCHH); 
13
C NMR (125 MHz; 
CDCl3) δ: 211.0 (C=O), 156.5, 137.7, 131.0, 123.0, 119.9, 114.5, 77.1 (CHOH), 65.0 
(CH2OH); m/z (HR ES+) found [MH]
+ 
183.0663. C9H11O4
 
requires 183.0673. 
(3S)-1,3-Dihydroxy-1-(3-hydroxyphenyl)propan-2-one (S-
103)[85] 
 
 
 
The standard biotransformation procedure was performed with F434A TK cell-free 
lysate (2 mL) and 3-hydroxybenzaldehyde (50 mM) for 48 hours. The crude reaction 
mixture was then dry-loaded onto silica and purified by flash silica chromatography 
(EtOAc:hexane, 1:1) to give the title compound as a colourless oil (0.011 g, 6 %), 
[α]20D = + 93.3
 
(c
 
0.08, MeOH). 
Characterisation data was as found for the racemic product (rac-103). 
 
3-(3-(Benzoyloxy)-1-hydroxy-2-oxopropyl)phenyl benzoate 
(103-B)[85] 
 
 
 
To a stirred solution of 103 (0.010 g, 0.05 mmol) in CH2Cl2 (2 mL) was added 2,4,6-
collidine (0.030 mL, 0.23 mmol) and benzoyl chloride (0.030 mL, 0.26 mmol). The 
reaction was stirred at room temperature overnight and monitored by TLC before 
being washed with HCl (2 M, 75 mL) and extracted with CH2Cl2 (50 mL). The 
organic layer was dried over magnesium sulfate, filtered and product dry-loaded onto 
silica before being purified by flash silica chromatography (EtOAc:hexane, 2:8) to 
give 103-B as a colourless oil (10 mg, 50%), Rf = 0.2 (EtOAc:hexane, 3:7). 
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1
H NMR (600 MHz; CDCl3) δ: 8.19 (2H, d, J = 7.9 Hz, Ar H), 8.12 (4H, d, J = 7.9 
Hz, Ar H), 8.05 (2H, d, J = 7.9 Hz, Ar H), 7.68-7.26 (6H, m, Ar H), 5.40 (1H, s, 
CHOH), 5.10 (1H, d, J = 17.2 Hz, COCHH), 4.85 (1H, d, J = 17.2 Hz, COCHH); 
13
C 
NMR (150 MHz; CDCl3) δ: 202.3 (C=O), 171.6 (C=O), 165.9 (C=O), 165.1, 151.6, 
138.7, 134.0, 133.9 (signals overlapping), 130.5, 130.3, 130.1, 128.8 (signals 
overlapping), 128.7, 128.6, 124.7, 122.7, 120.1, 78.4 (CHOH), 65.7 (CH2OH). 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 20:80, 1 mL/min) gave 
retention times of 13.5 minutes (S-isomer) and 18.8 minutes (R-isomer). 
 
(R)-3-(1-Hydroxy-2-oxo-3-(((R)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoyl)oxy)propyl)phenyl 3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (103-C) 
 
 
 
To a stirred solution of 103 (0.003 g, 0.02 mmol) in CH2Cl2
 
(2 mL) was added 2,4,6-
collidine (0.010 mL, 0.08 mmol) and (S)-MTPA-Cl (0.010 mL. 0.04 mmol). The 
reaction was stirred for 36 hours at room temperature before being dry loaded onto 
silica and purified by flash silica chromatography (EtOAc:hexane, 3:7) to give 103-
C as a colourless oil (1 mg, 8 %), Rf = 0.14 (EtOAc:hexane, 3:7). 
max/cm
-1
(neat)
 
3420, 2930, 2855, 1734; 
1
H NMR (600 MHz; CDCl3) 7.60–7.25 
(14H, m, Ar), 5.20 (1H, s, CHOH), 5.02 (1 H, d, J = 16.9 Hz, CHHO (2R,3'R)), 4.95 
(0.07H, d, J = 5.0 Hz, CHHO (2S,3'R)), 4.88 (0.07H, d, J = 5.0 Hz, CHHO (2S,3'R)), 
4.74 (1H, d, J = 16.9 Hz, CHHO (2R,3'R)), 3.62 (6H, s, OCH3); 
13
C NMR (150 
MHz; CDCl3)  201.8 (C=O), 166.6 (C=O), 156.4 (C=O), 138.5, 131.8, 131.1, 
130.0, 129.8, 128.6, 127.5, 127.3, 77.1 (CHOH), 66.5, 55.9 (OCH3); 
19
F NMR (282 
MHz; CDCl3)  – 72.2 (CF3); m/z (ES+) [MH]
+ 
found 615.09. C29H25F6O8 requires 
615.13. 
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(S)-3-(1-Hydroxy-2-oxo-3-(((S)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoyl)oxy)propyl)phenyl 3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (103-D)[85] 
 
 
 
To a stirred solution of 103 (0.003 g, 0.02 mmol) in CH2Cl2
 
(2 mL) was added 2,4,6-
collidine (0.010 mL, 0.08 mmol) and (R)-MTPA-Cl (0.010 mL. 0.04 mmol). The 
reaction was stirred for 36 hours at room temperature before being dry-loaded onto 
silica gel and purified by flash silica chromatography (EtOAc:hexane, 3:7) to give 
103-D as a colourless oil (0.001 g, 8 %), Rf = 0.14 (EtOAc:hexane, 3:7). 
max/cm
-1
(neat)
 
3420, 2930, 2855, 1734; 
1
H NMR (600 MHz; CDCl3) 7.60–7.24 
(14H, m, Ar), 5.20 (1H, m, CHOH), 5.02 (0.3H, d, J = 16.9 Hz, CHHO (2S,3'S)), 
4.91 (0.82H, d, J = 16.9 Hz, CHHO (2R,3'S)), 4.88 (0.82H, d, J = 16.9, CHHO 
(2R,3'S)), 4.74 (0.3H, d, J = 16.9 Hz, CHHO (2S,3'S)), 4.01-3.62 (6H, m, OCH3); 
13
C 
NMR (150 MHz; CDCl3) 205.3 (C=O), 166.9 (C=O), 159.2 (C=O), 132.0, 131.9, 
131.1, 129.6, 129.8, 128.4, 127.1, 120.0, 71.2 (CHOH), 63.6 (CH2O), 57.1 (OCH3); 
19
F NMR (282 MHz; CDCl3)   – 72.2 (CF3). 
 
1-(3-Bromophenyl)-1,3-dihydroxypropan-2-one (104) 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total), 
at room temperature. 3-Bromobenzaldehyde (0.120 mL, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature for 24 
hours and monitored by TLC analysis. The crude reaction mixture was then dry-
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loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 3:7) 
to give 104 as a colourless oil (0.051 g, 20% yield), Rf = 0.29 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3426, 2924, 2854, 1728, 1190; 
1
H NMR (500 MHz; CDCl3) δ: 7.85-
7.07 (4H, m, Ar H), 5.21 (1H, s, CHOH), 4.36 (1H, d, J = 19.5 Hz, COCHH), 4.26 
(1H, d, J = 19.5 Hz, COCHH); 
13
C NMR (150 MHz; CDCl3) δ: 208.3 (C=O), 139.4, 
132.4, 130.7, 129.8 (Signals overlapping), 125.5, 76.8 (CHOH), 65.0 (CH2OH); m/z 
(HR ES+) found [MH]
+
 244.9817. C9H10BrO3 requires 244.9813. 
 
Rac-methyl 3-(1,3-dihydroxy-2-oxopropyl)benzoate (rac-
106)[79] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total), 
at room temperature. Methyl-3-formylbenzoate (0.160 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature for 24 
hours and monitored by TLC analysis. The crude reaction mixture was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 3:7), 
to give rac-106  as a colourless oil (0.064 g, 29% yield), Rf = 0.28 (EtOAc:hexane, 
1:1). 
νmax/cm
-1
 (neat): 3441, 2954, 1719, 1272; 
1
H NMR (600 MHz; CDCl3) δ: 8.05 (2H, 
m, Ar H), 7.51 (2H, m, Ar H), 5.33 (1H, d, J = 3.9 Hz, CHOH), 4.40 (1H, dd, J = 
19.4 Hz, 5.0 Hz, COCHH), 4.23 (1H, dd, J = 19.4 Hz, 5.0 Hz, COCHH), 3.93 (4H, 
m, OCH3, OH), 2.69 (1H, t, J = 5.0 Hz, OH); 
13
C NMR (125 MHz; CDCl3) δ: 209.0 
(C=O), 166.5 (C=O), 137.9, 131.4, 131.3, 130.5, 129.5, 128.2, 77.3 (CHOH), 65.3 
(CH2OH), 52.5 (OCH3); m/z (HR ES+) found [MH]
+
 225.0763. C11H12O5 requires 
225.0756 
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(3S)-Methyl 3-(1,3-dihydroxy-2-oxopropyl)benzoate (S-106) 
 
 
 
The standard biotransformation procedure was performed with 
S385T/D469T/R520Q TK cell-free lysate (4 mL) and methyl-3-formylbenzoate (25 
mM) for 24 hours. The crude reaction mixture was then purified by flash silica 
chromatography (EtOAc:hexane, 1:4) to give S-106 as a colourless oil (0.040 g, 
34%). 
Characterisation data was as found for the racemic product (rac-106).  
 
Methyl 3-(3-(benzoyloxy)-1-hydroxy-2-oxopropyl)benzoate 
(106-B)[79] 
 
 
 
To a stirred solution of 106 (0.064 g, 0.29 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.020 mL, 0.15 mmol) and benzoyl chloride (0.020 mL, 0.16 mmol). The 
reaction was stirred at room temperature overnight and followed by TLC analysis. 
The crude reaction mixture was then washed with HCl (2 M, 25 mL) and extracted 
with CH2Cl2 (20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9) to give 106-B as a colourless oil (0.015 g, 
27%), Rf = 0.15 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3441, 3074, 2954, 1719, 1272; 
1
H NMR (600 MHz; CDCl3) δ: 8.19-
8.01 (4H, m, Ar H), 7.40-7.26 (5H, m, Ar H), 5.42 (1H, s, CHOH), 5.03 (1H, d, J = 
17.2 Hz, COCHH), 4.82 (1H, d, J = 17.2 Hz, COCHH), 3.91 (3H, s, OCH3); 
13
C 
NMR (150 MHz; CDCl3) δ: 203.0 (C=O), 171.2 (C=O), 166.5 (C=O), 137.6, 133.8, 
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131.7, 131.3, 130.5, 130.3, 130.1, 129.6, 129.2, 128.7, 77.7 (CHOH), 65.6 (CH2OH), 
52.5 (OCH3); m/z (HR ES+) found [MH]
+ 
329.1011. C18H17O6 requires 329.1025.  
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 10:90, 1 mL/min) gave 
retention times of 21.9 minutes (S-isomer) and 24.3 minutes (R-isomer).  
 
Rac-1,3-dihydroxy-1-(3-vinylphenyl)propan-2-one (Rac-107) 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total), 
at room temperature. 3-Vinylbenzaldehyde (0.130 mL, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature 
overnight and monitored by TLC analysis. The crude reaction mixture was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 2:8) 
to give rac-107 as a colourless oil (11 mg, 6%), Rf = 0.30 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3404, 2922, 1726, 1652, 1276; 
1
H NMR (600 MHz; CDCl3) δ: 7.50-
7.30 (4H, m, Ar H), 6.70 (1H, dd, J = 17.4Hz, 10.9 Hz, CHCHH), 5.78 (1H, d, J = 
17.4 Hz, CHCHH), 5.31 (1H, d, J = 10.9 Hz, CHCHH), 5.25 (1H, d, J = 3.7 Hz, 
CHOH), 4.37 (1H, dd, J = 19.5 Hz, 4.9 Hz, COCHH), 4.25 (1H, dd, J = 19.5 Hz, 4.9 
Hz, COCHH), 3.82 (1H, d, J = 3.7 Hz, OH), 2.68 (1H, t, J = 4.9 Hz, OH); 
13
C NMR 
(150 MHz; CDCl3) δ: 209.0 (C=O), 138.8 (CHCH2), 136.2, 129.6 (signals 
overlapping), 127.1, 126.4, 124.8, 115.2 (CHCH2), 77.7 (CHOH), 65.2 (CH2OH); 
m/z (HR ES+) found [MH]
+ 
193.0861. C11H13O3 requires 193.0864.  
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(3S)-1,3-Dihydroxy-1-(3-vinylphenyl)propan-2-one (S-107) 
 
 
 
The standard biotransformation procedure was performed with 
S385T/D469T/R520Q TK cell-free lysate (4 mL) and 3-vinylbenzaldehyde (25 mM) 
for 24 hours. Solvent was then removed and the crude product purified by flash silica 
chromatography (EtOAc:hexane, 1:4). Solvent was removed to give S-107 as a 
colourless oil (0.005 g, 4 %). 
Characterisation data was as found for the racemic product (rac-107)  
 
3-Hydroxy-2-oxo-3-(3-vinylphenyl)propyl benzoate (107-B) 
 
 
 
To a stirred solution of 107 (0.004 g, 0.02 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.022 mL, 0.16 mmol) and benzoyl chloride (0.018 mL, 0.16 mmol). The 
reaction was followed by TLC analysis and stirred overnight at room temperature. 
The reaction was then washed with HCl (2 M, 25 mL) and extracted with CH2Cl2 
(20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9), to give 107-B as a colourless oil (0.002 g, 
34% yield), Rf = 0.20 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 2927, 2677, 1686, 1292; 
1
H NMR (600 MHz; CDCl3) δ: 8.03-7.84 
(2H, d, J = 7.8 Hz, Ar H), 7.60 (1H, t, J = 7.8 Hz, Ar H), 7.48-7.35 (6H, m, Ar H) 
6.69 (1H, dd, J = 17.7 Hz, 10.8 Hz, CHCHH), 5.76 (1H, d, J = 17.7 Hz, CHCHH), 
5.35 (1H, s, CHOH), 5.29 (1H, d, J = 10.8 Hz, CHCHH), 5.03 (1H, d, J = 17.1 Hz, 
COCHH), 4.79 (1H, d, J = 17.1 Hz, COCHH), 
13
C NMR (150 MHz; CDCl3) δ: 
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203.3 (C=O), 165.8 (C=O), 138.8 (CHCH2), 137.3, 136.2, 133.8, 130.0, 129.6, 
128.9, 128.7, 127.2, 126.7, 125.4, 115.1 (CHCH2), 77.1 (CHOH), 65.4 (CH2OH); 
m/z (HR CI+) found [M-OH]
+ 
279.1029. C18H15O3 requires 279.1099.  
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 10:90, 1 mL/min) gave 
retention times of 13.5 minutes (S-isomer) and 16.4 minutes (R-isomer).  
 
3-(1,3-Dihydroxy-2-oxopropyl)benzoic acid (Rac-108) 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total), 
at room temperature. 3-Formylbenzoic acid (0.150 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature 
overnight, then the solvent was removed in vacuo and the crude mixture carried 
through to the benzoylation reaction.  
 
(3S)-(1,3-Dihydroxy-2-oxopropyl)benzoic acid (S-108)[91] 
 
 
 
The standard biotransformation procedure was performed with D469T TK cell-free 
lysate (2 mL) and 3-formylbenzoic acid (50 mM) for 24 hours. The crude reaction 
mixture was then dry-loaded onto silica and the product purified by flash silica 
chromatography (CH2Cl2:MeOH, 9:1, then 8:2), to give S-108 as an amorphous 
green solid (0.200 g, 90%). Rf = 0.57 (CH2Cl2:MeOH, 8:2). 
Mp (Decomposed before melting), Rf = 0.57 (CH2Cl2:MeOH, 4:1); νmax (neat)/cm
–1
 
3252, 2946, 2843, 1693, 1606; 
1
H NMR (300 MHz; CD3OD)  8.08-8.01 (1H, s, Ar 
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H), 7.96 (1H, dt, J = 7.7 Hz , 1.4 Hz, Ar H), 7.61 (1H, d, J = 7.7 Hz, Ar H), 7.45 
(1H, t, J = 7.7 Hz, Ar H), 5.36 (1H, s, CHOH), 4.46 (1H, d, J = 19.2 Hz, CHHOH), 
4.39 (1H, d, J = 19.2 Hz, CHHOH); 
13
C NMR (125 MHz; D2O)  211.2 (C=O), 
175.3 (CO2H), 137.7, 137.6, 130.5, 130.0, 129.7, 128.2, 77.2 (CHOH), 65.2 
(CH2OH); m/z (NSI-) 209 ([M-H]
–
, 100%), 179 (27), 149 (27); m/z (NSI-) found [M-
H]
–
 209.0453. C10H9O5 requires 209.0455. 
 
3-(1,3-Bis(benzoyloxy)-2-oxopropyl)benzoic acid (108-B) 
 
 
 
To a stirred solution of 108 (0.050 g, 0.24 mmol) in tetrahydrofuran (10 mL) was 
added 2,4,6-collidine (0.250 mL, 1.90 mmol) and benzoyl chloride (0.250 mL, 1.90 
mmol). The reaction was followed by TLC analysis and stirred overnight at room 
temperature. Solvent was then removed under reduced pressure, and the solid was re-
dissolved in CH2Cl2 (30 mL) and washed with HCl (2 M, 25 mL). The product was 
extracted with further CH2Cl2 (20 mL), before being dry-loaded onto silica and 
purified by flash silica chromatography (EtOAc:hexane, 1:9) to give 108-B as a 
colourless oil (0.020 g, 20%), Rf = 0.14 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3066, 2927, 1789, 1721, 1691; 
1
H NMR (600 MHz; CDCl3) δ: 8.10-
7.30 (14H, m, Ar H), 6.54 (1H, s, CHO), 5.36 (1H, d, J = 17.2 Hz, COCHH); 5.00 
(1H, d, J = 17.2 Hz, COCHH) 
13
C NMR (150 MHz; CDCl3) δ: 197.9 (C=O), 190.9 
(CO2H), 169.6 (C=O) 165.9 (C=O), 134.8, 134.2, 134.1, 134.0, 133.9, 133.7, 131.7, 
130.8, 130.3, 130.1, 130.0, 129.1, 128.8, 128.6, 78.4 (CHOH), 66.6 (CH2OH); m/z 
(HR CI+) found [MH]
+
 419.1134. C24H19O7 requires 419.1130 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 23:77, 1 mL/min) gave 
retention times of 33.2 minutes (R-isomer) and 37.0 minutes (S-isomer).  
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1,3-Dihydroxy-1-(3-nitrophenyl)propan-2-one (Rac-109) 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total), 
at room temperature. 3-Nitrobenzaldehyde (0.150 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature for 24 
hours and monitored by TLC analysis. The crude reaction mixture was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 3:7) 
to give rac-109 as a colourless oil (0.047 g, 22%), Rf = 0.28 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3467, 2924, 2854, 1738, 1529; 
1
H NMR (600 MHz; CDCl3) δ: 8.50-
8.25 (2H, m, Ar H), 7.80-7.60 (2H, m, Ar H), 5.41 (1H, s, CHOH), 4.44 (1H, d, J = 
19.6 Hz, COCHH), 4.33 (1H, d, J = 19.6 Hz, COCHH); 
13
C NMR (150 MHz; 
CDCl3) δ: 208.1 (C=O), 147.2 (C-NO2), 134.8, 132.8, 130.6, 129.5, 124.4, 77.4 
(CHOH), 65.3 (CH2OH); m/z (HR ES+) found [MH]
+
 212.0555. C16H10O5N requires 
212.0559. 
 
Rac-3-(1,3-dihydroxy-2-oxopropyl)benzonitrile (Rac-110) 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (10 mL total 
volume), at room temperature. 3-Formylbenzonitrile (0.065 g, 0.5 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature 
overnight and monitored by TLC analysis. The crude reaction mixture was then dry-
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loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 3:7) 
to give rac-110 as a colourless oil (0.010 g, 10%), Rf = 0.35 (EtOAc:hexane, 1:1). 
Characterisation data was as found for the biotransformation product (S-110). 
 
(3S)-(1,3-Dihydroxy-2-oxopropyl)benzonitrile (S-110) 
 
 
 
The standard biotransformation procedure was performed with 
S385T/D469T/R520Q TK cell-free lysate (4 mL) and 3-formylbenzonitrile (25 mM) 
for 24 hours. The crude reaction mixture was then dry-loaded onto silica and purified 
by flash silica chromatography (EtOAc:hexane, 4:6) to give S-110 as a colourless oil 
(0.025 g, 26 %), Rf = 0.35 (EtOAc:hexane, 7:3).  
νmax/cm
-1
 (neat): 3409, 2904, 2232, 1727; 
1
H NMR (600 MHz; CDCl3)  7.73 (1H, 
s, Ar H), 7.70 (1H, d, J = 7.7 Hz, Ar H), 7.62 (1H, d, J = 7.7 Hz, Ar H) 7.53 (1H, t, J 
= 7.7 Hz, Ar H), 5.34 (1H, s, CHOH), 4.41 (1H, d, J = 19.8 Hz, CHHOH), 4.30 (1H, 
d, J = 19.8 Hz, CHHOH); 
13
C NMR (125 MHz; CDCl3)  208.1 (C=O), 139.0, 
132.8, 131.3, 130.6, 130.1, 118.2 (CN), 113.5 (C-CN), 76.8 (CHOH), 65.4 
(CH2OH); m/z (HR ES-) found [M-H]
-
 190.0494. C10H8NO3 requires 190.0504. 
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3-(3-Cyanophenyl)-3-hydroxy-2-oxopropyl benzoate (110-B) 
 
 
 
To a stirred solution of 110 (0.020 g, 0.10 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.020 mL, 0.16 mmol) and benzoyl chloride (0.020 mL, 0.16 mmol). The 
reaction was followed by TLC analysis and stirred overnight at room temperature. 
The reaction was then washed with HCl (2 M, 25 mL) and extracted with CH2Cl2 
(20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9) to give 110-B as a colourless oil (0.010 g, 
24%), Rf = 0.15 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3449, 2925, 2854, 2232, 1724, 1274; 
1
H NMR (600 MHz; CDCl3) 
δ: 8.10 (1H, d, J = 7.8 Hz, Ar H), 8.02 (2H, d, J = 7.8 Hz, Ar H), 7.70 (1H, s, Ar H), 
7.68 (1H, d, J = 7.8 Hz, Ar H), 7.62 (1H, t, J = 7.8 Hz, Ar H), 7.54 (1H, t, J = 7.8 
Hz, Ar H), 7.47 (2H, t, J = 7.8 Hz, Ar H), 5.38 (1H, s, CHOH), 5.01 (1H, d, J = 17.0 
Hz, COCHH), 4.87 (1H, d, J = 17.0 Hz, COCHH); 
13
C NMR (150 MHz; CDCl3) δ: 
202.4 (C=O), 165.8 (C=O), 138.7, 134.0, 132.9, 131.6, 131.0, 130.2, 130.0, 128.8, 
128.6, 118.2 (CN), 113.5 (C-CN), 77.4 (CHOH), 65.6 (CH2OH); m/z (HR ES-) 
found [M-H]
- 
294.0778 C17H12NO4 requires 294.0766; [α]
20
D
 
(S-110-B) = - 16.0 (c 
0.15, CH2Cl2) 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 10:90, 1 mL/min) gave 
retention times of 14.9 mins (S-isomer) and 19.5 mins (R-isomer). 
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1-(4-Chlorophenyl)-1,3-dihydroxypropan-2-one (111)[79] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (5 mL total), at 
room temperature. 4-Chlorobenzaldehyde (0.141 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature and 
monitored by TLC analysis. The crude reaction mixture was then dry-loaded onto 
silica and purified by flash silica chromatography (EtOAc:hexane, 2:8) to give 111 
as a colourless oil (0.002 g, 2%), Rf = 0.14 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3344, 2923, 1728, 1598; 
1
H NMR (300 MHz; CDCl3) δ: 7.30-7.10 
(4H, m, Ar H), 5.24 (1H, d, J = 3.5 Hz, CHOH), 4.35 (1H, dd, J = 19.6 Hz, 4.1 Hz, 
COCHH), 4.23 (1H, dd, J = 19.6 Hz, 4.1 Hz, COCHH), 3.81 (1H, d, J = 3.5 Hz, 
OH), 2.67 (1H, t, J = 4.1 Hz, OH); 
13
C NMR (150 MHz; CDCl3) δ: 208.6 (C=O), 
135.4 (signals overlapping), 128.9, 128.8, 77.3 (CHOH), 65.2 (CH2OH); m/z (HR 
EI+) found [MH]
+ 
201 0313. C9H10ClO3 requires 201.0318. 
1-(4-Fluorophenyl)-1,3-dihydroxypropan-2-one (112)[79] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 1:1 (5 mL total), at 
room temperature. 4-Fluorobenzaldehyde (0.124 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature for 24 
hours and monitored by TLC analysis. Then the crude reaction mixture was dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 2:8) 
to give 112 as a colourless oil (0.004 g, 2%), Rf = 0.37 (EtOAc:hexane, 7:3). 
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νmax/cm
-1
 (neat): 3377, 2924, 1725,1603, 1509; 
1
H NMR (300 MHz; CDCl3) δ: 7.30-
7.11 (4H, m, Ar H), 5.25 (1H, d, J = 3.9 Hz, CHOH), 4.35 (1H, dd, J = 19.8 Hz, 5.0 
Hz, COCHH), 4.25 (1H, dd, J = 19.8 Hz, 5.0 Hz, COCHH), 3.80 (1H, d, J = 3.9 Hz, 
OH), 2.67 (1H, t, J = 5.0 Hz, OH),
13
C NMR (125 MHz; CDCl3) δ: 208.9 (C=O); 
163.2 (d, 
1
JC-F = 247.0 Hz, C-F), 133.2, 128.9 (d, 
3
JC-F = 8.0 Hz), 116.4 (d, 
2
JC-F = 
21.3 Hz), 77.4 (CHOH), 65.2 (CH2OH); 
19
F NMR (282 MHz; CDCl3) δ: −112.4; m/z 
(HR EI+) found (MH)
+ 
185.0622. C9H10FO3 requires 185.0536. 
 
1-(4-Bromophenyl)-1,3-dihydroxypropan-2-one (113)[79] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 3:2 (5 mL total), at 
room temperature. 4-Bromobenzaldehyde (0.190 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature for 24 
hours and monitored by TLC analysis. The crude reaction mixture was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 2:8) 
to give 113 as a colourless oil (0.002 g, 1%), Rf = 0.42 (EtOAc:hexane, 7:3). 
νmax/cm
-1
 (neat): 3390, 2923, 1725, 1590; 
1
H NMR (300 MHz; CDCl3) δ: 7.61-7.10 
(4H, m, Ar H), 5.22 (1H, s, CHOH), 4.36 (1H, d, J = 19.8 Hz, COCHH), 4.24 (1H, 
d, J = 19.8 Hz, COCHH); 
13
C NMR (125 MHz; CDCl3) δ: 208.6 (C=O), 136.4 (C-
Br), 132.5, 131.1, 128.7, 77.3 (CHOH), 65.2 (CH2OH); m/z (HR EI+) found [MH]
+ 
244.9811. C9H10BrO3 requires 244.9813. 
 
1-(4-Iodophenyl)-1,3-dihydroxypropan-2-one (114) 
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Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:acetonitrile, 3:2 (5 mL total), at 
room temperature. 4-Iodobenzaldehyde (0.230 g, 1.0 mmol) and N-
methylmorpholine (0.110 mL, 1.0 mmol) were added and the pH was adjusted to 7 
with hydrochloric acid (1 M). The reaction was stirred at room temperature for 24 
hours and monitored by TLC analysis. The crude reaction mixture was then dry-
loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 2:8) 
to give 114 as a colourless oil (0.010 mg, 3%), Rf = 0.24 (EtOAc:hexane, 1:1). 
1
H NMR (300 MHz; CDCl3) δ: 8.02-7.14 (4H, m, Ar H), 5.21 (1H, s, CHOH), 4.35 
(1H, d, J = 18.3 Hz, COCHH), 4.24 (1H, d, J = 18.3 Hz, COCHH); 
13
C NMR (125 
MHz; CDCl3) δ: 208.6 (C=O), 138.5 (C-I), 137.0, 130.9, 128.8, 77.3 (CHOH), 65.2 
(CH2OH); m/z (HR EI-) found [M-H]
- 
290.9525. C9H8IO3 requires 290.9518. 
 
3,4-Dimethylcyclohex-3-enecarbaldehyde (122) 
 
 
 
Acrolein (1.93 mL, 29.0 mmol), 2,3-dimethyl-1,3-butadiene (1.93 mL, 17.2 mmol) 
and zinc chloride (0.10 g, 0.68 mmol) were added together in a sealed tube and 
stirred at 60 
0
C behind a blast shield for 6 hours. The reaction was then allowed to 
cool and quenched with ice. The product was extracted with diethyl ether and 
purified by flash silica chromatography (EtOAc:hexane, 1:9) to afford 122 as a 
colourless liquid (1.32 g, 56%), Rf = 0.57 (EtOAc:Hexane, 1:9). 
νmax/cm
-1
 (neat): 2923, 1720; 
1
H NMR (300 MHz; CDCl3) δ: 9.50 (1H, s, CHO), 2.30 
(1H, m, CH2CHCHO), 2.10-1.70 (6H, m, CH2CHCH2CH2), 1.60-1.40 (6H, m, 
(CH3)2); 
13
C NMR (75 MHz; CDCl3) δ: 203.8 (C=O), 125.7 (CH3C), 123.3 (CH3C), 
46.8 (CHCHO), 30.6 (CH2), 30.0 (CH2), 22.9 (CH2), 18.8 (CH3), 14.0 (CH3); m/z 
(HR CI) found [M] 138.1035. C9H14O
 
requires 138.1045 
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Rac-1,3-dihydroxyoctan-2-one (Rac-123)[26] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water (10 mL) at room temperature. 
Butanal (0.090 mL, 1.0 mmol) and N-methylmorpholine (0.110 mL, 1.0 mmol) were 
added and the pH was adjusted to 8 with hydrochloric acid (1 M). The reaction 
mixture was stirred at room temperature for 24 hours and monitored by TLC 
analysis. The crude reaction mixture was dry-loaded onto silica and purified by flash 
silica chromatography (EtOAc:hexane, 1:1) to give rac-123 as a colourless solid 
(0.080 g, 56%), Rf = 0.30 (EtOAc:hexane, 1:1). 
Characterisation data was as found for the biotransformation product (S-123). 
 
(3S)-1,3-Dihydroxyhexan-2-one (S-123)[26] 
 
 
 
The standard biotransformation procedure was performed with D469Y/R520V TK 
cell-free lysate (4 mL) and butanal (50 mM) for 48 hours. The crude reaction 
mixture was then dry-loaded onto silica and purified by flash silica chromatography 
(EtOAc:hexane, 3:7). Solvent was removed to give S-123 as a colourless oil (0.014 
g, 11%), Rf = 0.25 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3413, 2960, 2935, 2874, 1720; 
1
H NMR (600 MHz; CDCl3) δ: 4.50 
(1H, d, J = 19.3 Hz, COCHH), 4.39 (1H, d, J = 19.3 Hz, COCHH), 4.31 (1H, dd, J = 
8.0 Hz, 3.8 Hz, CHOH), 1.76 (1H, m, CH2CHH), 1.58 (1H, m, CH2CHH), 1.43 (2H, 
m, CH3CH2), 0.96 (1H, t, J = 7.1 Hz, CH3CH2); 
13
C NMR (125 MHz; CDCl3) δ: 
211.8 (C=O), 74.8 (CHOH), 65.6 (CH2OH), 36.4 (CH2CH)  18.1 (CH3CH2), 13.9 
(CH3); m/z (HR ES+) found [MH]
+
 133.0866. C6H13O3
 
requires 133.0864. 
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3-Hydroxy-2-oxohexyl benzoate (123-B) 
 
 
 
To a stirred solution of 123 (0.014 g, 0.10 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.014 mL, 0.11 mmol) and benzoyl chloride (0.021 mL, 0.11 mmol). The 
reaction was stirred at room temperature overnight and followed by TLC analysis. 
The reaction was then washed with HCl (2 M, 25 mL) and extracted with CH2Cl2 
(20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9) to give 123-B as a colourless oil (0.022 g, 
85%), Rf = 0.19 (EtOAc:hexane, 2:8). 
νmax/cm
-1
 (neat): 3480, 2960, 2925, 2854, 1724, 1275; 
1
H NMR (500 MHz; CDCl3) 
δ: 8.09 (2H, m, Ar H), 7.60 (1H, m, Ar H), 7.49 (2H, t, J = 7.8 Hz, Ar H), 5.14 (1H, 
d, J = 17.2 Hz, COCHH), 5.04 (1H, d, J = 17.2 Hz, COCHH), 4.43 (1H, dd, J = 8.1 
Hz, 3.7 Hz, CHOH), 1.66 (1H, m, CH2CHH), 1.52 (1H, m, CH2CHH), 1.43 (2H, m, 
CH3CH2), 0.96 (1H, t, J = 7.3 Hz, CH3CH2); 
13
C NMR (125 MHz; CDCl3) δ: 206.0 
(C=O), 170.1 (C=O), 133.7, 129.8 (Signals overlapping), 128.6, 74.9 (CHOH), 66.1 
(COCH2), 36.4 (CH2CH), 18.2 (CH2), 13.9 (CH3); m/z (HR ES+) found [MH]
+ 
237.1118. C13H17O4 requires 237.1126. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 3:97, 1 mL/min) gave 
retention times of 18.5 mins (R-isomer) and 20.5 mins (S-isomer). 
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Rac-1,3-dihydroxyheptan-2-one (Rac-124)[26] 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water (10 mL) at room temperature. 
Pentanal (0.106 mL, 1.0 mmol) and N-methylmorpholine (0.110 mL, 1.0 mmol) 
were added and the pH was adjusted to 8 with hydrochloric acid (1 M). The reaction 
was stirred at room temperature overnight and monitored by TLC analysis. The 
crude reaction mixture was then dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:3) to give rac-124 as a colourless solid (0.080 
mg, 48%), Rf = 0.37 (EtOAc:hexane, 1 : 1). 
Characterisation data was as found for the biotransformation product. 
 
(3S)-1,3-Dihydroxyheptan-2-one (S-124)[26] 
 
 
 
The standard biotransformation procedure was performed with D469Y/R520V TK 
cell-free lysate (2 mL) and pentanal (50 mM) for 48 hours. The crude reaction 
mixture was then purified by flash silica chromatography (EtOAc:hexane, 3:7) to 
give S-124 as a colourless oil (0.015 mg, 10%), Rf = 0.25 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3434, 3266, 2955, 1718; 
1
H NMR (500 MHz; CDCl3) δ: 4.49 (1H, 
d, J = 19.3 Hz, COCHH), 4.39 (1H, d, J = 19.3 Hz, COCHH) 4.30 (1H, dd, J = 7.9 
Hz, 3.9 Hz, CHOH), 2.96 (2H, br s, OH), 1.78 (1H, m, CH2CHH), 1.65-1.30 (5H, m, 
CH3CH2CH2CHH), 0.90 (3H, m, CH3); 
13
C NMR (150 MHz; CDCl3) δ: 211.8 
(C=O), 75.0 (CHOH), 65.6 (CH2OH), 34.0 (CH2CHOH), 29.8 (CH3CH2CH2), 26.0 
(CH3CH2), 13.9 (CH3); m/z (HR ES+) found [MH]
+ 
147.1027. C7H15O3
 
requires 
147.1021.  
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3-Hydroxy-2-oxoheptyl benzoate (124-B) 
 
 
 
To a stirred solution of 124 (0.015 g, 0.10 mmol) in CH2Cl2 (5 mL) was added 2,4,6-
collidine (0.014 mL, 0.11 mmol) and benzoyl chloride (0.021 mL, 0.11 mmol). The 
reaction was stirred at room temperature overnight and followed by TLC analysis. 
The crude reaction mixture was then washed with HCl (2 M, 25 mL) and extracted 
with CH2Cl2 (20 mL), before being dry-loaded onto silica and purified by flash silica 
chromatography (EtOAc:hexane, 1:9) to give 124-B as a colourless oil (0.020 mg, 
85%), Rf = 0.20 (EtOAc : hexane, 2 : 8)). 
νmax (neat)/cm
-1
: 3439, 2957, 2929, 2856, 1725, 1275: 
1
H NMR (600 MHz; CDCl3) 
δ: 8.10-8.01 (2H, m, Ar H), 7.61 (1H, m, Ar H), 7.48 (2H, m, Ar H), 5.13 (1H, d, J = 
17.0 Hz, COCHH), 5.03 (1H, d, J = 17.0 Hz, COCHH), 4.41 (1H, dd, J = 8.0, 3.9 Hz, 
CHOH), 3.10 (1H, s, OH), 1.80-1.70 (1H, m, CH2CH2CHH), 1.65-1.30 (5H, m, 
CH3CH2CH2CHH), 0.90 (3H, t, J = 7.2 Hz, CH3); 
13
C NMR (150 MHz; CDCl3) δ: 
206.0 (C=O), 169.8 (C=O), 133.8, 129.8 (Signals overlapping), 128.6, 75.1 (CHOH), 
66.2 (CH2), 33.8 (CH2), 27.0 (CH2), 14.0 (CH3); m/z (HR ES+) found [MH]
+ 
251.1285. C14H19O4 
 
requires 251.1283. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 3:97, 1 mL/min) gave 
retention times of 18.2 mins (R-isomer) and 20.9 mins (S-isomer). 
 
1-(3,4-Dimethylcyclohex-3-en-1-yl)-1,3-dihydroxypropan-2-
one (Rac-125) 
 
 
 
Li-HPA (0.110 g, 1.0 mmol) was dissolved in water:tetrahydrofuran, 1:1 (5 mL 
total), at room temperature. 122 (0.150 g, 1.1 mmol) and N-methylmorpholine (0.110 
mL, 1.0 mmol) were added and the pH was adjusted to 7 with hydrochloric acid (1 
M). The reaction was stirred at room temperature for 24 hours and monitored by 
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TLC analysis. The crude reaction mixture was then dry-loaded onto silica and 
purified by flash silica chromatography (EtOAc:hexane, 2:8) to give rac-125 as a 
colourless oil (0.007 g, 4 %), Rf = 0.40 (EtOAc:hexane, 1:1). 
νmax/cm
-1
 (neat): 3456, 2893, 1721; 
1
H NMR (300 MHz; CDCl3) δ: 4.60-4.30 (2H, m, 
CH2OH), 4.31-4.20 (1H, m, CHOH), 3.00-2.80 (1H, m, CHCHOH), 2.11-1.72 (6H, 
m, CH2CHCH2CH2), 1.43-1.21 (6H, m, CH3CCCH3); 
13
C NMR (75 MHz; CDCl3) δ: 
211.4 (C=O), 125.7 (CH3C), 124.6 (CH3C), 77.3 (CHOH), 66.2 (CH2OH), 38.8 
(CHCHOH), 34.4 (CH2), 31.6 (CH2), 22.9 (CH2), 19.2 (CH3), 18.8 (CH3).  
 
Biotrans-1-(3,4-dimethylcyclohex-3-en-1-yl)-1,3-
dihydroxypropan-2-one (Biotrans-125) 
 
 
 
The standard biotransformation procedure was performed with F434A TK cell-free 
lysate (2 mL) and 122 (50 mM) for 48 hours. The crude reaction mixture was then 
dry-loaded onto silica and purified by flash silica chromatography (EtOAc:hexane, 
2:8) to give biotrans-125 as a colourless oil (0.013 g, 11 %). 
Characterisation data was as found for racemic product (rac-125). 
 
4-(1,3-Dihydroxy-2-oxopropyl)benzoic acid (154)[91] 
 
 
 
The standard biotransformation procedure was performed with 
S385Y/D469T/R520Q TK cell-free lysate (2 mL) and 4-formylbenzoic acid (50 
mM) for 24 hours. The crude reaction mixture was then dry-loaded onto silica and 
purified by flash silica chromatography (CH2Cl2:MeOH, 9:1, then 8:2) to give 154 as 
a colourless oil (0.020 g, 10 %), Rf = 0.57 (CH2Cl2:MeOH, 8:2). 
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νmax/cm
-1
 (neat): 3356, 2946, 1634, 1412; 
1
H NMR (600 MHz; MeOD) δ: 8.02 (2H, 
d, J = 8.3 Hz, Ar H), 7.53 (2H, d, J = 8.3 Hz, Ar H), 5.35 (1H, s, CHOH), 4.42 (2H, 
app. t, J = 19.4 Hz, CH2OH); 
13C NMR (150 MHz; MeOD) δ: 210.7 (C=O), 193.8 
(CO2H), 144.9, 130.6 (signals overlapping), 127.8, 78.6 (CHOH), 65.9 (CH2OH); 
m/z (NSI-) 209 [M-H]
–
, 100%), 179 (15), 149 (86), 75 (47); m/z (NSI-) found [M-H]
-
 
209.0453. C10H9O5 requires 209.0455. 
 
1-(4-(Methylsulfonyl)phenyl)-2-oxopropane-1,3-diyl 
dibenzoate (159-B) 
 
 
The standard biotransformation procedure was performed with 
S385Y/D469T/R520Q TK cell-free lysate (4 mL) and 4-
(methylsulfonyl)benzaldehyde (50 mM) for 24 hours. Solvent was then removed and 
the crude product was redissolved in dichloromethane (20 mL) and 2,4,6-collidine 
(0.250 mL, 1.9 mmol) and benzoyl chloride (0.250 mL, 2.2 mmol) were added. The 
reaction was stirred at room temperature overnight and followed by TLC analysis. 
The crude reaction mixture was then washed with HCl (2 M, 50 mL) and the product 
extracted with further CH2Cl2 (20 mL), before being dry-loaded onto silica and 
purified by flash silica chromatography (EtOAc:hexane, 15:85) to give 159-B as a 
white powder (0.020 mg, 9%), Rf = 0.57 (EtOAc : hexane, 1 : 1). 
mp = 110-118 
o
C; νmax/cm
-1
 (neat): 2962, 2927, 1723, 1600; 
1
H NMR (600 MHz; 
CDCl3) δ: 8.12 (2H, d, J = 7.5 Hz, Ar H) 8.02 (4H, t, J = 8.0 Hz, Ar H), 7.76 (2H, d, 
J = 8.0 Hz, Ar H), 7.65 (1H, t, J= 7.5 Hz, Ar H), 7.60 (1H, t, J = 7.5 Hz H), 7.50 (2H, 
t, J = 8.0 Hz, Ar H), 7.45 (2H, t, J = 8.0 Hz, Ar H), 6.52 (1H, s, CHOH), 5.26 (1H, d, 
J = 17.2 Hz, COCHH), 5.13 (1H, d, J = 17.2 Hz, COCHH); 
13
C NMR (150 MHz; 
CDCl3) δ: 207.2 (C=O), 197.6 (C=O), 165.7 (C=O), 141.7, 139.1, 134.3, 133.8, 
130.1, 130.0, 128.9, 128.8, 128.7, 128.4 (signals overlapping), 78.1 (CHOH), 66.5 
216 
 
(CH2OH), 44.6 (SO2CH3); m/z (HR CI+) found [MH]
+
 453.0995. C24H20O7S 
requires 453.1008. 
HPLC analysis (Chiralpak AD column, isopropanol:hexane, 18:82, 1 mL/min) gave 
retention times of 37.8 minutes (R-isomer) and 42.2 minutes (S-isomer) 
 
(3S)-Hydroxyheptan-2-one (174) 
 
 
 
MgCl2 (0.390 mL of 100 mg/mL solution, 0.4 mmol) was added to ThDP (0.022 g, 
48 mmol) in water (10 mL) at pH 7. D469E TK cell-free lysate (2 mL) was added 
and the mixture was incubated for 20 minutes. In a separate flask, sodium pyruvate 
(0.110 g, 1.0 mmol) was dissolved in water (10 mL) with pentanal (0.106 mL, 1.0 
mmol) and the pH adjusted to 7. This was then added to the enzyme suspension and 
stirred in an autotitrator for 18 hours and the reaction was followed by TLC analysis. 
The product was then extracted with Et2O (2 x 500 mL), and the organic layer was 
dried over magnesium sulfate, filtered and then dry-loaded onto silica before being 
purified by flash silica chromatography (Et2O:pentane, 5:95) to give 174 as a pale 
green oil (0.006g, 5%), Rf = 0.20 (EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 3450, 2957, 2927, 2859, 1714; 
1
H NMR (600 MHz; CDCl3) δ: 4.19 
(1H, m, CHOH), 3.47 (1H, d, J = 4.7 Hz, CHOH), 2.20 (3H, s, COCH3), 1.84-1.25 
(6H, m, CH2CH2CH2), 0.91 (3H, t J = 7.2 Hz, CH3CH2); 
13
C NMR (150 MHz; 
CDCl3) δ: 210.2 (C=O), 77.1 (CHOH), 33.6 (CH2), 26.9 (CH2), 25.5 (CH3) 22.2 
(CH2), 15.4 (CH3), [α]
20
D = +33.3 (c 0.30, Et2O). 
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(S)-(S)-2-oxoheptan-3-yl-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate (174-B)  
 
 
 
To a stirred solution of 174 (0.006 g, 0.05 mmol) in CH2Cl2 (5 mL) was added 
triethylamine (0.020 mL, 0.14 mmol) and (R)-MTPA-Cl (0.020 mL, 0.1 mmol) and 
the reaction stirred at room temperature overnight. The crude reaction mixture was 
then dry-loaded onto silica and purified by flash silica chromatography 
(EtOAc:hexane, 5:95) to give 174-B as a colourless oil (0.001 g, 6%), Rf = 0.5 
(EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 2948, 2862, 1753, 1732; 
1
H NMR (600 MHz; CDCl3) δ: 7.64 (2H, 
m, Ar H), 7.43 (3H, m, Ar H),  5.17 (1H, dd, J = 4.53 Hz, 4.14 Hz, CHO), 3.64 (3H, 
s, OCH3), 2.21 (3H, s, (2R,5S), COCH3), 2.13 (0.04H, s,(2R,5R), COCH3), 1.79 (2H, 
m, CH2CHO) 1.24 (4H, m, CH2CH2), 0.83 (3H, t, J = 7.14 Hz, CH3CH2); 
13
C NMR 
(150 MHz; CDCl3) δ: 203.7 (C=O), 166.6 (C=O), 132.1, 129.8, 128.5, 127.6, 84.7 
(q, 
2
JCF = 22.4 Hz), 80.5 (CHO), 55.8 (OCH3) 29.8 (CH2), 27.1 (CH2), 26.6 (CH3) 
22.1 (CH2), 13.8 (CH3); 
19
F NMR (282 MHz; CDCl3)   –72.1 (CF3); m/z (HR CI+) 
found [MH]
+ 
347.1477. C17H22O4F3 requires 347.1470. 
 
(3S)-Hydroxyoctan-2-one (175) 
 
 
 
MgCl2 (0.390 mL of 100 mg/mL solution, 0.4 mmol) was added to ThDP (0.022 g, 
48 mmol) in water (10 mL) at pH 7. D469E TK cell-free lysate (2 mL) was added 
and the mixture was incubated for 20 minutes. In a separate flask, sodium pyruvate 
(0.110 g, 1.0 mmol) was dissolved in water (10 mL) with hexanal (0.122 mL, 1.0 
mmol) and the pH adjusted to 7. This was then added to the enzyme suspension and 
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stirred in an autotitrator for 18 hours and the reaction was followed by TLC analysis. 
The product was then extracted with Et2O (2 x 500 mL), and the organic layer was 
dried over magnesium sulfate, filtered and the crude product was then dry-loaded 
onto silica and purified by flash silica chromatography (Et2O:pentane, 5:95) to give 
175 as a pale green oil (0.007 g, 6%), Rf = 0.20 (EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 3449, 2956, 2926, 2858, 1716; 
1
H NMR (600 MHz; CDCl3) δ: 4.18 
(1H, m, CHOH), 3.46 (1H, d, J = 4.9 Hz, CHOH), 2.19 (3H, s, COCH3), 1.83-1.20 
(8H, m, CH2CH2CH2), 0.91 (3H, m, CH3CH2); 
13
C NMR (150 MHz; CDCl3) δ: 
210.2 (C=O), 77.2 (CHOH), 33.7 (CH2), 32.0 (CH2), 25.4 (CH3), 24.5 (CH2), 22.5 
(CH2), 14.2 (CH3), [α]
20
D = +8.5 (c 0.35, Et2O). 
 
(S)-(S)-2-oxooctan-3-yl-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate (175-B)[104] 
 
 
 
To a stirred solution of 175 (0.007 g, 0.05 mmol) in CH2Cl2 (5 mL) was added 
triethylamine (0.020 mL, 0.14 mmol) and (R)-MTPA-Cl (0.020 mL, 0.1 mmol) and 
the reaction was stirred at room temperature overnight. The crude reaction mixture 
was then dry-loaded onto silica and purified by flash silica chromatography 
(EtOAc:hexane, 5:95) to give 175-B as a colourless oil (0.001 g, 5%), Rf = 0.5 
(EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 2930, 2856, 1717, 1667; 
1
H NMR (600 MHz; CDCl3) δ: 7.65 (2H, 
m, Ar H), 7.43 (3H, m, Ar H),  5.18 (1H, dd, J = 4.6 Hz, 4.1 Hz, CHO), 3.63 (3H, s, 
CF3COCH3), 2.22 (2.95 H, s, (2R,5S), COCH3), 2.13 (0.05 H, s, (2R,5R), COCH3) 
1.83-1.05 (8H, m, (CH2)4), 0.82 (3H, m, CH3CH2); 
13
C NMR (150 MHz; CDCl3) δ: 
203.7 (C=O), 166.5 (C=O), 132.1, 129.8, 128.5, 127.4, 84.7 (q, 
2
JCF = 28.1 Hz), 80.7 
(CHOCO), 55.7 (OCH3), 31.3 (CH2), 30.0 (CH2), 25.5 (CH2), 24.8 (CH3) 22.3 
(CH2), 13.9 (CH3); m/z (HR CI+) found [MH]
+ 
361.1636. C18H23O4F3 requires 
361.1621. 
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(4S)-Hydroxyoctan-3-one (176) 
 
 
 
MgCl2 (0.390 mL of 100 mg/mL solution, 0.4 mmol) was added to ThDP (0.022 g, 
48 mmol) in water (10 mL) at pH 7.S385T/D469T/R520Q TK cell free lysate (2 mL) 
was added and the mixture was incubated for 20 minutes. In a separate flask, 2-
ketobutyric acid (0.102 g, 1.0 mmol) was dissolved in water (10 mL) with pentanal 
(0.106 mL, 1.0 mmol) and the pH adjusted to 7. This was then added to the enzyme 
suspension and stirred in an autotitrator for 18 hours and the reaction was followed 
by TLC analysis. The product was then extracted with Et2O (2 x 500 mL), and the 
organic layer was dried over magnesium sulfate, filtered and dry-loaded onto silica 
before being purified by flash silica chromatography (Et2O:pentane, 5:95) to give 
176 as a pale green oil (0.006 g, 4%), Rf = 0.21 (EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 3502, 2953, 2850, 1712; 
1
H NMR (600 MHz; CDCl3) δ: 3.80 (1H, 
m, CHOH), 3.49 (1H, s, OH), 2.49 (2H, m, COCH2), 1.83 (1H, m, CHHCHOH), 
1.54 (1H, m, CHHCHOH), 1.45-1.25 (4H, m, CH2CH2), 1.12 (3H, t, J = 7.4 Hz, 
COCH2CH3); 0.91 (3H, t, J = 7.2 Hz, CH3); 
13
C NMR (150 MHz; CDCl3) δ: 213.0 
(C=O), 76.4 (CHOH), 34.2 (CH2), 31.3 (CH2), 26.5 (CH2), 22.7 (CH2), 14.3, (CH3), 
7.6 (CH3); m/z (HR CI+) found [MH]
+ 
145.1232. C8H17O2 requires 145.1228. [α]
20
D 
= + 83.3 (c 0.15, CDCl3). 
(S)-(S)-3-oxooctan-4-yl-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate (176-B) 
 
 
 
To a stirred solution of 176 (0.006 g, 0.04 mmol) in CH2Cl2 (5 mL) was added 
triethylamine (0.020 mL, 0.14 mmol) and (R)-MTPA-Cl (0.020 mL, 0.1 mmol) and 
the reaction was stirred at room temperature overnight. The crude reaction mixture 
220 
 
was dry-loaded onto silica and purified by flash silica chromatography 
(EtOAc:hexane, 5:95) to give 176-B as a colourless oil (0.001 g, 6%), Rf = 0.52 
(EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 2938, 2857, 1753, 1715; 
1
H NMR (600 MHz; CDCl3) δ: 7.65-7.42 
(5H, m, Ar H), 5.17 (1H, m, CHCO), 3.64 (3H, s, OCH3), 2.51 (2H, m, COCH2CH3), 
1.84-1.18 (6H, m, CH2CH2CH2), 1.10 (3H, t, J = 7.3 Hz, COCH2CH3), 0.82 (3H, t, J 
= 7.0 Hz, CH3CH2); 
13
C NMR (150 MHz; CDCl3) δ: 206.5 (C=O), 166.5 (C=O), 
132.1, 129.8, 128.9, 127.6, 84.7 (q, 
2
JCF = 28.1 Hz), 80.1 (CHO), 55.8 (OCH3) 33.9, 
(CH2), 29.8 (CH2), 27.1 (CH2), 25.4 (CH2), 14.3 (CH3), 7.4 (CH3); 
19
F NMR (282 
MHz; CDCl3)   –72.1 (CF3); m/z (HR CI+) found [MH]
+ 
361.1627. C18H23F3O4 
requires 361.1633. 
 
4-hydroxynonan-3-one (177) 
 
 
 
MgCl2 (0.390 mL of 100 mg/mL solution, 0.4 mmol) was added to ThDP (0.022 g, 
48 mmol) in water (10 mL) at pH 7. D469E/R520Q TK cell free lysate (2 mL) was 
added and the mixture was incubated for 20 minutes. In a separate flask, 2-
ketobutyric acid (0.102 g, 1.0 mmol) was dissolved in water (10 mL) with hexanal 
(0.122 mL, 1.0 mmol) and the pH adjusted to 7. This was then added to the enzyme 
suspension and stirred in an autotitrator for 18 hours and the reaction was followed 
by TLC analysis. The product was then extracted with Et2O (2 x 500 mL), and the 
organic layer was dried over magnesium sulfate, filtered and dry-loaded onto silica 
before being purified by flash silica chromatography (Et2O:pentane, 5:95) to give 
177 as a pale green oil (0.013 g, 8%), Rf = 0.21 (EtOAc:hexane, 1:9). 
νmax/cm
-1
 (neat): 3451, 2932, 2860, 1712; 
1
H NMR (300 MHz; CDCl3) δ: 4.19 (1H, 
m, CHOH), 2.49 (2H, m, COCH2), 1.40-0.74 (14H, m, CH3CH2CH2CH2CH2, 
COCH2CH3); 
13
C NMR (75 MHz; CDCl3) δ: 212.9 (C=O), 76.2 (CHOH), 34.1 
(CH2), 33.8 (CH2), 31.7 (CH2), 31.1 (CH2), 24.5 (CH2), 22.3 (CH2), 7.6 (CH3); m/z 
(HR CI+) found [MH]
+ 
159.1394. C9H19O2 requires 159.1385, [α]
20
D = + 95.3 (c 
0.15, CDCl3). 
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